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ABSTRACT 
 Substituted heterocycles are common building-blocks for biologically relevant 
molecules and represent challenging synthetic targets.  Due to limited methods available 
for their preparation and derivatization, direct C–H functionalization protocols offer 
considerable advantages. Radical chemistry has shown great potential in this regard; 
however traditional approaches are unattractive due to poor selectivity and harsh reaction 
conditions. Visible light photoredox catalysis, on the other hand, is a mild alternative for 
alkyl radical generation and has proven its utility in organic synthesis. The work 
encompassed in this thesis details the efforts towards the development of practical 
photoredox-based functionalizations of heterocycles. Specific focus is placed upon 
overcoming obstacles pertaining to H-atom abstraction, back electron transfer, and redox 
strength of photocatalysts to achieve efficient C–Br bond reductions, amine oxidations, 
and C–C bond formations.  
In pursuit of these objectives, a C2-selective malonation of indoles and other 
electron-rich heteroarenes was accomplished in high yields using photocatalyst 
  
vi 
 
Ru(bpy)3Cl2, p-CH3OC6H4NPh, and blue LEDs as the light source. Use of a triarylamine 
over a trialkylamine suppressed H-atom abstraction and promoted C–C bond formation. 
Subsequent exploitation of the reductive quenching cycle of Ru(bpy)3Cl2 and use of 
Cl3CBr as an alternative oxidant led to an oxidative nucleophilic trapping of 
tetrahydroisoquinolines to provide a diverse set of analogues.  
Finally, photoredox catalysis was utilized for the creation of C–C bonds in the 
context of complex molecule synthesis. A variety of bromopyrroloindolines and indoles 
were coupled to furnish C3–C3’ and C3–C2’ bisindole alkaloids, which was successfully 
applied to the total synthesis of gliocladin C and related analogues. Moreover, fine-tuning 
of the redox cycle with photocatalyst Ir(ppy)2(dtbbpy)PF6 and LiB(cat)2 as the reductive 
quencher enabled the coupling less-reactive substrates and suppression of back electron 
transfer.  
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CHAPTER 1.  DIRECT INDOLE FUNCTIONALIZATION 
1.1 Overview 
The development of a practical synthetic route to complex alkaloids often relies 
upon the expedient generation of substituted heterocycles. Heteroaromatic molecules 
such as indoles, pyrroles, and furans are ubiquitous in nature and usually exist as densely 
functionalized core units in biologically active compounds, including natural products 
and pharmaceuticals.
1
 Due to the potentially beneficial properties exhibited by these 
molecules, much attention has been garnered by scientists in the fields of organic 
chemistry, agriculture and materials science.
2
 Representative examples of heteroaromatic 
natural products are illustrated in Figure 1.1. Indole alkaloids constitute a large class of 
complex natural products with a wide range of molecular diversity and biological 
activity. Examples include actinophyllic acid (1.02),
3
 a potential fibrinolytic agent,
4
 
vinblastine (1.04),
5
 an antitumor agent,
6
 and gliocladin C (1.05),
7
 which has shown to 
target leukemia. As a consequence, the facile preparation of this class of compounds has 
been the subject of intense focus by synthetic organic chemists.  
2 
 
 
 
Figure 1.1 Heterocycle-containing biologically active alkaloids 
After decades of guided research efforts, a number of methods have been made 
available for the synthesis of substituted heterocycles.
8
 Traditional approaches often 
utilize a stepwise sequence involving the joining of pre-functionalized building blocks 
(Figure 1.2). For example, indoles are commonly prepared from condensation/cyclization 
reactions of substituted hydrazines with aldehydes or ketones, otherwise known as the 
Fischer indole synthesis.
9
 Alternatively, nitrotoluene substrates can react with iminium 
ions or oxalates, known respectively as the Leimgruber-Batcho
10
 and Reissert
11
 indole 
syntheses. An intramolecular variant of the Reissert method has been utilized for the 
synthesis of 1.02 to prepare the functionalized indole core. Other methods involve 
reactions of substituted anilines with alkynes (Larock)
12
, nitroarenes with vinyl Grignard 
agents (Bartoli),
13
 and aryl diazonium salts with 1,3-dicarbonyl compounds (Japp-
Klingemann).
14
  
3 
 
 
 
Figure 1.2 Overview of indole syntheses 
Pyrroles can be similarly prepared utilizing a condensation/cyclization sequence. A 
widely used method is the Knorr pyrrole synthesis,
15
 which involves the condensation of 
α-amino ketones with 1,3-dicarbonyl compounds (Figure 1.3). Alternatively, the 
Hantzsch pyrrole synthesis employs α-chloro ketones with ammonia.16 Both pyrroles and 
furans may be generated using the Paal-Knorr method via the condensation of 1,4-
dicarbonyl compounds with ammonia or acid, respectively.
17
 The Paal-Knorr approach 
has been utilized in the total synthesis of streptorubin B (1.06, Figure 1.1) for the 
generation of the transannular pyrrole unit and consequently helped to establish absolute 
configuration of this complex molecule.
18
 Furans may also be prepared via the Feist-
Benary protocol, which employs an α-chloro ketone in combination with a 1,3-dicarbonyl 
compound.
19
 
4 
 
 
 
Figure 1.3 Overview of pyrrole and furan syntheses 
Despite the widespread usage of stepwise approaches to the preparation of 
substituted indoles and other heterocycles, there is also a need for alternative methods 
that allow for the direct intermolecular functionalization of an intact heterocycle (Figure 
1.4). Such transformations are advantageous given that they require fewer overall steps 
by obviating a sequential building of the desired heterocycles and enabling a more 
concise route. This could allow for coupling reactions between either highly 
functionalized fragments or readily available heterocycles in a complex setting such as a 
total synthesis.  
 
Figure 1.4 Numbering scheme for indoles, pyrroles, and furans 
Intermolecular coupling strategies are highly convergent and thus, lend a greater 
degree of synthetic applications. Methods that involve C–H substitutions are ideal since 
5 
 
 
they preclude the need to pre-functionalize or activate the heterocycle. Another key 
aspect of the development of direct intermolecular functionalization methods is the 
ability to control the regioselectivity, or in the case of nitrogen heteroaromatics, 
chemoselectivity of the transformation. For example, indoles are predisposed to reactivity 
at the C3 or N positions rather than at C2, which involves the use of more indirect means 
(vide infra). This chapter will provide an overview of selected methods that involve the 
direct C–H intermolecular functionalization of indoles with a focus on C2-selective 
methods. In general, there are three categories of transformations that will be discussed: 
(1) nucleophilic/electrophilic additions, (2) transition metal-mediated functionalizations, 
and (3) radical-mediated reactions.  
1.2 Electrophilic/Nucleophilic Additions 
Indoles 
In general, the most reactive sites on indole are found on pyrrole ring at the C3, 
C2, and N-positions (Figure 1.5). Indoles may react with both electrophilic and 
nucleophilic reagents, though given their π-excessive properties these heteroaromatic 
structures are more susceptible to electrophilic attack. For the purposes of carbon-
centered electrophilic substitution, C3 is the preferred nucleophile, though N-substitution 
may also be competitive and is usually favored in basic conditions or with harder 
electrophiles.
20
 Protonation of indole has been shown to form the 3H-indolium cation 
1.07 as the thermodynamically most stable cationic intermediate, rationalized by the 
retention of carbocyclic aromaticity as well as by the nitrogen lone pair-assisted 
6 
 
 
stabilization of charge.
21
  Indole reacts with a variety of acylating reagents at C3 
including acetic anhydride,
22
 acyl chlorides,
23
 oxalates,
24
 and Vilsmeier Haack reagents,
25
 
to name a few. Similarly, alkylation with alkynyl-,
26
 and allyl halides
27
 can lead to C–C 
bond formation at C3. Many alkylations with softer electrophiles often require the use of 
a Lewis acid. Additions onto alkenes can be accomplished under Tsuji-Trost conditions
28
 
or via conjugate additions onto α,β-unsaturated carbonyl compounds.29 
 
Figure 1.5 Summary of electrophilic indole substitution 
For C2-selective electrophilic additions, α-lithiation has traditionally been the 
preferred method for the generation of a competent nucleophile (1.08, Figure 1.6).
30
 
Metalations with strong lithium bases such as tert-butyllithium are usually directed by N-
protecting groups such as carbamates. In the case of N-unprotected indoles, deprotonation 
will first occur at the nitrogen, however in the presence of CO2 and with sequential 
additions of base, a transient lithium carbamate protecting group will form, allowing for 
7 
 
 
C2 metalation to occur (Figure 1.6, b).
31
 This dianion (1.09) can then react with a variety 
of electrophiles with concommitant collapse of the N-carbamate upon work up. For 
neutral indoles, electrophilic substitution on C2 is favored intramolecularly to make a six 
membered fused ring using C3-tethered electrophiles (Figure 1.6, c). For example, 
condensation of tryptamine (1.10) with aldehydes results in Mannich-type addition of the 
indole at C2, followed by deprotonation to form the β-carboline (1.11).32 
 
Figure 1.6 C2 electrophilic indole additions 
Nucleophilic additions onto indoles generally occur at the C2 position, but 
typically first require activation by an electrophilic reagent. Bourne et al. demonstrated a 
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protocyclization reaction of tryptophan derivative 1.12 that illustrates this behavior 
(Figure 1.7, a). Treatment of 1.12 with phosphoric acid results in protonation at the C3 
position, forming an electrophilic indolium cation 1.13 which is trapped by cyclization of 
the pendant N-nucleophile to form saturated indoline 1.14.
33
 Danishefsky has shown that 
if tryptophan 1.15 is treated with an electrophilic halogenation reagent such as tert-butyl 
hypochlorite, upon trapping of 3-chloroindolenine 1.16 with the desired nucleophile, the 
halide will eliminate to regain aromaticity (1.17).
34
 Alternatively, neutral indoles may be 
activated towards nucleophiles by the introduction of an N-alkoxy substituent as well as a 
C3 electron-withdrawing group. Somei and co-workers have utilized this substitution 
pattern to achieve C2-malonations of 1.18 under basic conditions.
35
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Figure 1.7 C2 nucleophilic additions onto indoles 
Pyrroles 
Unlike their indole counterparts, pyrroles are primarily nucleophilic at the alpha 
or C2 position and less so at the beta or C3 position (Figure 1.8).
20
 Alkylations on the 
pyrrole nitrogen are rare in its neutral form due to lack of resonance stabilization. 
However, pyrryl anions formed via deprotonation of the acidic N–H (pKa 17.5) can be 
preferentially alkylated or acylated (1.20).
36
 Acylation with acid chlorides
37
 or Vilsmeier 
Haack reagents
38
 on the neutral molecule occur sequentially at the C2-position (1.21), 
followed by the C4 position (1.22), owing to the electronic nature of the deactivated 
pyrrole. Condensations with aldehydes also occur preferentially at C2, however unless 
the pyrrole is already substituted at the other alpha position or deactivated with an 
electron withdrawing group, uncontrolled polymerization will occur.
39
 In addition, simple 
alkyl halides usually do not react with pyrroles and more activated halides result in 
polymerization. Thus, alkylations of pyrroles remain challenging by electrophilic 
substitution. Pyrroles also undergo alpha-lithiation (Figure 1.8, b) and behave in a 
manner similar to indoles.
40
 Nucleophilic attack on pyrroles at the C2 position is only 
known to occur on substrates substituted with a C2-leaving group as well as a C5-
electron withdrawing group (Figure 1.8, c).
41
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Figure 1.8 Substitutions of pyrroles and furans 
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Furans  
Furans are even less likely than indoles and pyrroles to undergo nucleophilic 
substitutions and highly favor electrophilic substitutions. The regiochemical reactivity 
profile is similar to pyrroles, with the alpha or C2-position being predisposed to 
electrophilic attack.  Acylations
42
 and condensations onto imines
43
 are readily achieved 
on furans (Figure 1.8, d). Similarly, alpha lithiations have long been used to affect C2 
alkylations with electrophiles.
44
 
1.3 Transition-Metal Mediated Methods 
Metal-catalyzed cross coupling reactions have been well developed in the context 
of sp
2
-sp
2
 bond formations, particularly with aryl, vinyl, and alkynyl halides. 
Heteroaromatics, owing to their electron-rich nature, have the potential to engage in C–C 
cross coupling reactions directly without the need to prefunctionalize through 
halogenation or lithiation. However, given the nucleophilicity of the C3 and N-positions, 
selective C2 functionalizations are challenging. This section will provide an overview of 
selected methods for the intermolecular functionalization of indoles and pyrroles at the 
C2-position. 
N-Substituted Directing Groups 
Direct C–H arylation of pyrroles and indoles with aryl iodides was pioneered in 
the group of Sames in 2006 using 5 mol% Pd(OAc)2.
45
 To make the indole more reactive 
at C2, magnesium oxide was added to form an indolyl Grignard salt and the reaction was 
heated to 150 ˚C. A number of heterocycles were functionalized using this method in 
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high yields and with excellent C2 selectivity for p-substituted arenes and moderate 
selectivities for o-substituted arenes. Later in 2008, Arrayas and Carretero developed a 
slightly milder method using N-(3-pyridyl)sulfonyl indoles as C2 directing groups with 
10 mol% of [Pd(MeCN)2Cl2] and Cu(OAc)2•H2O as the oxidant.
46
 Upon heating at 110 
˚C in dimethylacetamide, a variety of alkenes were coupled to indoles. Similar directing 
group strategies have been used for this transformation using other metals. The Fagnou 
group has disclosed the use of an N,N-dimethylcarbamoyl protecting group for the Rh
3+
 
catalyzed hydroarylation of internal alkynes.
47
 This was proposed to initiate via a 
metalation/deprotonation step. Yoshikai and Ding also reported in 2012 the use of cobalt 
catalysis at room temperature for the alkenylation of N-pyrimidylindoles with 
dialkylacetylenes.
48
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Figure 1.9 Transition metal-mediated heterocycle functionalization 
Directing Group-Free 
A non-directed C2-functionalization approach was taken by Yu and co-workers 
utilizing Ru carbene chemistry (Figure 1.10).
49
 In this case, α-diazoesters undergo 
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cyclopropanation at C2-C3 of unprotected indoles and pyrroles using [RuCl2(p-cymene)]2 
with subsequent ring-opening at C3 to provide the C2-functionalized product. The 
regioselectivity of the ring-opening event is presumably due to better resonance 
stabilization through the benzene unit. 
 
Figure 1.10 Ru carbene approach to C2 functionalization 
Advancement in palladium-catalyzed C–H functionalization has been reported by 
Bach and Jiao, in which they were able to functionalize unprotected and unactivated 
indoles with alkyl halides with excellent C2 selectivity (Figure 1.11).
50
 Key to their 
strategy was the use of norbornene as a ligand, which is able to oxidatively add a C3-
bound indolyl Pd
2+
 species across its double bond, thereby positioning the metal in the 
vicinity of the C2-position for C–H activation. This allows for the second oxidative 
addition of an alkyl halide to the C2-bound Pd
2+
 species, which then reductively 
eliminates to form the desired C2-alykylated product. Another directing group-free 
metal-catalyzed alkylation of indoles was shown using a cationic ruthenium complex by 
Yi and co-workers.
51
 This particular system was able to directly functionalize the C2-
position via dehydration of alkyl alcohols. The mechanism of the dehydration was 
proposed to operate via C-O bond cleavage by an alkenyl cationic Ru
4+
 species with 
concommitant reductive elimination of the alkyl and alkenyl substituents. 
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Figure 1.11 Alkylations of un-activated indoles 
1.4 Radical-Mediated Functionalizations 
The addition of carbon-centered radicals onto indoles and pyrroles represent yet 
another mode of direct heterocycle functionalization. One major advantage of this 
method over others is the inherent C2-regioselectivity. However, the drawbacks that 
render radical chemistry less attractive in a practical sense are usually the associated 
conditions, which are typically harsh or environmentally unfriendly. Common reactions 
for alkyl radical generation involve the use of toxic organotin initiators, expensive UV 
reactors, dangerous peroxides or triethylborane, as well as superstoichiometric amounts 
of oxidants. Given these issues, radical additions to heteroaromatics remained 
underdeveloped for several years. The following is an overview of contributions to this 
field. 
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Reductions of Organoheteroatoms 
One of the earliest reports of successful alkyl radical additions onto 
heteroaromatics utilized organo halide reduction chemistry. In this pioneering report, 
Baciocchi and co-workers were able to reductively generate electron-deficient carbon-
centered radicals from a variety of alkyl iodides using hydrogen peroxide in combination 
with Fe
2+
 in DMSO at room temperature.
52
 Results ranged from 60-66% yield for 
indoles, 55-90% for pyrroles, and 65% for furan and established the C2 regiochemical 
preference. Some limitations included the requirement of a 10-fold excess of 
heterocycle/halide to prevent overfunctionalization as well as a potential oxidative 
decomposition of less reactive substrates. Later, Byers and co-workers developed a 
protocol involving photoreduction of alkyl halides using a 450W Hanovia lamp in the 
presence of sodium thiosulfate, propylene oxide and a phase transfer agent, 
tetrabutylammonium bromide. Pyrroles and indoles were alkylated in up to 85% yield.
53
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Figure 1.12 Radical additions onto heteroaromatics via reductive dehalogenation 
Reductions of α-xanthate esters with dilauroyl peroxide (DLP) at elevated 
temperatures have also been employed for C2-alkylations of indoles, pyrroles, furans, and 
thiophenes (Figure 1.12).
54
 A method developed by Miranda and co-workers used a more 
favorable stoichiometric ratio between the heterocycle and alkylating agent (1:1.2) and 
was later applied to the synthesis of the tetracyclic core of tronocarpine (1.23).
55
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Furthermore, it demonstrated that the alkylation of C2-substitued pyrroles and furans 
occurred at the other α-position at C5. This reaction could also be performed at room 
temperature using triethylborane and iron sulfate.
56
 
 
Figure 1.13 Radical Coupling of Xanthate esters and heteroaromatics 
 Organotin reagents have been utilized to affect reductions of aryl iodides for 
intramolecular cyclizations onto indoles. An interesting report by Flanagan et al. 
showcased the dichotomy between C2 and C3 reactivity. When indole C2-tethered aryl 
iodide (1.24) was subjected to tributyltin hydride and azobisisobutyronitrile (AIBN), 
spirocycle 1.25 was formed as the major product in 55% yield (Figure 1.13).
57
 
Cyclization onto the C3-position could be biased however, with a cis alkene tether such 
as 1.26, to give benzo carbazole 1.27 in 58% yield with 26% recovered starting material. 
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Figure 1.14 Tin-based radical additions to indoles 
Oxidative Radical Additions 
Manganese(III) chemistry is well-established in the context of the oxidative 
generation of electron-deficient alkyl radicals.
58
 In particular, the single-electron oxidant 
Mn(OAc)3 has been widely used for the oxidization of 1,3-dicarbonyl compounds to 
generate alkyl radicals that have been exploited for heteroarene functionalization. 
Successful preparation of C2-functionalized heteroaromatics using this strategy has been 
achieved mostly for intramolecular malonations of N-tethered indoles and pyrroles 
(Figure 1.14).
59
 Kerr and co-workers were able to affect a C2-cyclization onto indoles to 
prepare the tetracyclic core of 1.23 as well as a similar transformation on an indoline for 
the key step in their synthesis of mersicarpine (1.28).
60
 However, intermolecular 
functionalizations with Mn(OAc)3 mostly results in over-oxidation. This will be 
discussed further in Section 3.2. 
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Figure 1.15 Mn
3+
 mediated intramolecular malonations of heteroaromatics 
Promising new alternatives to traditional methods for alkyl radical generation can 
be found in the rapidly expanding field of photoredox catalysis. Transition metal 
complexes can be selectively activated over organic molecules by an energy source and 
used to initiate a number of single electron transfer (SET) events. These complexes often 
function in a catalytic capacity at room temperature, utilize visible light, and perform 
chemoselective electron transfer reactions. The net result is the mild and selective 
formation of carbon-centered radicals that can react in a manner typical of electron-
deficient species without the negative aspects usually associated with radical chemistry. 
As this chemistry is currently under precipitous development, and is another key focus of 
the research presented herein, it will be discussed in greater detail in the following 
chapter.  
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1.5 Conclusion 
Though many methods exist for the synthesis of functionalized indoles, there are 
still several limitations and challenges to overcome with regards to generality and 
practicality.  Intermolecular functionalizations of heteroaromatic C–H bonds pose great 
advantages over stepwise syntheses of the core units. Fewer operations, better functional 
group tolerance, and higher convergence represent some of the benefits over other 
methods. However, C2 regioselectivity remains difficult for electrophilic substitution 
reactions and there are very few examples of nucleophilic additions onto indoles, 
pyrroles, and furans.  Transition metal-based C–H functionalization processes offer 
solutions to these problems with the adjustment of ligands and directing groups, but have 
yet to be tested in a more complex setting. Radical chemistry, on the other hand, has been 
implemented in total synthesis and has an intrinsic preference for C2 additions, but many 
long-established methods suffer from undesirable reaction conditions that may limit the 
generality. In this regard, the development of photoredox catalysis, which offers a milder 
and more selective route to the generation of alkyl radicals, could expand the potential of 
radical chemistry into a more viable and attractive means for heterocycle 
functionalization. 
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CHAPTER 2.  FORMATION OF C–C BONDS UTILIZING PHOTOREDOX 
CATALYSIS 
2.1 Introduction 
As discussed in the previous chapter, alkyl radicals are potentially valuable 
intermediates for the formation of C–C bonds via their distinct reactivities. Depending 
upon the reaction environment, such species can be considered either electron-deficient 
or electron-rich intermediates and thus, can be stabilized by both electron-donating and -
withdrawing groups. This property facilitates both reductive and oxidative (redox) 
transformations of organic molecules. Radical chemistry can be promoted under a variety 
of conditions that have typically entailed the use of an initiator, a light source, and/or 
high temperatures. Traditional methods have utilized initiators such as organotin 
reagents, triethylborane, and peroxides to undergo homolytic cleavage to generate the 
desired radical. The drawbacks of these methods include toxicity (Bu3SnH), explosion 
hazards (Et3B, H2O2), and the frequent requirement to use those reagents in 
stoichiometric amounts. Other methods rely upon excitation of molecules with high 
energy sources such as UV light, which can be non-selective given the UV absorbance of 
many organic functional groups, and often require expensive reactors. 
As synthetic chemists are becoming more conscious of laboratory and 
environmental hazards, new methods for alkyl radical generation are being devised that 
make use of more benign reaction conditions. Visible light-promoted photochemistry has 
been considered as an ideal alternative.
61
 Some of the most promising and commonly 
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studied visible light-active photocatalysts are metal-based polypyridyl complexes such as 
Ru(bpy)3Cl2,
62
 Ir (ppy)2(dtbbpy)PF6,
63
 Ir(dF(CF3)ppy)2(dtbbpy)PF6,
64
 and fac-Ir(ppy)3.
65
  
The redox properties of Ru(bpy)3Cl2
66
 have been well studied,
67
 often in the context of 
water splitting,
68
 photovoltaic cells,
69
 and energy storage.
70
 Redox cycles of Ru(bpy)3Cl2 
have been exploited since the 1970s for a variety of synthetic transformations,
71
 but has 
only recently achieved the general interest of chemists, resulting in an intense resurgence 
of guided research in this area. Reports have demonstrated advantages such as room 
temperature (mild) reaction conditions, chemoselectivity, and low catalyst loading. The 
following sections will provide a general overview of the major concepts of photoredox 
catalysis including the photophysical properties, mechanistic pathways, as well as 
relevant examples that pertain to C–C bond constructions. 
2.2 Photophysical properties  
The activation mechanism of polypyridyl photocatalysts are summarized in the 
generalized Jablonski diagram illustrated in Figure 2.1.  Upon visible light excitation, 
photon absorption by the ground state photocatalyst, PC (
1
A1), initiates a metal-to-ligand 
charge transfer (MLCT) to generate one of several spin-allowed high energy singlet 
excited states, PC
*
 (
1
MLCTn). With multiple excited states possible, broad spectrum 
irradiation can accomplish productive excitation of the catalyst without the need to 
irradiate at a particular wavelength. Thus, energy sources such as a light bulb and 
sunlight can be used for this purpose. Relaxation from the excited state occurs initially 
through internal conversion (kic) to the lowest spin-allowed excited state, PC
*
 (
1
MLCT1). 
This then rapidly undergoes intersystem crossing (kisc) and internal conversion to 
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generate a long-lived triplet excited state, PC
*
 (
3
MLCT1). At this point the photocatalyst 
can be exploited for bimolecular quenching reactions via electron transfer or in some 
cases, energy transfer to organic molecules. Non-productive relaxation pathways also 
exist including fluorescence (kf), phosphorescence (kp), and internal conversion. 
However, intersystem crossing to the triplet state for catalysts such as Ru(bpy)3Cl2 is so 
rapid that other pathways have a minor effect on the overall quantum yield.  
 
Figure 2.1 Generalized Jablonski diagram for photoredox catalysts 
The excited state of the photocatalyst can be considered as a single electron 
oxidation of the metal center and a single electron reduction of the ligand (Figure 2.2). 
Bimolecular quenching via single electron transfer (SET) with another molecule can 
occur either through accepting of an electron (reductive quenching) at the metal center or 
donation of an electron (oxidative quenching) by the ligand radical anion. Using 
Ru(bpy)3
2+
* as an example, reductive quenching with a suitable donor will generate 
Ru(bpy)3
+
, which is a powerful single electron reductant. Alternatively, oxidative 
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quenching with an acceptor will form Ru(bpy)3
3+
, a strong single electron oxidant. 
Representative single electron donors and acceptors are shown in Figure 2.2. Each 
quadrant of the redox cycle can be utilized to affect transformations of organic molecules 
such as reductions of C-Y bonds (Y = Cl, Br, I, O, N, P, H, and B), amine oxidations, 
enolate reductions, and homolytic cleavage of π-bonds.72  
 
Figure 2.2 Quenching pathways of Ru(bpy)3
2+
* 
 The abilities of photocatalysts to affect organic redox reactions can be evaluated 
upon certain properties such as reduction potentials, maximum absorbance, excited state 
lifetimes, quantum yields, and extinction coefficients.
73
  Furthermore, many of these 
properties can be manipulated via modification of the ligands and/or metal centers. This 
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enables chemists to fine-tune catalysts to optimize the desired type of reactivity. For 
example, when considering the reduction or oxidation strength of the photocatalyst, an 
appropriate indication is provided by the reduction potentials.  The reduction potential 
refers to the potential of the electrochemical half-reaction written in the direction where 
the more oxidized species is being reduced: 
Li+ + e− → Li, (Ered [Li
+/Li] = −3.39 V)   (1) 
There are two sets of reduction potentials
74
 associated with photocatalysts: those of the 
ground state and those of the excited state. Excited states reduction potentials cannot be 
directly measured and can be extrapolated from known ground state cyclic voltammetry 
(CV) and spectroscopic data.
75
 The excited state potentials of a catalyst are related to its 
ground state potentials by a spectroscopic parameter known as the zero-zero excitation 
energy (E0,0), which can be estimated by the emission maximum.
76
   
Since photocatalysts can perform a variety of redox transformations, fine-tuning of a 
desired photophysical property is usually accomplished through careful selection of 
metal/ligand combinations. For example, photoredox catalysts can oxidize organic 
molecules such as tertiary amines,
77
 p-methoxybenzyl ethers,
78
 and electron-rich 
styrenes
79
 (Figure 2.3). To improve the oxidizing ability of a catalyst (i.e. make the 
reduction potential more positive), use of a more electron-rich ligand will affect the 
electron density at the metal center and increase its susceptibility towards oxidation and 
decrease its susceptibility towards reduction. This explains why the oxidizing ability of 
the Ru
3+
/Ru
2+
 couple in ruthenium-based photocatalysts weakens with the use of more 
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anionic ligands. See the following trend: Ru(bpz)3
 
(+1.86 V)
80
 > Ru(bpy)3 (+1.26 V) > 
Ru(bpy)2(pz)2
 
(+0.30 V)
81
 (Figure 2.3). 
 
With iridium-based complexes, this trend is also 
observed. 
 
Figure 2.3 Effects of ligands on oxidizing power 
On the other hand, for the reduction of organic compounds such as alkyl halides, use 
of more electron-rich ligands will improve the reducing strength of the catalyst with a 
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more negative reduction potential. Based on this behavior, the reduction potential of the 
Ru
2+
/ Ru
+
 couple of photocatalysts with more electron-poor ligands is weaker than those 
with more electron-rich ligands. For comparison: Ru(dmb)3
+
 (-1.45 V)
82
 > Ru(bpy)3
2+
 (-
1.35 V) > mer-Ru(4-O2N-bpy)3
2+
 (-0.63 V) (Figure 2.4). The relative reduction potentials 
of the alkyl halides can also be used to select the appropriate catalyst. For example, aryl 
and alkyl iodides are typically more difficult to reduce than polyhalomethanes and would 
require a stronger reductant such as fac-Ir(ppy)3.
83
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Figure 2.4 Effect of ligands on reduction potential 
 Changing the metal can also affect the redox potentials of photocatalysts. Iridium-
based complexes usually have larger Stokes shifts compared to ruthenium-based 
complexes, which means a larger E0,0 term. This causes them to be stronger ground state 
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and excited state oxidants and reductants. For example, Ru(bpy)3
2+
 has an observed 
Stokes shift of 205 nm at 400 nm, while Ir(ppy)2(dtbbpy)
+
 has an observed Stokes shift of 
181 nm at the same wavelength of irradiation.
84
  
For a productive photoredox cycle, quenching of the catalyst excited state and 
subsequent regeneration of catalyst must occur via outer sphere electron transfers. 
However, there are certain kinetic barriers that must be overcome for a successful cycle. 
Using the reductive quenching cycle as an example, the reaction begins with visible light 
excitation of the photocatalyst to generate *PC (Figure 2.5). Non-productive radiationless 
decay or decay in the form of light or heat can also occur at this point. Otherwise, 
association of the quencher (Q) with PC* forms a solvated precursor complex (A). 
Electron transfer from the quencher (ket) to the metal center of the photocatalyst then 
forms the successor complex B. This successor complex is comprised of an oxidized 
quencher (Q
+
) and a reduced photocatalyst species (PC
–
). A reorganization of the two 
species in the solvent cage can occur such that the quencher cation aligns with the anionic 
ligand of the photocatalyst (C), resulting in charge recombination, also known as back 
electron transfer (kbt). This non-productive process simply regenerates the quencher and 
photocatalyst. However, a successful reaction coordinate depends upon solvent cage 
escape (kce) of the quenching products of B, to give the desired species PC
–
 and Q
+
. 
Subsequent outer sphere electron transfers to regenerate the ground state photocatalyst 
(PC
–
 → PC) depend upon similar association and solvent cage escape events. 
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Figure 2.5 Productive and non-productive pathways of the photocatalysts 
Since electron transfer events within the solvent cage are much faster than events 
that occur outside, parameters that influence association and cage escape yield become 
important for overcoming non-productive pathways. Solvent cage escape yields (ηce) are 
dependent upon the relative rates of each process, particularly back electron transfer, and 
can be summarized by the following relationship: ηce = kce/(kce + kbt). Factors such as 
ionic strength and pH of the solution, encounter distance, temperature, bulk viscosity, and 
bulk dielectric constant can have an effect on ηce. For example, in the quenching of 
Ru(bpy)3
2+
* with methyl viologen (MV
2+
),  ηce was found to decrease with higher ionic 
strength.
85
 Furthermore, increased solvent polarity has also been proposed to improve 
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reaction efficiencies of Ru
2+
*.
86
  Therefore, it can be concluded that better solvation of 
electron transfer products of B enhances ηce 
   
2.3 Synthetic Applications 
 Photoredox catalysis has been utilized in organic synthesis since the early 1970’s 
for a variety of transformations. The following section will provide a brief overview of 
contributions to the field, mostly pertaining to the formation of C–C bonds.  Early work 
was largely focused on the reductions of carbon-sulfur,
87
 -phosphorus, -nitrogen,
88
 and -
halide
89
 bonds to the corresponding hydrocarbon. Pioneering studies towards C–C bond 
formation were reported by Cano-Yelo and Deronzier in 1984, in which Ru(bpy)3Cl2 was 
used to affect a photocatalytic Pschorr reaction to make phenanthrenes.
90
 In this case, the 
oxidative quenching cycle of the photocatalyst was accessed via direct reduction of an 
aryl diazonium salt by Ru(bpy)3
2+
*. Reductive quenching conditions have been utilized 
by Okada and Oda for radical decarboxylation of N-(acyloxy)phthalimides in the 
presence of Ru(bpy)3Cl2, 1-benzyl-1,4-dihydronicotinimide (BNAH), and light to 
generate alkyl radicals that react with α,β-unsaturated ketones to form β-alkylated 
products.
91
 In addition to reduction of C–Y bonds, Ru(bpy)3Cl2 can also perform direct 
oxidations of phenols to generate cross-linked proteins. In 1999, Kodadek and Fancy 
showed that in the presence of Ru(bpy)3
3+
nearby tyrosine residues oxidize and combine 
rapidly (~0.5 s) to form the bis(phenol) linked protein in good yield.
92
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Figure 2.6 Early examples of photoredox-mediated C–C bond formations 
  In 2008, Nicewicz and MacMillan developed a catalytic enantioselective 
alkylation of aldehydes with alkyl halides by merging photoredox catalysis with 
organocatalysis.
93
 A general mechanism is depicted in Figure 2.6. This dual catalytic 
system has also been implemented for the asymmetric α-trifluoromethylation94 and α-
benzylation
95
 of aldehydes in high yields and enantioselectivity. Gagné and co-workers 
demonstrated the reduction of glycosyl halides to α-oxy radicals using the reductive 
quenching cycle of Ru(bpy)3(BF4)2.  Addition of the radical onto electron-deficient 
alkenes will form exclusively the α-substituted product in high yields.86 
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Figure 2.7 Reductions of C–Br bonds and radical additions onto π-systems 
 Yoon and co-workers have reported the reduction of aryl bis-enones to the radical 
anion species by Ru(bpy)3
+
 under reductive quenching conditions of Ru(bpy)3
2+*
 with 
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Ru(bpy)3Cl2,
  
iPr2NEt, and LiBr as a Lewis acid using a flood lamp or under ambient 
sunlight (eq. 2).
96
 This process was shown to initiate both intra- and intermolecular 
formal [2+2] cycloadditions of symmetric and unsymmetrical
97
 enones in high 
diastereomeric ratio (dr) and yield. 
 
 Iridium-based photocatalysts have also demonstrated utility for C–C bond 
constructions, particularly through the oxidative quenching pathway. For example, 
fluorinated iridium catalyst Ir(dF(CF3)ppy)2(dtbbpy)PF6 has a much greater reducing 
ability of its excited state (Ered (Ir
3+
*
/4+
) = -1.21 V vs. SCE) compared with Ru(bpy)3
2+
* 
(Ered  = -0.86 V). This catalyst has been used by the Stephenson group for atom transfer 
radical additions (ATRA) of alkyl halides onto un-activated olefins in excellent yields 
(eq. 3).
98
 
 
2.3 Conclusion  
 Photoredox catalysis is a potentially powerful method to mildly access organic 
radical species and form new C–C bonds. Traditional methods that rely on stronger redox 
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agents are often plagued by explosion and environmental hazards, lack of 
chemoselectivity and control of oxidation state, functional group intolerance, as well as 
formation of toxic byproducts. In contrast, metal-based polypyridyl photocatalysts are 
activated by ambient light at room temperature, are considerably less toxic or harmful to 
the environment, and can be utilized in sub-stoichiometric amounts. Furthermore, there is 
a greater degree of control and chemoselectivity exhibited by these photocatalyst, which 
can be attributed to tunable redox properties. The following chapters will demonstrate 
these advantages, particularly in the context of heterocycle functionalization and total 
synthesis.  
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CHAPTER 3.  INTERMOLECULAR RADICAL ALKYLATIONS OF 
ELECTRON-RICH HETEROCYCLES 
 
3.1 Background  
The goal of developing practical means for direct heterocycle functionalization 
came about during the pursuit of the synthesis of indole alkaloid natural products. In the 
context of total synthesis, the development of direct indole C–H functionalization 
methods can be valuable in terms of step economy as well as fragment coupling 
convergence. The ability to take readily or commercially available heterocycles and join 
them in a single operation to highly functionalized fragments can rapidly generate 
molecular complexity and reshape a synthetic strategy. Conversely, the joining of simple 
fragments to polysubstituted heterocycles can also lead to diversity oriented synthesis and 
analogue generation (see Chapter 5).  
Research efforts were initially geared towards a practical synthesis of complex 
indole alkaloid actinophyllic acid, a natural product shown to be a potent inhibitor of 
carboxy peptidase U (IC50 0.84 µm).
3
 Such inhibitors have been implicated as fibrinolytic 
agents.
4
 In addition to its biological activity, this compound has an interesting structural 
architecture, including an 1-azabicyclo[4.4.2]dodecane and 1-azabicyclo[4.2.1]nonane  
ring system. A proposal for a total synthesis of this molecule is illustrated in Scheme 3.1. 
Compound 3.01 was identified as the key intermediate and could be further disconnected 
into two simpler units, 2-malonyl-3-formylindole (3.02) and an eight-membered azocine 
(3.03). This proposal depended upon the union of the malonate CH with the azocine α-
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carbonyl carbon, which would then potentially allow for an intramolecular condensation 
of the secondary amine onto the aldehyde, followed by a transannular Mannich reaction 
to access intermediate 3.01. 
 
Scheme 3.1 Synthetic proposal for actinophyllic acid 
During the course of this investigation, an elegant synthesis of actinophyllic acid 
was published by the Overman group in which they also accessed 3.01 as their key 
intermediate via an aza-Cope-Mannich sequence.
99
 This was derived in four subsequent 
steps to the natural product. From this point onwards, the research focus shifted to the 
development of a practical method for generating malonated indoles, such as intermediate 
3.02. In general, malonates are extremely versatile structural units since they can be 
further manipulated through a number of different reactions, including carbonyl 
additions, reductions, Michael reactions, and Aldol condensations. Interestingly, 
Overman and co-workers accessed C2-malonated indole 3.05 as an early intermediate in 
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their synthetic route (Scheme 3.2). For the synthesis of this compound, the authors opted 
to follow a modified Reissert indole synthesis in two steps beginning from 3.04. 
However, a more direct route to malonated indoles could eventually broaden the scope of 
heteroaromatic fragment coupling in the context of total synthesis. 
 
Scheme 3.2 Overman’s route to indole-2-malonate 
As discussed in sections 1.2–1.4, there are many processes available to 
accomplish intermolecular C2 and C3 substitutions of heteroaromatics, including 
nucleophilic and electrophilic substitutions, transition metal-mediated transformations, 
and radical-based additions. For complex fragment couplings, radical chemistry has 
already proven its utility in the setting of total synthesis. An interesting example of a 
proposed radical-mediated intermolecular indole coupling in a total synthesis was 
reported by Baran and Richter for the syntheses of natural products (+)-hapalindole U 
(3.10) and (-)-12-epi-fischerindole U isothiocyanate (3.11).
100
 In their work, they treat a 
mixture of unsubstituted indole and carvone (3.06) with copper(II)2-ethylhexanoate 
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under basic conditions to form coupled compound 3.09 in 53% yield. The result of the 
reaction is formation of a C–C bond between the ketone α-position and the indole C3-
position.  The suggested mechanism involves initial deprotonation of the indole and 
carbonyl partners, followed by oxidation of both anions by Cu
2+
 to form radicals 3.07 and 
3.08, respectively. The authors then propose dimerization by radical combination to form 
the observed product 3.09. Another possibility is addition of the C3-indolyl radical to the 
enolate followed by oxidation. Nevertheless, the direct oxidation of the heterocycle anion 
to form the 3-indolyl radical species 3.07 likely explains the regioselectivity of the 
coupling reaction. This is mechanistically distinct from additions of alkyl radicals onto 
neutral indoles, in which addition occurs at the C2-position. With the formation of 3.09, 
Baran and Richter were able to carry this highly functionalized indole intermediate on to 
both (+)-hapalindole Q (3.10) and (-)-12-epi-fischerindole U isothiocyanate (3.11) in just 
4 to 5 subsequent steps. In addition, other carbonyl substrates were coupled to indole 
using this method such as chromanone, a steroid, and Evans and Oppolzer auxiliary-
appended amides in 30-54% yields. 
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Figure 3.1 Baran’s oxidative coupling of enolates (top) and synthetic applications 
(bottom) 
Baran and co-workers were also able to use the same conditions to effect 
intermolecular pyrrole C2-functionalizations (Figure 3.2).
101
 Several experimental 
observations from this work led the authors to propose a rationale for the observed C2 
selectivity of 3.12 involving an N-Cu
2+
 chelated intermediate. They also suggested that a 
similar mechanism may be operative for the analogous reactions with indoles depicted in 
Figure 3.1. Interestingly, these conditions were unable to carry out intramolecular pyrrole 
alkylations, lending more support to the chelate model. For the purposes of the 
intramolecular annulations, the authors instead found that ferrocenium 
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hexafluorophosphate could affect enolate oxidation of chiral sultam-tethered pyrrole 
3.13, followed by radical cyclization to form a bicyclic pyrrole en route to ketorolac 3.14. 
However, these conditions could not be used to achieve the intermolecular couplings.  
 
Figure 3.2 Baran’s oxidative pyrrole functionalizations 
 Similar to the limitations of Baran’s Fe2+ annulation chemistry, use of the single 
electron oxidant Mn(OAc)3 has been successful for intramolecular C2-malonations of 
indoles, as reported by Kerr and co-workers (Section 1.4). However, it was typically 
more successful for intermolecular reactions. Chuang and co-workers had explored the 
coupling of N-protected indoles with malonates using Mn(OAc)3 (Figure 3.3).
102
 Rather 
than the C2-malonated indole, the authors unexpectedly observed formation of 3-
oxoindolin-2-ylidene 3.15. This was apparently the result of uncontrollable benzylic 
oxidation by excess reagent. Over-oxidation was also observed with reactions of 2-
nitroindoles under the same conditions as reported by Gribble and co-workers, in which 
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they obtained the corresponding 2-oxoindolin-3-ylidene 3.16.
103
 Once again, over-
oxidation occurred at the α-amino carbon, followed by Nef hydrolysis of the 2-nitro 
group. Interestingly, no reaction was observed with 3-nitroindoles. The authors suggested 
that this regioisomer poorly stabilizes the intermediate adduct radical. 
 
Figure 3.3 Mn
3+
-mediated intermolecular indole functionalization 
3.2 Results and Discussion: Mn
3+
 Mediated Functionalization of Indoles 
Given the literature precedence involving Mn
3+
-mediated indole malonations, it 
seemed that the results might be dependent upon the substitution pattern of the indole. 
Thus, these conditions were investigated further, presuming that the degree of oxidation 
might be controlled by the heteroarene electronics. The initial goal was to investigate the 
reaction of 3-formylindole 3.17 given its potential utility for actinophyllic acid. 
Accordingly, treatment of 3.17 with 2 equiv. of dimethyl malonate (3.18) and 6 equiv. of 
Mn(OAc)3 resulted in the formation of compound 3.19, with incorporation of acetate, as 
the major product in 38% yield without any detectable traces of 3.20 (Scheme 3.3).
104
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Despite over-oxidation, compound 3.19 could potentially be synthetically useful and 
efforts were garnered to optimize this transformation. Different solvents (MeOH, DMF, 
TFA), concentrations, temperatures, order of substrate addition, as well as the use of a 
copper(II) co-oxidant were screened;
105
 however, all attempts failed to significantly 
improve overall yield. 
 
Scheme 3.3 Oxidative malonation of indole-3-carboxaldehyde  
Best results were obtained from slow and simultaneous addition of substrates 3.17 
and 3.18 over a period of 4-6 hours to a slurry of 6 equiv. of Mn(OAc)3 in acetic acid at 
85 °C. Full conversion of the indole starting material is observed after an additional 12 
hours of stirring; however, some undesirable byproducts such as malonate dimers are also 
observed. A proposed mechanism for the formation of 3.19 is illustrated in Scheme 3.4. 
One electron oxidation of the malonyl Mn
3+
 enolate 3.21 generates a stabilized radical 
(3.22) that then adds across 3.17 to form an adduct radical (3.23), which is subject to an 
additional oxidation by another equivalent of Mn
3+
. Deprotonation by acetate provides 
the desired product of this reaction (3.20). However, upon enolization of 3.25, two Mn
3+
 
oxidation steps take place rapidly to produce a benzylic cation that will get trapped by 
acetate to form 3.19. Based on this mechanistic proposal, at least four equivalents of 
Mn(OAc)3 are necessary. 
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Scheme 3.4 Proposed mechanism for Mn
3+
-mediated Malonation of indoles 
In order to explore the scope of indole substitution, the same conditions were 
applied to substituted indole-3-carboxaldehydes (Table 3.1, entries 1, 2, 7), 3-
acetylindole (entry 3), and methyl indole 3- and 2-carboxylates (entries 4-6).
104
 In 
general, yields were low with either electron-rich or poor substituents and over-oxidation 
was always observed. Interestingly, TIPS protection of the indole nitrogen only resulted 
in deprotection. The best results were obtained with methyl indole-3-carboxylate (3.28), 
giving a significantly improved yield of 83% for coupled compound 3.29. The scope of 
dicarbonyl compound was also explored by reacting 3.17 with dimethyl methyl malonate, 
providing compound 3.35 in 52% yield.  
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Table 3.1 Mn
3+
 Coupling substrate scope 
 
With the rapid oxidation of the indolyl malonate 3.20, trapping by other 
nucleophiles was investigated to determine whether it was possible to outcompete 
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acetoxylation. Accordingly, this possibilty was tested on indole-3-carboxylic acid 3.37, 
which contains a pendant nucleophile that might trap to form lactone 3.38 (Scheme 3.5). 
Surprisingly, upon the reaction of 3.37 and malonate 3.18 in the presence of Mn(OAc)3, 
no traces of cyclized product were detected and instead 3-oxoindole-2-ylidene 3.39 was 
obtained in 40%.  
 
Scheme 3.5 Formation of 3-oxoindole-2-ylidene 
A proposed mechanism is illustrated in Scheme 3.6. The reaction of 3.37 and 3.18 
should first give 3.40, as expected, with acetate incorporation at the benzylic carbon. 
Formal [1,3]-acetate migration can occur via nitrogen lone pair-assisted elimination to 
form the indolium cation A, followed by acetate reincorporation at the indole 3-position, 
providing intermediate B. At this stage, the carboxylic acid moiety of B is uniquely 
poised to undergo decarboxylation via a retro-ene reaction that leads to 3-acetoxyindole 
intermediate C. Under these conditions, intermediate C is sequentially oxidized to give 
the acetyl oxocarbenium E, which is subject to hydrolysis to form product 3.39. 
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Scheme 3.6 Proposed mechanism for 3-oxoindole-2-ylidene formation 
In addition to indoles, 7-azaindole
106
 was transformed to the corresponding 3-
oxazaindol-2-ylidene (3.41) upon reaction with 3.18 in the presence of Mn(OAc)3 (eq. 
1).These results are similar to the results of Chuang and co-workers for the malonation of 
2,3-unsubstituted indoles, for which they obtained 3-oxoindol-2-ylidenes, such as 3.15. 
 
3.3 Results and Discussion: Visible Light-Mediated Malonation of Heterocycles 
With the disappointing results of the Mn
3+
-mediated indole malonations, an 
alternative means of generating alkyl radicals was then sought after. Photoredox catalysis 
had been gaining attention from the synthetic community, particularly from the groups of 
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MacMillan
93–95
 and Yoon,
96,97
 for the mild and chemoselective ability to generate carbon-
centered radicals. There are significant advantages of this method over Mn
3+
 methods, 
particularly with regards to catalytic activity and milder reaction conditions. 
Superstoichiometric amounts of Mn(OAc)3 (6 equiv) were required for the malonation 
reactions, which were carried out in hot acetic acid and thus limited the substrate scope 
due to poor functional group tolerance.   On the other hand, photoredox catalysis is 
typically performed with <5 mol% of the catalyst and under ambient conditions. 
Early exploration of the reductive quenching cycle of photocatalyst Ru(bpy)3Cl2 
by our group was conducted on dehalogenation reactions of activated alkyl halides.
107
 In 
that study, the authors determined that the tertiary amine reductive quencher (iPr2NEt) 
and formic acid were a major hydrogen atom source. The subsequent investigation tested 
the feasibility of C–C bond formation over hydrogen atom abstraction with the 
intramolecular cyclization of bromomalonate-tethered indoles and pyrroles (Figure 3.4). 
Excellent results were obtained for the formation of six-membered rings in the presence 
of Ru(bpy)3Cl2 (1 mol%) and  Et3N (2 equiv) under visible light irradiation using a 
compact fluorescent light (CFL) bulb. 
77
 Interestingly, for less reactive substrates such as 
3.42, a number of side products were observed. In addition to the isolation of desired 
product 3.43 in 22% yield, reductive dehalogenation product 3.44 as well as acetaldehyde 
product 3.45 were also obtained in 32 and 20 % yields, respectively. 
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Figure 3.4 Photoredox-mediated intramolecular functionalization of indoles 
 From the analysis of these results, it was apparent that the triethylamine was 
responsible for the observed side reactions. Quenching of excited state Ru(bpy)3
2+
* by 
single electron donation by Et3N, results in the generation of Ru(bpy)3
+
 as well as an 
amine radical cation (3.46, Figure 3.5). The amine radical cation has a weakened α-C–H 
bond relative to the neutral species and can be readily abstracted by the in situ generated 
alkyl radical (3.47) to form the product of reductive dehalogenation (3.44). This will also 
generate the corresponding iminium ion or enamine tautomer, which are also highly 
reactive and can be intercepted by another equivalent of alkyl radical. Hydrolysis upon 
work-up leads to observed acetaldehyde product 3.45. 
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Figure 3.5 Alternative reaction pathways for amine radical cations 
Reaction Optimization and Mechanistic Analysis
108
 
Despite the problems associated with trialkyl amines, they remain attractive as 
quenchers given their ease of oxidation, commercial availability, and low cost. Thus, 
Et3N (Ered = +0.73 V vs SCE)
109
 was initially chosen to gauge the viability of the 
intermolecular malonation of indoles. Screening began with the alkylation of 1-
methylindole (3.46) with diethyl bromomalonate (3.47) in the presence of Ru(bpy)3Cl2 
(2.5 mol%) and Et3N (2 equiv) in DMF under visible light irradiation. Only 25% isolated 
yield of coupled product was obtained after 24 h and an excess of the indole substrate 
was required in order to bias C–C bond formation over H-atom abstraction (Table 3.2, 
entry 1). Given these unsatisfactory results, attention was focused upon alternative 
quenchers. Triaryl amines, while typically possessing higher redox potentials relative to 
trialkyl amines, have the advantage of lacking α-C–H bonds that could be competitively 
abstracted. However, when Et3N was replaced with triphenylamine (Ered(Ph3N)= +0.92 V 
vs SCE)
110
 in the reaction of 3.46 with 3.47, no conversion of starting materials was 
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observed (entry 2). Further optimization with electron rich 4-methoxy N,N-
diphenylaniline (3.49, p-CH3OC6H4NPh, Ered = +0.76 V vs SCE)
110
 led to significantly 
enhanced results. Under the new conditions, a more favorable reagent stoichiometry 
could be employed in which the indole was the limiting substrate and the catalyst loading 
was dropped to just 1 mol%. Furthermore, use of blue LEDs as the light source greatly 
accelerated the rate of the reaction, which was complete within 6 h to give the desired 
product in 82% yield (entry 3). This compares to over 5 d required for the same 
conditions using a CFL. The rate acceleration is explained by the complimentary overlap 
of the emission maximum of the blue LEDs (435 nm  ± 15 nm at half-maximum 
intensity) with the absorption max of the Ru(bpy)3Cl2 catalyst (~452 nm). 
Table 3.2 Optimization of intermolecular indole malonation 
 
Entry Conditions Yield 3.48 
1 Ru(bpy)3Cl2 (2.5 mol%), Et3N (2 equiv), DMF, CFL, 24 h 25% 
2 Ru(bpy)3Cl2 (2.5 mol%), Ph3N (2 equiv), DMF, CFL, 24 h N.R. 
3 Ru(bpy)3Cl2 (1 mol%), 3.49 (2 equiv), DMF, blue LEDs, 6 h 82% 
 
 The proposed mechanism of this transformation is illustrated in Scheme 
3.6. First, visible light irradiation produces excited state Ru(bpy)3
2+
*, which is reduced by 
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the triaryl amine to produce Ru(bpy)3
+
 and the amine radical cation. A single electron 
transfer (SET) by Ru(bpy)3
+
 to the activated C–Br bond forms the carbon-centered 
radical and regenerates ground state Ru(bpy)3
2+
. The malonyl radical then adds across the 
indole π-system preferentially at the C2-position to form a stabilized benzylic adduct 
radical. This species is then oxidized to a benzylic cation followed by a subsequent re-
aromatization to form product. The oxidation of the adduct radical can be accomplished 
by a few possible mechanisms. For example, excited-state Ru(bpy)3
2+
* can accept this 
electron to form Ru(bpy)3
+
 and the benzylic cation or a radical-chain transfer mechanism 
could be operative in which the benzylic radical abstracts a bromide to form the alkyl 
radical species and a bromoindoline that eventually eliminates to the indole. However, it 
is also possible that adventitious oxygen or triaryl ammonium radical cation could be 
responsible for the oxidation. 
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Scheme 3.7 Proposed Mechanism  
Control reactions were run in support of the proposed mechanism. No reactivity 
was observed in the absence of light or catalyst. Luminescence quenching studies were 
performed to lend additional substantiation to the proposed catalytic cycle. These studies 
were performed by measuring the intensity of emission of solutions of the photocatalysts 
with varying concentrations of tested quencher. Results revealed that the triaryl amine, p-
CH3OC6H4NPh was the only component in this reaction that was observed to quench 
excited state Ru(bpy)3
2+
* (Figure 3.6). The lack of quenching by the diethyl 
bromomalonate precludes an oxidative quenching pathway to form Ru(bpy)3
3+
 and 
instead supports reduction of the C–Br bond by Ru(bpy)3
+
. Similarly, lack of quenching 
by the indole substrate also excludes a direct oxidation of the heteroarene that was seen in 
Baran’s Cu(II)-mediated indole functionalization.100 
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Figure 3.6 Luminesce quenching of Ru(bpy)3
2+
* 
Substrate Scope 
 Upon optimization of the reaction, the substrate scope with respect to the 
heteroarene was explored (Table 3.3). A variety of N-protected and unprotected indoles 
underwent alkylation in good to excellent yields at the C2-position preferentially. Both 
electron-rich (3.50) and poor (3.52) substituents on the indole provided good results. 
Substitution at the C3-position occurred in the case of a C2-blocking group (3.53, 92%).  
Table 3.3 Photoredox indole malonations 
56 
 
 
 
Sensitive functional groups were then tested under these conditions. Based on the 
proposed mechanism, HBr may be generated during the course of the reaction, which 
could be detrimental to acid-labile carbamates, such as N-Boc-tryptamine 3.56a (Table 
3.4). Despite this, malonation product 3.57 was isolated in 85% yield. The reaction was 
also scalable, as the coupling of 3.56a with 3.47 on a 2.0 mmol scale smoothly converted 
to the desired product 3.57 in 73% yield. Coupling of Bis-Boc protected tryptamine 3.56b 
exhibited no change in efficiency or yield under these conditions. In addition to 
carbamates, other potentially sensitive functional groups were well tolerated under the 
photoredox conditions, including enantiopure amino acid derivatives. Boc-tryptophan 
57 
 
 
methyl ester (3.59a, Table 3.4), diketopiperazine 3.62, and dipeptide 3.64 underwent 
alkylation in 77% (3.60), 70% (3.63), and 67% yield (3.65), respectively, without any 
observed decomposition or epimerization. However, Boc-tryptophan (3.59b), with a free 
carboxylic acid, underwent malonation in only 40% yield (3.61, based on recovered 
starting material).  
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Table 3.4 Photoredox indole malonations continued 
 
The chemoselectivity of the photocatalytic reduction was tested on bromo 
substituted indoles. Selectivity for the reduction of diethyl bromomalonate was excellent 
with these conditions, as the catalyst preferentially reduced 3.49 in the presence of aryl 
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bromides (3.66 → 3.67, 91%, Figure 3.7) and primary alkyl bromides (3.68 → 3.69, 
76%).  
 
Figure 3.7 Demonstration of chemoselectivity 
In addition to indoles, other heterocycles could be alkylated as well. 3-Acetyl-1-
methylpyrrole reacted to form C2-substituted product 3.71 (Table 3.5, 72%). In the case 
of 2-ethylpyrrole, C5-substituted product 3.73 was produced in 78% yield. Direct 
functionalization of furan was also accomplished, providing 3.75 in 68% yield. Even 5-
bromoazaindole underwent functionalization, albeit in low yield (3.77, 49%).  
 
 
 
 
 
 
 
 
 
60 
 
 
Table 3.5 Photoredox malonation of heterocycles 
 
  The limitations of this transformation were probed by screening different alkyl 
bromides. Surprisingly, when methyl α-bromophenylacetate (3.78) was subjected to the 
optimized conditions with 3.46, no reaction was observed and starting material was 
recovered (Figure 3.8, a). The inability of 3.78 to undergo reduction was counterintuitive 
to the trends observed in the reductive dehalogenation study, in which similarly activated 
alkyl halides were reduced by Ru(bpy)3
+
. With the major differences between these 
studies being the reductive quencher and termination event, this led to a re-evaluation of 
the catalytic cycle and possible non-productive pathways.  It was speculated that the 
triaryl amine radical cation could competitively undergo a back electron transfer
111
 from 
Ru(bpy)3
+
 to regenerate Ru(bpy)3
2+
 and the neutral amine species. Therefore, reduction of 
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3.80 by Ru(bpy)3
+
 is faster than the corresponding reduction of 3.78, which halts the 
progression of the forward reaction to generate desired product 3.79. 
 
Figure 3.8 Photoreduction of alkyl bromides vs. back electron transfer 
 If back electron transfer were responsible for the lack of reactivity of 3.78, it was 
presumed that a more electron-rich quencher would disfavor this process and that 
reduction of the alkyl bromide should take place. To test this hypothesis, bis-methoxy 
triaryl amine 3.81 was prepared and tested in the coupling reaction of 3.46 with 3.78 in 
the presence of Ru(bpy)3Cl2 (Figure 3.8, b). Indeed, reduction of 3.78 was observed, 
however the electron-deficient radical preferentially added to the highly nucleophilic 
aniline quencher over the indole substrate, producing 3.82 among other alkylation 
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products, with no traces of desired product 3.79. Despite the undesired reactivity, this 
experiment supported the possibility of back electron transfer as a competitive non-
productive pathway in photoredox C–C bond forming reactions. Moreover, it 
demonstrated that the outcome of photoredox cycles can be affected by altering the 
electronic properties of reagents. 
3.4 Conclusion  
The direct functionalization of indoles and other heterocycles was explored under 
two separate radical-based conditions and produced very different results. Under 
oxidative conditions using Mn(OAc)3, C2-coupled compounds were produced in low 
yields with over-oxidation occurring in all substrates that contained additional activated 
C–H bonds. In addition, superstoichiometric amounts of Mn3+ were required and 
conditions were not amenable to a broad variety of functional groups on the heteroarene. 
Substrates required a C3- or C2-electron withdrawing substituent in order to prevent 
oxidation of the five-membered ring. In contrast, use of photoredox catalysis led to more 
optimal results. Low catalyst loading, mild conditions, room temperature reactions, 
chemoselectivity, scalability, and high functional group tolerance highlights some of the 
many benefits of photoredox catalysis over Mn
3+
 oxidation. Results compare favorably to 
other direct functionalization techniques, including radical-based as well as transition 
metal-based methods. The use of p-CH3OC6H4NPh (3.49) as a reductive quencher for this 
reaction, while imposing some challenges with regards to non-productive back electron 
transfer, was able to resolve issues attributed to trialkylamine quenchers and showcases 
the ability to fine-tune photocatalytic cycles.   
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3.5 Experimental Section. 
General Information: All reactions were performed using common dry, inert 
atmosphere techniques. Reactions were monitored by TLC and visualized by a dual short 
wave/long wave UV lamp and stained with an ethanolic solution of potassium 
permanganate or p-anisaldehyde. Column flash chromatography was performed using 
230-400 mesh silica gel. NMR spectra were recorded on Varian Mercury 300, Varian 
Unity Plus 400, and Varian Mercury 400 spectrometers. Chemical shifts for 
1
H NMR 
were reported as δ, parts per million, relative to the signal of CHCl3 at 7.26 ppm. 
Chemical shifts for 
13C NMR were reported as δ, parts per million, relative to the center 
line signal of the CDCl3 triplet at 77.0 ppm. Proton and carbon assignments were 
established using spectral data of similar compounds. The abbreviations s, br. s, d, dd, br. 
d, ddd, t, q,  br. q, m, and br. m stand for the resonance multiplicity singlet, broad singlet, 
doublet, doublet of doublets, broad doublet, doublet of doublet of doublets, triplet, 
quartet, broad quartet, multiplet and broad multiplet, respectively. IR spectra were 
recorded on an Avatar 360 FT-IR spectrometer. Mass spectra were recorded at the Mass 
Spectrometry Facility at the Department of Chemistry of the Boston University in 
Boston, MA on a Waters Q-Tof API-US with ESI high resolution mass spectrometer. 
Concentration refers to removal of solvent under reduced pressure (house vacuum at ca. 
20 mm Hg). 
Mn
3+
 Malonation of Indoles 
General procedure 3.1: To a solution of the indole and Mn(OAc)3•2H2O in AcOH at 
85°C was added the malonate. The mixture was stirred at reflux for 12 to 24 h or until 
64 
 
 
TLC showed complete consumption of starting material. After cooling the reaction 
mixture, the AcOH was removed under reduced pressure and water was added. The 
aqueous layer was extracted three times with EtOAc and the combined organic phases 
were washed twice with water and once with brine. The solution was then dried over 
Na2SO4(s), filtered, and concentrated. Purification by flash chromatography in EtOAc-
hexanes afforded products.  
 
Dimethyl 2-acetoxy-2-(3-formyl-1H-indole-2-yl)malonate (3.19). A solution of indole-
3-carboxaldehyde (0.14 g, 0.34 mmol) in 3.0 mL AcOH was sonicated and degased for 
30 min. Separately, a solution of the malonate 3.18 (0.16 mL, 1.4 mmol, 4.0 equiv.) in 
3.0 mL AcOH was prepared. The two solutions were added slowly and simultaneously 
over 6 h to a stirring slurry of Mn(OAc)3•2H2O (0.55 g, 2.1 mmol, 6.0 equiv.) in 25 mL 
AcOH at 85°C. The mixture was stirred for an additional 12 to 24 h or until TLC showed 
complete consumption of starting material. After cooling the reaction mixture, the AcOH 
was removed under reduced pressure and water was added. The aqueous layer was 
extracted three times with EtOAc and the combined organic phases were washed twice 
with water and once with brine. The solution was then dried over Na2SO4(s), filtered, and 
concentrated. Purification by flash chromatography in EtOAc-hexanes afforded 3.19 as a 
yellow oil (48 mg, 38%) upon purification on SiO2. 
1
H NMR (CDCl3, 400 MHz) δ 10.89 
(br. s, 1H), 10.47 (s, 1H), 8.4 (1H, d), 7.49 (1H, d), 7.32 (2H, m), 3.89 (6H, s), 2.2 (3H, 
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s); 
13
C NMR (CDCl3) δ 186.5, 169.5, 165.3, 138.7, 134.7, 125.6, 125.1, 123.8, 122.8, 
116.4, 112.1, 77.8, 54.7, 21.0. 
 
Dimethyl 2-acetoxy-2-(3-formyl-4-(methoxycarbonyl)-1H-indol-2-yl)malonate (3.27). 
According to general procedure 3.1, a solution of 3.26 (50 mg, 0.25 mmol), 
Mn(OAc)3•2H2O (0.4 g, 1.5 mmol, 6.0 equiv.), and  malonate 3.18 (90 μL, 0.79 mmol, 
3.0 equiv)  in 20 mL AcOH at 85°C afforded 3.27 (55 mg, 56%) as an orange solid after 
purification on SiO2. 
1
H NMR (CDCl3) δ 10.93 (1H, br. s), 10.41 (1H, s), 8.55 (1H, d), 
7.42 (1H, dt), 7.33 (1H,dd), 3.870 (6H, s), 3.85 (3H, s), 2.22 (3H, s). 
 
Dimethyl 2-acetoxy-2-(3-acetyl-1H-indol-2-yl)malonate (3.29).        According to 
general procedure 3.1, 3.28 (50 mg, 0.31 mmol), malonate 3.18 (100 μL, 0.94 mmol, 3.0 
equiv), and Mn(OAc)3•2H2O (0.43 g, 1.6 mmol, 5.0 equiv) in 10 mL AcOH at 85°C 
afforded 3.29 (61 mg, 59%) as a brown oil upon purification on SiO2.
1
H NMR (CDCl3) δ 
10.72 (1H, br. s), 7.90 (1H, dd), 7.51 (1H, d), 7.32 (2H, m), 3.89 (6H, s), 2.77 (3H, s), 
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2.14 (3H, s); 
13
C NMR (CDCl3) δ 194.2, 170.5, 165.9, 136.7, 134.4, 125.3, 124.0, 122.7, 
121.0, 115.1, 112.9, 78.5, 54.4, 31.3, 21.0. 
 
Dimethyl 2-acetoxy-2-(3-(methoxylcarbonyl)-1-indol-2-yl)malonate. According to 
general procedure 3.1, 3.30 (100 mg, 0.57 mmol), malonate 3.18 (0.26 mL, 2.3 mmol, 4.0 
equiv), and Mn(OAc)3•2H2O (0.92 g, 3.5 mmol, 6.0 equiv.) in 60 mL AcOH at 85°C 
afforded 3.31 (170 mg, 83%) as a yellow oil upon purification on SiO2. 
1
H NMR (CDCl3) 
δ 10.54 (1H, br. s), 8.11 (1H, d), 7.48 (1H, d), 7.28 (2H, dt), 3.92 (3H, s), 3.87 (6H, s), 
2.11 (3H, s); 
13
C NMR (CDCl3) δ 170.2, 165.9, 165.1, 137.0, 134.1, 126.1, 124.3, 122.5, 
122.1, 112.3, 106.1, 78.2, 76.8, 54.4, 51.3, 20.1. 
 
Dimethyl 2-acetoxy-2-(2-(methoxycarbonyl)-1H-indol-3-yl)malonate (3.33). 
According to general procedure 3.1, 3.32 (20 mg, 0.11 mmol), malonate 3.18 (50 μL, 
0.44 mmol, 4.0 equiv), and Mn(OAc)3•2H2O (0.18 g, 0.66 mmol, 6.0 equiv) in 3.0 mL 
AcOH at 85°C afforded 3.33 (16 mg, 40%) as a yellow solid upon purification on SiO2.
 
1
H NMR (400 MHz, CDCl3)  2.25 (s, 6 H) 3.85 (s, 11 H) 3.88 - 3.98 (m, 6 H) 7.18 (ddd, 
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J=8.22, 7.04, 0.78 Hz, 2 H) 7.30 - 7.50 (m, 4 H) 7.76 (d, J=8.41 Hz, 3 H) 9.07 (br. s., 2 
H);  
13
C NMR (100 MHz):  δ 169.3, 166.8, 160.9, 135.2, 126.5, 126, 124.6, 122.7, 121.8, 
115.2, 112.2, 81.6, 53.7, 52.5, 21.2. 
 
Dimethyl 2-acetoxy-2-(5-methoxy-3-(methoxycarbonyl)-1-H-indole-2-yl)malonate 
(3.35). A solution of 3.34 (23 mg, 0.11 mmol) in 3 mL AcOH was sonicated and degased 
for 30 min. Separately, a solution of the malonate 3.18 (25 μL, 0.22 mmol, 2.0 equiv.) in 
3 mL AcOH was prepared. The two solutions were added slowly and simultaneously over 
6 h to a stirring slurry of Mn(OAc)3•2H2O (0.18 g, 0.66 mmol, 6.0 equiv.) in 6.0 mL 
AcOH at 85°C. The mixture was stirred for an additional 24 h. After cooling the reaction 
mixture, the AcOH was removed under reduced pressure and water was added. The 
aqueous layer was extracted three times with EtOAc and the combined organic phases 
were washed twice with water and once with brine. The solution was then dried over 
Na2SO4(s), filtered, and concentrated. Purification by flash chromatography in EtOAc-
hexanes afforded 3.35 (19 mg, 44%) as a white solid upon purification on SiO2. 
1
H NMR 
(CDCl3) δ 10.46 (1H, br. s), 7.57 (1H, d), 7.34 (1H, d), 6.94 (2H, dd), 3.89 (3H, s), 
3.87(3H, s), 3.86 (6H, s); 
13C NMR (CDCl3) δ 170.2, 165.9, 165.1, 156.3, 136.8, 129.2, 
127.0, 115.1, 113.2, 105.6, 103.0, 78.2, 76.8, 56.0, 54.4, 51.2, 20.9. 
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Dimethyl 2-(3-formyl-1H-indol-2-yl)-2-methylmalonate (3.36). 
1H NMR (CDCl3) δ 
10.70 (1H, br. s), 10.19 (1H,s), 8.19 (1H, m), 7.45 (1H, m), 7.29 (2H, m), 3.82 (6H, s), 
2.00 (3H, s); 
13C NMR (CDCl3) δ 184.6, 170.8, 143.2, 134.1, 127.1, 124.1, 123.3, 120.5, 
113.9, 112.1, 54.5, 54.0, 25.5; m/z =290.2 [M+1]. 
 
Dimethyl 2-(3-oxo-1H-pyrrolo[2,3-b]pyridin-2(3H)-ylidene)malonate (3.41). 
According to general procedure 3.1, 7-azaindole (50 mg, 0.42 mmol), malonate 3.18 
(0.19 mL, 1.7 mmol, 4.0 equiv), and Mn(OAc)3•2H2O (0.68 g, 2.5 mmol, 6.0 equiv.) in 
3.0 mL AcOH at 85°C afforded 3.41 (30 mg, 40 %) as a bright yellow solid upon 
purification on SiO2.
 1
H NMR (302 MHz)  3.87 (s, 6 H) 3.94 (s, 6 H) 7.00 (dd, J=7.51, 
5.08 Hz, 2 H) 7.93 (d, J=7.51 Hz, 2 H) 8.42 (dd, J=4.97, 1.66 Hz, 2 H) 9.39 - 9.53 (m, 2 
H); 
13
C NMR (100 MHz):  183.9, 165.7, 165.0, 164.3, 156.4, 141.8, 134.3, 118.4, 113.4, 
103.8, 53.3, 53.1. 
Photoredox Catalyzed Alkylation of Heteroaromatics 
General Procedure 3.2: A flame dried 10 mL round bottom flask was equipped with a 
rubber septum and magnetic stir bar and was charged with the heteroaromatic compound 
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(0.15 mmol, 1.0 equiv), tris(2,2´-bipyridyl)ruthenium(II) chloride hexahydrate (1.5 µmol, 
0.01 equiv), 4-methoxytriphenylamine (0.30 mmol, 2.0 equiv), diethyl bromomalonate 
(0.30 mmol, 2.0 equiv) and DMF (1.5 mL). The mixture was degassed via the freeze-
pump-thaw method and placed at a distance of ~2-5 cm from blue light emitting diodes 
(LEDs). After the reaction was complete (as judged by TLC analysis), the mixture was 
poured into a separatory funnel containing 25 mL of EtOAc and 25 mL of H2O. The 
layers were separated and the aqueous layer was extracted with EtOAc (2 X 50 mL). The 
combined organic layers were washed with 25 mL of water and 25 mL of brine, dried 
(Na2SO4) and concentrated. The residue was purified by chromatography on silica gel, 
using the solvent system indicated, to afford the desired alkylated product. 
 
Diethyl 2-(1-methyl-1H-indol-2-yl)malonate (3.48). According to general procedure 
3.2,  N-methylindole (0.10 g, 0.76 mmol), diethyl bromomalonate (0.20 mL, 1.2 mmol), 
4-methoxytriphenylamine (0.42 g, 1.6 mmol) and tris(2,2´-bipyridyl)ruthenium(II) 
chloride hexahydrate (6.0 mg, 7.6 µmol) afforded the coupled product (0.18 g, 82%) as a 
yellow-orange oil after purification on SiO2 (95:5 hexanes/EtOAc) (18 h reaction time). 
Rf (95:5 hexanes/EtOAc) = 0.17; IR (neat): 3409, 5979, 2935, 1692, 1508, 1457, 1392, 
1366, 1244, 1167, 1028, 741 cm
-1
; 
1
H NMR (400 MHz): δ 7.78 (d, J = 7.8 Hz, 1 H), 7.59 
– 7.46 (m, 1 H), 7.47 – 7.33 (m, 1 H), 7.37 – 7.25 (m,1 H), 6.78 (s, 1 H),  5.12 (s, 1 H),  
4.64 – 4.30 (m, 4 H),  3.91 (s, 3 H), 1.49 (t, J = 7.1 Hz, 6 H); 13C NMR (100 MHz):  δ 
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167.6, 156.2, 136.4, 136.3, 127.7, 125.9, 122.9, 119.8, 119.2, 122.6, 111.5, 62.7, 62.7, 
49.5, 41.3, 28.7, 25.0, 14.3; HRMS (ESI) m/z calculated for C16H19NO4 [M+1]
+
 
290.1392, found 290.1394. 
 
Diethyl 2-(3-methyl-1H-indol-2-yl)malonate (3.51). According to general procedure 
3.2, 3-methylindole (50 mg, 0.38 mmol), diethyl bromomalonate (91 μL, 0.53 mmol,), 4-
methoxytriphenylamine (0.21 g, 0.53 mmol) and tris(2,2´-bipyridyl)ruthenium(II) 
chloride hexahydrate (3.0 mg, 3.8 µmol) afforded the coupled product (92 mg, 84%) as a 
yellow oil after  
purification on SiO2 (90:5:5 hexanes/EtOAc/AcOH) (8 h reaction time). Rf (93:5:2 
hexanes/EtOAc/AcOH) = 0.50; IR (neat): 3414, 3060, 2982, 2936, 1731, 1621, 
1460,1369, 1318, 1243 cm
-1
; 
1H NMR (400 MHz): δ 8.93 (br s, 1 H, NH), 7.55 (dd, J = 
7.8, 1.2 Hz, 1 H), 7.42 – 7.30 (m, 1 H), 7.23 – 7.16 (m, 1 H), 7.16 – 7.04 (m, 1 H), 4.38 – 
4.13 (m, 4 H), 2.39 – 2.21 (m, 3 H), 1.36 – 1.20 (m, 6 H); 13C NMR (100 MHz) δ 167.4, 
135.8, 128.2, 124.5, 122.4, 119.2, 118.8, 111.1, 110.6, 62.3, 49.3, 49.3, 14.0, 8.5; HRMS 
(ESI) m/z calculated for C16H19NO4 [M+1]
+
 290.1392, found 290.1390. 
 
71 
 
 
Diethyl 2-(2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl)malonate (3.53). According 
to general procedure 3.2, methyl 1-methylindole-2-carboxylate (50 mg. 0.26 mmol), 
diethyl bromomalonate (90 μL, 0.53 mmol,), 4-methoxytriphenylamine (0.14 g, 0.53 
mmol) and tris(2,2´-bipyridyl)ruthenium(II) chloride hexahydrate (2.0 mg, 2.6 µmol) 
afforded the coupled product (84 mg, 93%) as a light green solid after purification on 
SiO2 (1:9 hexanes/EtOAc) (24 h reaction time). Rf (90:10 hexanes/EtOAc) = 0.14; IR 
(neat): 2983, 2956, 2362, 2331, 1732, 1714, 1532, 1468, 1441, 1398, 1368, 1311, 1241, 
1150, 1109, 1050, 862, 745 cm
-1
; 
1H NMR (400 MHz): δ 7.78 – 7.64 (m, 1 H), 7.43 – 
7.30 (m, 2 H), 7.20 – 7.10 (m, 1 H), 5.75 (s, 1 H), 4.32 – 4.15 (m, 4 H), 4.02 (s, 3 H), 
3.94 (s, 3 H), 1.24 (t, J = 7.1 Hz, 6 H); 
13C NMR (100 MHz):  δ 168.8, 162.7, 138.9, 
126.4, 125.9, 125.6, 122.2, 121.0, 114.7, 110.6, 61.9, 52.0, 50.2, 32.5, 14.3;  
HRMS (ESI) m/z calculated for C18H21NNaO6 [M+Na]
+
 370.1267, found 370.1272. 
 
Diethyl 2-(3-(3-methoxy-3-oxopropyl)-1H-indol-2-yl)malonate (3.55). According to 
general procedure 3.2, methyl indole-3-propionate (50 mg, 0.25 mmol), diethyl 
bromomalonate (83  μL, 0.50 mmol), 4-methoxytriphenylamine (0.14 g, 0.50 mmol) and 
tris(2,2´-bipyridyl)ruthenium(II) chloride hexahydrate (2.0 mg, 2.5 µmol) afforded the 
coupled product (70 mg, 78%) as a brown semi-solid oil after purification on SiO2 (9:1 
hexanes/EtOAc) (18 h reaction time). Rf (9:1 hexanes/EtOAc) = 0.19; IR (neat): 3399, 
2983, 1734, 1460, 1369, 1267, 1202, 1029, 744 cm
-1
; 
1H NMR (400 MHz): δ 8.91 (br s, 1 
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H, NH), 7.56 (m, 1 H), 7.36 (m, 1 H), 7.19 (ddd, J = 8.1, 7.1, 1.2 Hz, 1 H), 7.1 (m, 1H), 
5.1 (s, 1H) 4.23 (m, 4H), 3.64 (s, 3H),  3.09 (t, J = 7.5 Hz,  2H), 2.66 (t, J = 7.5 Hz, 2H), 
1.28 (t, J = 3.0 Hz, 6H); 
13C NMR (100 MHz):  δ 173.9, 167.6, 136.2, 127.4, 127.4, 
125.5, 122.7, 119.7, 118.8, 113.7, 111.6, 62.6, 51.8, 49.4, 35.0, 19.7, 14.2; HRMS (ESI) 
m/z calculated for C19H23NO6 [M+Na]
+
 384.1423, found 384.1435. 
 
Diethyl 2-(3-(2-((tert-butoxycarbonyl)amino)ethyl)-1H-indol-2-yl)malonate (3.57). 
According to general procedure 3.2, N-Boc-tryptamine (0.50 g, 2.0 mmol), diethyl 
bromomalonate (0.70 mL, 4.1 mmol), 4-methoxytriphenylamine (1.1 g, 4.1 mmol) and 
tris(2,2´- 
bipyridyl)ruthenium(II) chloride hexahydrate  (18 mg, 0.02 mmol) afforded The coupled 
product (0.62 g, 73%) as  a white solid after  purification on SiO2 (4:1 hexanes/EtOAc) 
(12 h reaction time). Rf (7:3 hexanes/EtOAc) = 0.40; IR (neat): 3409, 2979, 2935, 1692, 
1508, 1457, 1392, 1366, 1244, 1167, 1028, 741 cm
-1
; 
1H NMR (400 MHz): δ 8.94 (br s, 1 
H, NH), 7.59 (d, J = 7.8 Hz, 1 H), 7.37 (dd, J = 8.1, 0.7 Hz, 1 H), 7.2 (m, 1 H), 7.12 (m, 1 
H), 4.96 (s, 1 H), 4.75 (br s, 1 H, NH), 4.25 (m, 4 H), 3.42 (br s, 2H), 2.96 (t, J = 6.6 Hz, 
2 H), 1.44 (s, 9 H), 1.29 (td, J = 7.1, 0.7 Hz, 6 H); 
13
C NMR (100 MHz):  δ 167.6, 156.2, 
136.4, 136.3, 127.7, 125.9, 122.9, 119.8, 119.2, 122.6, 111.5, 62.7, 62.7, 49.5, 41.3, 28.7, 
25.0, 14.3; HRMS (ESI) m/z calculated for C22H30N2O6Na [M+Na]
+
 441.2002, found 
441.2010. 
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Diethyl 2-(1-(tert-butoxycarbonyl)-3-(2-((tert-butoxycarbonyl)amino)ethyl)-1H-
indol-2yl) malonate (3.58). According to general procedure 3.2, N,N’-di-Boctryptamine 
(50 mg, 0.14 mmol),  diethyl bromomalonate (50  μL, 0.28 mmol), 4-
methoxytriphenylamine (77 mg, 0.28 mmol) and tris(2,2´-bipyridyl)ruthenium(II) 
chloride hexahydrate (1.0 mg, 1.4 µmol) afforded the coupled product (62 mg, 85%) as a 
beige solid after purification on SiO2 (4:1, hexanes/EtOAc) (12  h reaction time). Rf (8:2 
hexanes/EtOAc) = 0.25; IR (neat): 3363, 2980, 2360, 2342, 1722, 1456, 1366, 1329, 
1233, 1162, 1131, 1039, 757 cm
-1
; 
1H NMR (400 MHz): δ 8.02 (d, J = 8.4 Hz, 1 H), 7.57 
(d, J = 7.7 Hz, 1 H), 5.21 (s, 1 H), 4.89 (brs, 1 H, NH), 4.35 – 4.14 (m, 4 H), 3.40 (d, J = 
5.7 Hz, 2 H), 2.88 (t, J = 6.4 Hz, 2 H), 1.66 (s, 9 H), 1.43 (s, 9 H), 1.24 (t, J = 7.2 Hz, 3 
H); 13C NMR (100 MHz):  δ 166.5, 156.0, 150.5, 135.6, 129.1, 129.0, 124.7, 122.6, 
119.5, 118.9, 115.8, 84.4, 79.2, 77.2, 61.8, 49.9, 40.2, 28.4, 28.2, 24.7, 14.1; HRMS 
(ESI) m/z calculated for C27H39N2O8 [M+1]
+
 519.2706, found  519.2706. 
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(S)-Diethyl 2-(3-(2-((tert-butoxycarbonyl)amino)-3-methoxy-3-oxopropyl)-1H-indol-
2-yl) malonate (3.60). According to the general procedure, N-Boc-tryptophan methyl 
ester (50 mg, 0.16 mmol), diethyl bromomalonate (53 μL, 0.31 mmol), 4-
methoxytriphenylamine (87 mg, 0.31 mmol) and tris(2,2´-bipyridyl)ruthenium(II) 
chloride hexahydrate (1.0 mg, 1.6 µmol) afforded the coupled product (60 mg, 77%)  as a 
tan solid after purification on SiO2 (4:1 hexanes/EtOAc) (20 h reaction time). Rf (75:25 
hexanes/EtOAc) = 0.24; IR (neat): 3399, 2982, 1748, 1640, 1368, 1267, 1028 cm
-1
; 
1
H 
NMR (400 Mhz): δ 8.93 (br s, 1 H, NH), 7.52 (d, J = 8.0 Hz, 1 H), 7.33 (d, J = 8.0 Hz, 1 
H), 7.17 (td, J = 7.5, 1.2 Hz, 1 H),  7.12 – 7.04 (m, 1 H),  5.24 (d, J = 8.0 Hz, 1 H),  4.96 
(s, 1 H, NH),  4.70 – 4.57 (m, 1 H);  4.33 – 4.13 (m, 4 H);  3.59 (s, 3 H);  3.26 (d, J = 5.9 
Hz, 2 H);  1.39 (s, 6 H); 1.27 (td, J = 7.1, 1.5 Hz, 6 H); 
13C NMR (100 MHz):  δ 172.6, 
167.3, 155.2, 136.0, 127.7, 126.6, 122.7, 119.7, 119.0, 111.2, 109.4, 79.8, 62.5, 54.1, 
52.3, 49.3, 28.3, 28.0, 27.0, 14.1, 14.0; HRMS (ESI) m/z calculated for C24H32N2O8 
[M+Na]
+
 499.2056, found 499.2046. 
 
Diethyl 2-(3-(((2S,5R)-5-benzyl-3,6-dioxopiperazin-2-yl)methyl)-1H-indol-2-
yl)malonate (3.63). According to general procedure 3.2, tryptophan/phenylalanine 
diketopiperzine (50 mg, 0.15 mmol), diethyl bromomalonate (51  μL, 0.30 mmol), 4-
methoxytriphenylamine (83 mg, 0.30 mmol) and tris(2,2´-bipyridyl)ruthenium(II) 
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chloride hexahydrate (1.1 mg, 1.5  µmol) afforded the coupled product (49 mg, 68%) as a 
grayish solid after purification on SiO2 (1:1 hexanes/EtOAc  100% CH2Cl2  9:1 
CH2Cl2/MeOH) (18 h reaction time). Rf (9:1 CH2Cl2/MeOH) = 0.55; IR (neat): 3297, 
2983, 2364, 1730, 1674, 1456, 2323, 1215, 1092, 1028, 910, 740 cm
-1
; 
1
H NMR (300 
MHz): δ 9.15 (s, 1 H, NH), 7.59 (d, J = 7.7 Hz, 1 H), 7.49 – 6.99 (m, 6 H), 6.84 (d, J = 
1.6 Hz, 1 H), 6.39 (d, J = 1.8 Hz, 1 H), 4.80 (s, 1 H), 4.44 – 4.02 (m, 4 H), 3.34 (dd, J = 
14.8, 2.6 Hz, 1 H), 3.05 (dd, J = 13.7, 3.8 Hz, 1 H), 2.70 (dd, J = 13.6, 6.7 Hz, 1 H), 2.11 
(dd, J = 14.6, 9.3 Hz, 1 H), 1.96 (br s, 1 H), 1.52 – 1.27 (m, 6 H);  13C NMR (100 MHz):  
δ 167.9, 167.7, 167.6, 166.2, 136.4, 135.6, 130.5, 129.2, 127.7, 127.2, 127.1, 123.4, 
120.4, 119.2, 111.7, 109.5, 76.9, 63.3, 62.8, 56.6, 55.9, 49.3, 40.3, 29.7, 14.3; HRMS 
(ESI) m/z calculated for C24H29N3NaO6 [M+Na]
+
 514.1954, found 514.1954. 
 
Diethyl 2-(3-((S)-2-((tert-butoxycarbonyl)amino)-3-(((S)-1-methoxy-1-oxo-3-
phenylpropan- 
2-yl)amino)-3-oxopropyl)-1H-indol-2-yl)malonate (3.65). According to general 
procedure 3.2, tryptophan-phenylalanine dipeptide (50 mg, 0.10 mmol), diethyl 
bromomalonate (51 μL, 0.20 mmol), 4-methoxytriphenylamine (59 mg, 0.20 mmol) and 
tris(2,2´-bipyridyl)ruthenium(II) chloride hexahydrate (0.8 mg, 8.0 µmol) afforded the 
coupled product (45 mg, 67%) as a tan solid after purification on SiO2 (7:3 
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hexanes/EtOAc) (12 h reaction time). Rf (7:3 hexanes/EtOAc) = 0.25; IR (neat): 3388, 
3064, 2982, 2936, 1745, 1674, 1497, 1459, 1368, 1246, 1211, 1180, 1028, cm
-1
; 
1
H NMR 
(300 MHz): δ 9.03 (s, 1 H, NH), 7.57 (d, J = 7.8 Hz, 1 H), 7.33 (d, J = 8.1 Hz, 1 H), 7.23 
– 7.00 (m, 4 H), 6.80 (br s, 2 H), 6.19 (d, J = 7.2 Hz, 1 H), 5.36 (br s, 1 H, NH), 5.14 (br 
s, 1 H, NH), 4.47 (d, J = 5.6 Hz, 2 H), 4.35 – 4.01 (m, 4 H), 3.48 (s, 2 H), 3.38 – 3.19 (m, 
1 H), 3.17– 2.99 (m, 1 H), 2.89 (d, J = 5.1 Hz, 2 H), 1.77 (br s, 1H), 1.42 (s, 9 H), 1.36 – 
1.11 (m, 6 H); 
13C NMR (100 MHz):  δ 171.4, 171.3, 171.2, 155.4, 136.3, 135.6, 129.1, 
128.4, 127.5, 127.0, 123.4, 122.2, 119.6, 118.8, 111.3, 110.2, 80.1, 60.4, 55.2, 53.2, 52.2, 
37.9, 28.3, 21.0, 14.2; HRMS (ESI) m/z calculated for C33H41N3NaO9 [M+Na]
+
 
646.2740, found 646.2738. 
 
Diethyl 2-(4-bromo-1-methyl-1H-indol-2-yl)malonate (3.67). According to general 
procedure 3.2, 4-bromo-1-methylindole (50 mg, 0.24 mmol), diethyl bromomalonate 
(0.08 mL, 0.48 mmol), 4-methoxytriphenylamine (0.13 g, 0.48 mmol) and tris(2,2´-
bipyridyl)ruthenium(II) chloride hexahydrate (2.0 mg, 2.4 µmol) afforded the coupled 
product (88 mg, 91%) as an orange oil after purification on SiO2 (98:2 hexanes/EtOAc) 
(4 days reaction time). Rf (90:10 hexanes/EtOAc) = 0.16; IR (neat): 2981, 2928, 1732, 
1653, 1537, 1457, 1424, 368, 1344, 1214, 1150, 1030, 764 cm
-1
; 
1H NMR (400 MHz): δ 
7.17 – 7.21 (m, 1 H), 7.00 – 7.03 (m,1 H), 6.59 (s, 1 H),  4.89 (s, 1 H), 4.18 – 4.34 (m, 4 
H),  3.64 (s, 3 H), 1.25 (t, J = 7.1 Hz,  H); 
13
C NMR (100 MHz): δ 166.9, 131.9, 128.2, 
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123.1, 122.9, 115.0, 108.8, 103.7, 62.6, 51.6, 31.1; HRMS (ESI) m/z calculated for 
C16H18BrNO4 [M+1]
+
 368.0497, found 368.0500. 
 
Diethyl 2-(3-(2-bromoethyl)-1H-indol-2-yl)malonate (3.69). According to general 
procedure 3.2, 3-(2-bromoethyl)indole (50 mg, 0.22 mmol), diethyl bromomalonate (75 
μL, 0.45 mmol,), 4-methoxytriphenylamine (0.12 g, 0.45 mmol) and tris(2,2´-
bipyridyl)ruthenium(II) chloride hexahydrate (3.0 mg, 2.2 µmol) afforded the coupled 
product (64 mg, 76%) as a light pink solid after purification on SiO2 (95:5 
hexanes/acetone)  (12 h reaction time). Rf (9:1 hexanes/EtOAc) 0.13; IR (neat): 3399, 
2982, 1729, 1459, 1310, 1242, 1204, 1151, 1030 cm
-1
;  
1
H NMR (400 MHz): δ 9.03 (br s, 
1 H, NH), 7.56 (d, J = 8.0 Hz, 1 H), 7.38 (dd, J = 8.1, 0.9 Hz, 1 H), 7.22 (tt, J = 7.6, 1.0 
Hz, 1 H), 7.17 – 7.10 (m, 1 H),  5.00 (s, 1 H), 4.36 – 4.12 (m, 4 H), 3.65 – 3.51 (m, 2 H), 
3.40 – 3.29 (m, 2 H), 1.29 (t, J = 6.6 Hz, 6 H); 13C NMR (100 MHz): δ 67.0, 135.8, 
125.9, 122.7, 119.8, 118.4, 112.2, 111.4, 77.2, 62.5, 49.2, 32.3, 28.3, 14.0; HRMS (ESI) 
m/z calculated for C17H21BrNO4 [M+1]
+
 382.0654, found  382.0650. 
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Diethyl 2-(3-acetyl-1-methyl-1H-pyrrol-2-yl)malonate  (3.71). According to general 
procedure 3.2, 3-acetyl-1-methylpyrrole  (50 mg, 0.25 mmol), diethyl bromomalonate (83 
μL, 0.50 mmol), 4-methoxytriphenylamine (0.14  g, 0.50 mmol) and tris(2,2´-
bipyridyl)ruthenium(II) chloride hexahydrate (2.0 mg, 2.5 µmol) afforded the coupled 
product (70 mg, 78%) as a brown oil after purification on SiO2 (9:1 hexanes/EtOAc) (18 
h reaction time). Rf (9:1 hexanes/EtOAc) = 0.14; IR (neat) : 3410, 1727, 1647, 1504, 
1219, 1146, 1021 cm
-1
; 
1H NMR (300 MHz): δ 6.61 (s, 1 H), 6.53 (dd, J = 15.3, 2.9 Hz,1 
H), 4.38 – 4.05 (m, 4 H), 3.63(s, 3 H), 2.40 (s, 3 H), 1.27 (t, J = 7.1 Hz, 6 H); 13C NMR 
(100 MHz): δ 195.5, 167.5, 127.8, 123.7, 122.5, 110.4, 61.9, 48.5, 35.2, 28.4, 14.0, 13.9; 
HRMS (ESI) m/z calculated for C14H20NO5 [M+1]
+
 282.1297, found 282.1317. 
 
Diethyl 2-(5-ethyl-1H-pyrrol-2-yl) malonate (3.73). According to general procedure 
3.2, 2-ethylpyrrole (50 mg, 0.53 mmol), diethyl bromomalonate (0.25 mL, 1.0 mmol,), 4-
methoxytriphenylamine (0.29 g, 1.0 mmol) and tris(2,2´-bipyridyl)ruthenium(II) chloride 
hexahydrate (3.9 mg, 5.3 µmol) afforded the coupled product (90 mg, 68%) as a dark oil 
after purification on SiO2 (9:1 hexanes/EtOAc) (12 h reaction time). Rf (9:1 
hexanes/EtOAc) = 0.28; IR (neat) 3398, 2981, 2936, 1736, 1466, 1370, 1304, 1190, 1150 
cm
-1
; 
1H NMR (400 MHz): δ 8.72 (br s, 1 H, NH), 6.02 (dd, J = 2.9 Hz, 1 H), 5.83 (t, J = 
3.0 Hz, 1 H),4.69 (s, 1 H), 4.40 – 4.08 (m, 4 H), 2.63 (q, J = 7.6 Hz, 2 H), 1.41 – 1.14 (m, 
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6 H); 13C NMR (100 MHz):  δ 168.2, 135.6, 120.0, 108.9, 104.4, 62.2, 51.4, 30.0, 21.1, 
14.2, 13.7, 13.6; HRMS (ESI) m/z calculated for [M+1]
+
 254.1392, found 254.1398. 
 
Diethyl 2-(furan-2-yl)malonate (3.75). A flame dried 10 mL round bottom flask was 
equipped with a rubber septum and magnetic stir bar and was charged with tris(2,2´-
bipyridyl)ruthenium(II) chloride hexahydrate (5.9 µmol, 0.01 equiv), 4-
methoxytriphenylamine (1.2 mmol, 2.0 equiv), diethyl bromomalonate (0.59 mmol, 1.0 
equiv) and DMF (2 mL). The mixture was degassed via the freeze-pump-thaw method, 
after which freshly distilled furan (0.22  
mL, 3.0 mmol) was added and exposed to blue light for 24 h. The reaction mixture was 
worked up in accordance with the general procedure. The coupled product (87 mg, 67%) 
was isolated as a yellow oil after purification on SiO2 (95:5 hexanes/EtOAc). Rf (9:1 
hexanes/EtOAc) = 0.13; 
1H NMR (300 MHz): δ 7.47 – 7.38 (m, 1 H), 6.44 (dd, J = 3.3, 
0.7 Hz, 1 H), 6.41 – 6.35 (m, 1 H), 4.77 (s, 1 H), 4.25 (q, J = 7.1 Hz, 4 H), 1.41 – 1.18 
(m, 7 H). 
  
Diethyl 2-(4-bromo-1-methyl-1H-pyrrolo[2,3-b]pyridin-2-yl)malonate (3.77). 
According to general procedure 3.2, 5-bromo-1-methyl-7-azaindole (0.10 g, 0.45 mmol), 
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diethyl bromomalonate (0.15 mL, 0.90 mmol), 4-methoxytriphenylamine (0.25 g, 0.90 
mmol,) and tris(2,2´-bipyridyl)ruthenium(II) chloride hexahydrate (3.4 mg, 4.5 µmol) 
afforded the coupled product (0.95 g, 49%) as a yellow oil after purification on SiO2 (9:1 
hexanes/EtOAc) (18 h reaction time). Rf (9:1 hexanes/EtOAc) = 0.31; IR (neat cm-1) 
2982, 2927, 2854, 2361, 2340, 1738, 1533, 1476, 1402, 1369, 1311, 1216, 1155, 1031, 
761 cm
-1
; 
1H NMR (500 MHz): δ 8.25 (d, J = 2.2 Hz, 1 H), 7.89 (dd, J = 2.2, 0.5 Hz, 1 
H), 6.44 (s, 1 H), 4.84 (s, 1 H),  4.30 – 4.11 (m, 4 H), 3.73 (s, 3 H), 1.22 (t, J = 7.1 Hz, 6 
H); 13C NMR (100 MHz): δ 166.4, 147.0, 143.7, 133.3, 30.6, 121.3, 111.9, 100.4, 62.6, 
51.3, 28.8, 14.1; HRMS (ESI) m/z calculated for C15H18BrN2O4 [M+1]
+
 369.0450, found 
369.0452. 
Luminescence Quenching of Ru(bpy)3Cl2.  
Emission intensities were measured using a Jobin Yvon Horiba FluoroMax 3 Fluorimeter 
equipped with an excitation/emission monochromator. Samples were excited at 452 nm 
and emission peaks were observed at 617 nm. Typical procedure: A stock solution of 
1.47 mM Ru(bpy)3Cl2 in DMF was prepared and degassed three times via freeze-pump-
thaw method.  The stock solution was then added to varying amounts of the tested 
quencher in a 1 cm quartz cuvette. Samples were prepared in five concentrations: 0.36M, 
0.18M, 0.09M, 0.045M, and 0.0225M. 
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CHAPTER 4.  IN SITU OXIDATION OF TETRAHYDROISO-QUINOLINES AND 
DIVERSE NUCLEOPHILIC TRAPPING 
4.1 Background 
 The generation of reactive iminium ions via oxidation of amino α-C–H bonds is 
an efficient and atom economical method of forming new C–C bonds. Trapping of the 
iminium ion with a variety of different nucleophiles can lead to the rapid preparation of 
amine derivatives. The tetrahydroisoquinoline motif is well known for its ability to 
undergo oxidation, which can be attributed to a highly activated C–H bond that adjacent 
to both a benzene unit and a nitrogen atom. Consequently, several studies have been 
geared towards functionalization of these molecules (vide infra).
112
 Benzylisoquinoline 
alkaloids are notable for their biological activities and prevalence in pharmaceuticals. 
Examples include noscapine (4.01),
113
 an antitussive agent, papaverine (4.02),
114
 a 
vasodilator, and apomorphine (4.03),
115
 a drug used for the treatment of Parkinson’s 
disease (Figure 4.1). 
 
Figure 4.1 Benzyl isoquinoline alkaloids 
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 Much attention has been focused on the direct functionalization of tertiary amines 
through selective activation of C–H bonds followed by in situ oxidation. In general, an 
activation or oxidation step must be coupled with a C–C bond forming event. Moreover, 
most known methods involve the activation of cyclic amines or anilines. Of the numerous 
advancements that have been made in the past decade, most direct α-amine 
functionalization strategies can be divided into three basic sub-categories (Figure 4.2): (1) 
direct C–H activation by a transition metal; (2) two-electron C–H oxidations and; (3) 
radical-mediated C–H oxidations. Due to mechanistic ambiguities, these categories are 
often blurred.  
 
Figure 4.2 Amine functionalization strategies 
Earlier methods have taken advantage of carbamate-directed α-C–H lithiation of 
cyclic tertiary amines
116
 to generate carbon-centered anions in the presence of metals 
such as Cu(I)
117
 or Zn(II)
118
 that can add to a variety of different electrophiles (Figure 
4.3).  
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Figure 4.3 α-Lithiations of tertiary amines 
 Ruthenium-based complexes have been especially powerful in affecting direct C–
H activation of amines (Figure 4.4). Chatani et al. were able to functionalize 2-
(pyrrolidin-1-yl)pyridine using a trinuclear Ru complex in the presence of ethylene.
119
 
The authors initially proposed a pyridine directed C–H insertion by the metal, followed 
by migratory insertion and reductive elimination of ethylene. Formation of the iminium 
ion was also invoked as an alternative mechanistic possibility. Different alkenes were 
later explored by Yi and co-workers for a similar transformation using a ruthenium 
hydride complex.
120
 In this case, no directing group was necessary and unprotected 
secondary amines were used as substrates. There have also been methods that propose a 
direct hydrogen atom abstraction by a ruthenium oxo intermediate. Such a transformation 
has been reported by Murahashi and co-workers for the oxidative cyanation of tertiary 
amines using RuCl3 in the presence of either H2O2 or O2.
121
 Another powerful method for 
direct C–H insertions is the use of metal carbenes. This method, developed by Davies, 
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was used for the asymmetric functionalization of N-Boc protected nitrogen heterocycles 
using chiral dirhodium complexes.
122
 These conditions could be used on a wide range of 
heterocycles, including pyrrolidines, piperidines, and indolines in high % ee and yields. 
 
Figure 4.4 C–H activation methods for α-amine functionalization 
 A different strategy for C–H oxidation involves the generation of iminium ions 
and subsequent trapping with nucleophiles (Figure 4.5). Weinreb and co-workers 
explored the unique reactivity of 2-aminobenzamidyl heterocycles in the presence of 
sodium nitrite and Cu(I) for the α-methoxylation of cyclic amides.123 Upon conversion to 
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the diazonium salt, Cu(I) reduction provides an aryl radical that can undergo a 1,5-
hydrogen atom abstraction to give an α-amino radical. Oxidation of this species forms an 
iminium ion, which is then trapped by methanol solvent. Prominent work in the area of 
copper-catalyzed C–H oxidations has been reported by Li and co-workers. Termed 
“cross-dehydrogenative coupling,” tetrahydroisoquinolines and anilines can be oxidized 
in situ using catalytic Cu(I) and t-butylperoxide and nucleophiles.
124
 A variety of 
nucleophiles were employed, including nitromethanes, enolates, indoles, and allylsilanes. 
Two mechanistic possibilities include either β-hydride elimination of an N-bound copper 
species or direct C–H abstraction by peroxide radical. Similar reactivities have been 
reported in the presence of hypervalent iodide.
125
 A mechanistically distinct method has 
been reported in 2011 by Allen and Lambert in which tropylium ion affected the 
oxidative cyanation of a broad scope of tertiary amines.
126
 Interestingly, the most 
electron-rich C–H bond could be selectively oxidized in the presence of either benzylic or 
allylic C–H bonds. It is currently unclear whether the reaction works by direct hydride 
abstraction or by single-election oxidation of the nitrogen. 
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Figure 4.5 Selected examples of C–H oxidations of amines 
 Radical-based approaches to α-C–H oxidation of amines involve the formation of 
an α-amino radical intermediate that reacts with suitable electrophiles. Many studies have 
exploited intramolecular hydrogen atom abstraction techniques through the initial 
generation of sp
2
-centered radicals.  Curran and Sneickus developed a tin-based reduction 
of vinyl bromide-tethered pyrrolidines that undergoes a 1,5-hydrogen atom abstraction to 
generate a carbon-centered radical adjacent to nitrogen.
127
 This can then react with 
radical acceptors, such as alkenes. Similarly, Ito and co-workers have affected amine 
oxidations via the reduction of 2-iodobenzylamines using samarium diiodide.
128
 The 
authors propose the subsequent formation of an organo-samarium anionic intermediate. 
Under these conditions, electrophiles such as carbonyl compounds can react with the α-
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amino radical to give amino alcohol products. Triethylboron has also been employed for 
similar reactions.
129
 Another method of obtaining α-amino radicals is through 
electrochemical redox reactions of amines. A high concentration of iminium ions 
generated through electrolysis can be subsequently reduced to the radical, which can then 
react with electrophiles such as methyl methacrylate.
130
 
 
Figure 4.6 Radical amine oxidations 
Photoredox Approaches 
Much attention has been focused on visible light photoredox approaches to α-
amine functionalization.
131
 Given the desire in the synthetic community to develop milder 
and more environmentally friendly methods for alkyl radical generation, processes which 
take advantage of energy from the sun have been under intense investigation. 
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Furthermore, metal catalysts are usually selectively excited over organic molecules, in 
contrast to other energy sources such as UV light, which lends a high degree of 
chemoselectivity to the process. The course of single electron transfer can then be 
dictated by thermodynamic and kinetic parameters. With the participation of tertiary 
amines in photoredox reductive quenching cycles, the susceptibility of these compounds 
towards oxidation can be exploited for further reactivity rather than merely for sacrificial 
electron donation. A pioneering example in this area by the Stephenson group showcased 
the power of visible light-mediated aza-Henry reactions (Figure 4.7).
132
 Using 
Ir(ppy)2(dtbbpy)PF6 as the photocatalyst, tertiary amines such as N-phenyl 
tetrahydroisoquinoline could readily undergo oxidation under white light irradiation to 
amine radical cation 4.04. Turnover of the catalyst by either nitromethane solvent or 
adventitious oxygen forms an oxy radical species that is capable of α-C–H abstraction. 
The iminium ion thus generated (4.05) can then undergo nucleophilic attack by 
nitromethane to form product (4.06).   
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Figure 4.7 Oxidative aza-Henry Reaction using visible light photoredox catalysis 
Following this report, many groups explored the use of different types of visible 
light-active photocatalysts for similar aza-Henry reactions of tertiary amines. Some of 
these methods utilized reusable catalyst such as TiO2, ZnO,
133
 and photocatalysts 
embedded on cross-linked polymers
134
 and metal-organic frameworks.
135
 Recyclable 
catalysts aid in isolation and minimize the production of waste.  Other methods include 
use of semiconductors like CdS
136
 or organic dyes such as Rose Bengal (RB)
137
 and 
Eosin Y.
138
 These methods generally produce comparable yields and involve similar 
amine substrate scopes.  
 In the oxidative aza-Henry reactions, nitroalkane nucleophiles might also be 
responsible for catalyst turnover. Therefore, conditions need to be adjusted for alternative 
trapping of iminium ions (Figure 4.8). Mannich-type reactions of tetrahydroisoquinolines 
using Ru(bpy)3
2+
* under aerobic conditions have been developed in the groups of 
Rueping and Xia. Rueping and co-workers utilized enamines as the nucleophile, prepared 
in situ with ketones and proline, in the presence of Ru(bpy)3PF6 in acetonitrile solvent 
under irradiation with a 5 W CFL.
139
 Alternatively, Xia and co-workers demonstrated 
silyl enol ethers as competent nucleophiles, in combination with Ru(bpy)3Cl2 in methanol 
and blue LEDs.
140
  The Rueping group has also disclosed oxidative cyanations of amines 
using photocatalyst Ir(tbp-py)2(bpy)PF6 and KCN in AcOH.
141
 A similar transformation 
can be accomplished using Rose Bengal and graphene oxide.
142
 When the substrate is 
ethyl 2-(3,4-dihydroisoquinolin-2(1H)-yl)acetate, a dipolarophile can be generated 
photocatalytically and engage in [3+2] cycloadditions with electron deficient alkenes, 
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followed by NBS oxidation to form pyrroles.
143
 The Rovis group coupled the processes 
of photoredox generation of iminium ions with NHC catalysis for asymmetric α-
acylations of N-aryl tetrahydroisoquinolines. Using Ru(bpy)3Cl2 as the catalyst with m-
dinitrobenzene (m-DNB) as the oxidant, products were obtained in high yields in up to 92 
% ee.
144
 Intramolecular trapping of the iminium ion has also been reported by Xiao and 
co-workers.
145
 Chiral diamine substrates can undergo oxidation preferentially at a 
benzylic C–H over an alkyl C–H using Ru(bpy)3Cl2 and cyclize to form 
tetrahydroimidazoles in the presence of base with good diastereoselectivity. With 
prolonged reaction times, the authors observed the epimerization of products via a 
subsequent oxidation of the originally formed product. 
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Figure 4.8 Alternative nucleophilic trapping of photoredox amine oxidations 
Rather than iminium ion generation, the amine radical cation can also undergo 
deprotonation to give an α-amino radical (Figure 4.9). These intermediates can then react 
with different acceptors. Upon screening up to 1000 different reagent combinations, the 
MacMillan group discovered an efficient α-arylation reaction of a wide variety of amines 
using Ir(ppy)3 as the photocatalyst along with electron-poor cyanoarenes and NaOAc as 
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base.
146
 The proposed C–C bond forming event involves coupling of the aryl radical 
anion with the α-amino radical. The α-amino radical can also participate in conjugate 
addition reactions with π-acceptors. For example, Reiser and co-workers reported the use 
of different photocatalysts and blue LEDs for the alkylation of N-aryl 
tetrahydroisoquinolines.
147
 Reactions were run under deoxygenated conditions to disfavor 
further oxidation to the iminium and instead promote reaction with a variety of Michael 
acceptors. Nishibayashi and co-workers similarly reported the reaction of anilines with 
Ir(ppy)2(dtbbpy)BF4 and alkylidene malonates with 14 W LEDs.
148
  
 
Figure 4.9 Photoredox reactions of α-amino radicals 
4.2 Results and Discussion
149
 
 The success of the photoredox aza-Henry reaction developed by our group
132 
(Figure 4.7) inspired the subsequent investigation into the trapping of iminium ions with 
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a wider variety of nucleophiles. The previously optimized conditions using 
Ir(ppy)2(dtbbpy)PF6 as the photocatalyst under aerobic conditions led to some issues. 
Specifically, in the absence of nitromethane the reaction leads to the formation of several 
side products resulting from the reaction of the amine radical cation with either the 
solvent (THF), oxygen, or from self-dimerization (Figure 4.10). In addition, with only the 
use of atmospheric oxygen to turn over the catalyst, the reaction is quite sluggish, which 
promotes the formation of undesired side reactions. Thus, in order to develop a reaction 
that would bias the pathway to the iminium ion, a new set of conditions needed to be 
designed involving a comprehensive screening of different photocatalysts and oxidants.  
 
Figure 4.10 Undesired reactions resulting from the α-amino radical 
 Prior to reaction screening, a thorough mechanistic analysis of each divergent 
pathway of the amine oxidation was studied (Figure 4.11). The driving forces of this 
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transformation were considered in more detail upon focusing on the photocatalyst 
Ru(bpy)3Cl2. Oxidation by Ru(bpy)3
2+
* (Ered = +0.84 V vs SCE) of tertiary amines 
(Ered(Et3N) = +0.73 V vs SCE) first forms the amine radical cation. This consequently 
lowers the bond dissociation energy (BDE) of the α-C–H bond from about 90.7 kcal mol-
1
 to approximately 34 kcal mol
-1
.
150, 151
  The significant weakening of this bond lends 
support to a hydrogen atom abstraction pathway leading to iminium ion formation.  
For the alternative pathway leading to the α-amino radical, the acidity needed to 
be evaluated. Researchers have shown that the pKa of the α-C–H bond of the amine 
radical cation can be correlated to the BDE(CHA) and redox potential of the amine 
(Ered).
152
 Accordingly, using the equation derived by Nicholas and Arnold, the simplified 
relationship is:
 153
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By using known values for Et3N
109
 (Figure 4.11), the pKa of (Et3N)
•+ 
 lowers from greater 
than 40 units to approximately 26.7 units. Thus, deprotonation of the amine radical cation 
to form the α-amino radical is certainly viable under photoredox conditions. In the case of 
the aza-Henry reaction, based on the proposed mechanism illustrated in Figure 4.7, 
hydroxide ion can be generated during the course of the reaction under oxygenated 
conditions. The formation of this strong base occurs via hydrogen-atom abstraction of the 
amine radical cation by superoxide radical anion that gets formed from the oxidation of 
Ir(ppy)2(dtbbpy)
2+
. Due to these factors, the development of deoxygenated conditions for 
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the photo-generation of iminium ions appeared to be a reasonable progression of 
methodology.  
 
Figure 4.11 Driving forces for divergent reaction pathways of amine radical cations 
 In order to improve reaction conditions for a wide scope of nucleophilic trapping, 
an oxygen-free protocol with a suitable stoichiometric oxidant was sought. During the 
course of the investigation, several reports were published that involved the use of similar 
metal-polypyridinyl photoredox catalysts for the tandem generation of iminium 
ions/nucleophilic trapping under aerobic conditions.
103-105, 143
 However, for each type of 
nucleophile used, a separate set of conditions were described. These included the use of 
different photocatalysts,
154
 solvents,
155
 light sources,
156
 and additives.
157
 For example, 
Rueping’s oxidative Mannich reactions provided better results in acetonitrile using a 5W 
CFL as the light source, whereas the Xia’s silyl enol ether additions performed better in 
methanol using blue LEDs as the light source. Therefore, it seemed that to better identify 
a unifying protocol that was amenable to a diverse set of nucleophiles, the reaction 
should be performed in the absence of oxygen. 
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 The screening of conditions commenced with the oxidative cyanation (or Strecker 
reaction) of N-phenyl tetrahydroisoquinoline (4.07) using Ir(ppy)2(dtbbpy)PF6 (4.08) as 
the photocatalyst and ethyl α-bromoacetate (EtO2CCH2Br) as an oxidant. The reaction 
was carried out with NaCN as the nucleophile in DMF solvent under white light 
irradiation. However, a low isolated yield of 4.10 was obtained (36%, Table 4.1, entry 1). 
With the lower redox potential—and therefore poorer oxidizing ability—of 
Ir(ppy)2(dtbbpy)
3+
* (Ered = +0.62 V vs SCE) compared with Ru(bpy)3
2+
* (Ered =  +0.84 V 
vs SCE), improving results with the Ir-based catalyst was considered to be a greater 
challenge. Therefore, the catalyst was switched to Ru(bpy)3Cl2 (4.09) and diethyl 
bromomalonate ((EtO2C)2CHBr) was chosen as the oxidant due to the precedented redox 
reactivity between these two compounds (Section 3.3). Using blue LEDs as the light 
source, a greatly enhanced isolated yield of 95% was obtained for 4.10 (entry 2). Despite 
the high yield, (EtO2C)2CHBr was determined to be unsuitable for wider application due 
to the potential issues arising from its byproducts. The reactive malonyl radical generated 
from C–Br reduction and diethylmalonate formed upon hydrogen-atom abstraction could 
interfere with nucleophilic trapping. Furthermore, the malonate is difficult to remove 
from the crude reaction mixture.  
Switching to CCl4 caused a rate deceleration and a decrease in yield in DMF, with 
a slight improvement in MeCN (Table 4.1, entries 3-4). Use of bromotrichloromethane 
(BrCCl3) as the stoichiometric oxidant led to an increase in rate, with full consumption of 
4.07 observed in < 3h. However, inconsistent results for the formation of 4.10 were 
observed, ranging from trace amounts to up to 85% yield (entry 5). It was soon 
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discovered that under the photoredox conditions, NaCN and BrCCl3 were reacting with 
each other to form trichloroacetonitrile, which hinders the catalytic cycle. By changing 
the protocol from simultaneous to sequential addition of reagents, this undesired 
reactivity could be rendered inconsequential. Accordingly, excess NaCN was added to 
the reaction mixture only after TLC analysis indicated full conversion of 4.07 to the 
iminium ion and the reaction flask was removed from the light (entry 6). With an 
encouraging 85% isolated yield, the solubility of the inorganic nucleophile was tested as 
a possible adverse factor and the same reaction was conducted using Bu4NCN as the 
source of cyanide. However, this resulted in a very low isolated yield (17%, entry 7), so a 
solvent screen was conducted to improve the solubility of the NaCN. Good results were 
obtained using a 2:1 mixture of THF/H2O, providing an 83% yield of 4.10 (entry 9) 
which was comparable to the results in DMF. No reaction was observed in just THF, 
presumable due to the low solubility of Ru(bpy)3Cl2 (entry 8).  
Table 4.1 Optimization of oxidative Strecker reaction 
 
Entry Conditions Yield
a
 
1 4.08 (1 mol%), EtO2CCH2Br (3 equiv), DMF, 5 W 
CFL, NaCN (5 equiv), 24 h 
36 
2 4.09 (1 mol%), (EtO2C)2CHBr (3 equiv), DMF, blue 
LEDs, NaCN (5 equiv), 5 h 
95 
3 4.09 (1 mol%), CCl4:DMF (1:1), blue LEDs, NaCN (5 
equiv), 24 h 
36 
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4 4.09 (1 mol%), CCl4 (3 equiv), CH3CN, blue LEDs, 
NaCN (5 equiv), 3 d 
53 
5 4.09 (1 mol%), BrCCl3 (3 equiv), DMF, blue LEDs, 
NaCN (5 equiv), 7 h 
60
b
 
6 4.09 (1 mol%), BrCCl3 (3 equiv), DMF, blue LEDs, 
2 h then no light, NaCN (5 equiv), 3 h 
85 
7 4.09 (1 mol%), BrCCl3 (3 equiv), DMF, blue LEDs, 2 
h then no light, Bu4NCN (5 equiv), 12 h 
17 
8 4.09 (1 mol%), BrCCl3 (3 equiv), THF, blue LEDs, 7 
h 
NR
c
 
9 4.09 (1 mol%), BrCCl3 (3 equiv), THF:H2O (2:1), 
blue LEDs, 4 h, then no light, NaCN (5 equiv), 2 h 
83 
a
Isolated percent yields after chromatography on SiO2. 
b
Inconsistent yields. 
c
Iminium ion 
formation was not observed. 
With successful conditions for the oxidative Strecker reaction (Table 4.1, entry 6), 
the aza-Henry reaction was then re-evaluated under the new procedure. When 4.07 was 
fully converted to the iminium ion, as monitored by TLC, the reaction was removed from 
light and nitromethane (5 equiv.) was added. This resulted in a slow conversion to 
product 4.11 (eq. 2).  
 
It was hypothesized that the faster rate observed for the aerobic aza-Henry 
reaction (Figure 4.7) was due to the generation of base as a beneficial component to drive 
the reaction forward. Thus, upon the addition of an equimolar amount of Et3N
158
 in the 
absence of light, the reaction completed in <4 h and aza-Henry product 4.11 was isolated 
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in 95% yield. In addition to improving the efficiency of this transformation compared to 
previously, these results also lent support to our proposed mechanism. Differentially 
substituted N-aryl tetrahydroisoquinolines and nitroalkanes were subjected to the same 
conditions, providing excellent yields with short reaction times (3-4 h) (Table 4.2). 
Table 4.2 Photoredox aza-Henry reaction substrate scope 
 
 Next, iminium trapping with allylsilanes was explored with these conditions. 
Unfortunately, upon full conversion to the iminium ion, the addition of allyl 
trimethylsilane did not provide the desired allylated products. It is possible that under the 
photoredox conditions, formation of the secondary β-silyl carbocation intermediate is not 
stable and prevents the forward reaction. Nevertheless, trapping with methallyl 
trimethylsilane, which forms a more stable tertiary carbocation, provided Sakurai-type 
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allylation products (Table 4.3).  Upon the introduction of electron-rich methoxy 
substituents on the N-aryl group or tetrahydroisoquinoline carbocycle, the yields dropped 
significantly compared to the allylation of 4.07. This is presumably due to the decreased 
electrophilicity of the iminium intermediate.  
Table 4.3 Photoredox Sakurai-type reaction substrate scope 
 
 The addition of carbonyl compounds was next explored using a variety of 
different nucleophiles. Silyl enol ethers, malonates, and methyl acetoacetates underwent 
addition to form Mannich-type reaction products in good yields (Table 4.4). 1,3-
Diketones such as acetoacetone also underwent addition; however, when product 
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isolation was attempted, decomposition was observed, likely due to a retro-Mannich 
pathway.  
Table 4.4 Photoredox Mannich-type reaction substrate scope 
 
 For the synthesis of polycyclic compounds, N-phenyl tetrahydroisoquinoline 
(4.07) was reacted with 2-silyloxyfuran under the optimized conditions, producing 
butenolide 4.24 in 55% isolated yield (eq. 3, 1:1 d.r.). A Friedel-Crafts reaction of the 
iminium ion with indole was also successful to provide C3-alkylated indole product 4.25 
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in 80% yield (eq. 4).  The use of a stronger base such as KOtBu in place of Et3N was 
shown to be beneficial in this case to enhance nucleophilicity of the indole.  
 
 The results from the nucleophilic addition reactions compare favorably in both 
scope and yield to alternative methods for α-amine functionalization. This includes both 
photoredox methods as well as non-photoredox methodology such as Li’s CuBr-mediated 
cross dehydrogenative coupling. In particular, the anaerobic photoredox conditions 
developed in this study using BrCCl3 as the oxidant allow for a unified approach to 
trapping of in situ generated iminium ions with broad set of nucleophiles. Furthermore, 
this photocatalytic process could be used in parallel with another metal-catalyzed process 
to affect alkyne additions (Figure 4.15). Upon visible light-mediated generation of the 
iminium ion, addition of terminal alkynes using 15 mol% CuBr in the presence of Et3N 
provides desired products 4.25-4.28 in good yields and also showcases the general 
tolerance of the photoredox reaction conditions.  In this case, the introduction of electron-
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rich methoxy substituents seemed to have little effect on the outcome of the alkynylation 
reaction (Table 4.5, 4.26 vs 4.28).  
Table 4.5 Copper-mediated alkynylation coupled with photoredox catalysis 
 
Mechanistic Analysis 
 The results obtained from this study support the intermediacy of an iminium ion 
based on the reactivity profile of the nucleophiles used. The addition of copper acetylenes 
as well as an indole at the C3-position is indicative of an electrophilic intermediate being 
generated under the conditions.   With the Ru(bpy)3Cl2/BrCCl3 system under 
deoxygenated conditions, the reaction rates were generally faster than with 
Ir(ppy)2(dtbbpy)PF6/MeNO2/O2, particularly for the aza-Henry reactions. To obtain a 
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better understanding of the oxidation mechanism and the rate of iminium ion formation, 
1
H NMR analysis was used to monitor the course of the reaction. Accordingly, 
tetrahydroisoquinoline 4.07 was placed in an NMR tube in DMF-d7 with 1 mol% 
Ru(bpy)3Cl2. Upon addition of BrCCl3 in the absence of light, no change was observed in 
the spectrum after 1 min (Figure 4.12). After 10 min of visible light irradiation, a new 
peak at 10.1 ppm appeared, corresponding to ~40% conversion to the iminium ion 4.07b. 
The conversion eventually reached to over 80% after 52 min of continuous monitoring 
(Figure 4.13). 
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Figure 4.12 
1
H NMR monitoring of iminium formation. Compound 4.07 and 
Ru(bpy)3Cl2 (1 mol%) in d7-DMF. (t) correlates to time elapsed upon the addition of 
BrCCl3 (3 equiv) into the reaction. 
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Figure 4.13 Plot of conversion vs. time 
 Upon closer inspection of the 
1
H NMR spectra, the gradual appearance of a new 
peak at 8.5 ppm was identified as corresponding to the formation of chloroform (CHCl3) 
from the reduction of BrCCl3. A side by side comparison of the proton spectra of 4.07 
and 4.07b is illustrated in Figure 4.14. This assignment was confirmed upon the addition 
of 3 equiv of CHCl3 to the NMR tube, which only resulted in an increase in intensity of 
the singlet at 8.5 ppm.  
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Figure 4.14 Evidence for BrCCl3 reduction to CHCl3 
With the experimental evidence supporting formation of the iminium ion and 
chloroform, a mechanism can be postulated for the α-amine functionalization involving 
nucleophilic trapping of an in situ generated iminium. Under the photoredox conditions, 
however, there are a few possible pathways to this intermediate. One possibilty begins 
with Ru(bpy)3
2+
 excitation to Ru(bpy)3
2+*
 followed by oxidation of the 
tetrahydroisoquinoline by Ru(bpy)3
2+
* to generate the amine radical cation and Ru(bpy)3
+ 
(Figure 4.15). Bromotrichloromethane (or other alkyl halide) can then re-oxidize 
Ru(bpy)3
+
 to Ru(bpy)3
2+
 and get reduced to trichloromethyl radical and bromide. The 
trichloromethyl radical can then abstract the α-C–H atom to generate the iminium ion and 
chloroform. Trapping by a nucleophile then completes the sequence.  
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Figure 4.15 Mechanistic hypothesis I 
 A second possibilty involves a radical chain process (Figure 4.16). Initiation via 
excitation of Ru(bpy)3
2+ 
to
 
Ru(bpy)3
2+
*
  
is followed by oxidation of the amine to the 
radical cation. Deprotonation can then occur to form an α-amino radical. Propagation of 
the radical chain can transpire through different pathways. Electron transfer from the α-
amino radical to BrCCl3 forms the iminium ion and generates trichloromethyl radical (A). 
Another pathway involves atom transfer from BrCCl3 to generate trichloromethyl radical 
as well as the α-bromo tetrahydroisoquinoline (B), which can then undergo ionization to 
the iminium ion (C).
159
 The trichloromethyl radical can engage in direct α-C–H atom 
abstraction to generate the α-amino radical and perpetuate the radical chain propagation.  
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Figure 4.16 Mechanistic hypothesis II 
 Another mechanistic possibility that cannot be ruled out involves the oxidative 
quenching cycle of the photocatalyst (Figure 4.17). Excitation of the catalyst forms 
Ru(bpy)3
2+
* (Ered (Ru
3+
/
2+
*) = –0.86 V vs SCE) which can directly reduce BrCCl3 to 
produce Ru(bpy)3
3+
 and trichloromethyl radical (Cl3C•). Oxidation of the 
tetrahydroisoquinoline by Ru(bpy)3
3+ 
(Ered (Ru
3+
/
2+
) = +1.27 V vs SCE) forms the amine 
radical cation and Ru(bpy)3
2+
. Hydrogen-atom abstraction by Cl3C• then forms the 
reactive iminium ion. While luminescence quenching of Ru(bpy)3
2+
* has been observed 
with the isoquinoline, quenching has also been observed with polyhalomethanes such as 
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CCl4.
160
 Furthermore, bromotrichloromethane has also been directly reduced by 
Ru(bpy)3Cl2 in the absence of an electron donor for atom transfer radical addition 
reactions.
161
 However, the reducing ability of Ru(bpy)3
2+
* compared to Ru(bpy)3
+ 
is 
much weaker (–0.86 V vs –1.31 V), which might disfavor this pathway. Overall, no 
conclusive pieces of information can point to one mechanism over the other at the 
moment. 
 
Figure 4.17 Mechanistic hypothesis III 
4.3 Conclusion 
 Direct methods for the functionalization of amines are becoming increasingly 
popular with the development of new oxidation protocols that are selective and mild. 
Photoredox catalysis in particular is a convenient means of generating iminium ions due 
to the low reduction potentials (high oxidation strength) of tertiary amines that can be 
readily exploited. As a consequence, selective α-amine functionalization can be 
accomplished at room temperature using visible light and low catalyst loading with the 
minimization of side reactions. Several photoredox-based methods exist for in situ 
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trapping of iminiums, however, a single protocol has been developed that can be used to 
achieve diverse nucleophilic additions. With Ru(bpy)3Cl2 and BrCCl3 as the oxidant, a 
unified set of conditions can be applied for several transformations including oxidative 
Strecker, Mannich-type, Friedel-Crafts, and Sakurai-type reactions in good yields.  
Furthermore, photoredox amine oxidation can be combined in a complimentary fashion 
with copper catalysis to affect α-amino alkynylations. 
4.4 Experimental 
General Information: All chemicals were purchased from Sigma-Aldrich and were used 
as received unless otherwise stated. Solvents including N,N-dimethylformamide (DMF), 
tetrahydrofuran (THF), acetonitrile (CH3CN), toluene, benzene, and dichloromethane 
were purchased from Fischer Scientific and further dried using Glass Contour Solvent 
System by SG Waters USA LLC. Unless stated differently, all reactions were performed 
under inert atmosphere (Argon) and previously dried using common anhydrous 
techniques. Reactions were monitored by TLC and visualized by a dual short wave/long 
wave UV lamp and stained with I2. All compounds were purified via flash column 
chromatography using 230–400 mesh silica gel. NMR spectra were recorded on Varian 
Unity Plus 400 and Varian Mercury 400 spectrometers. Chemical shifts for 
1
H NMR 
were reported as δ, parts per million, relative to the signal of CHCl3 at 7.26(s) ppm or 
DMF at 8.03 (s), 2.92(p), and 2.75(p) ppm. Chemical shifts for 
13
C NMR were reported 
as δ, parts per million, relative to the center line signal of the CDCl3 triplet at 77.0 ppm. 
Proton and carbon assignments were established using spectral data of similar 
compounds. The abbreviations s, br. s, d, dd, br. d, ddd, t, q, br. q, p, m, and br. m stand 
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for the resonance multiplicity singlet, broad singlet, doublet, doublet of doublets, broad 
doublet, doublet of doublet of doublets, triplet, quartet, broad quartet, pentet, multiplet 
and broad multiplet, respectively. IR spectra were recorded on an Avatar 360 FT-IR 
spectrometer. Mass spectra were recorded in the Mass Spectrometry Facility at the 
Department of Chemistry of Boston University in Boston, MA on a Waters Q-Tof API-
US with ESI high resolution mass spectrometer. Concentration refers to removal of 
solvent under reduced pressure (house vacuum at ca. 20 mmHg). 1,2,3,4-
etrahydroisoquinoline derivatives
162
 and 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline
163
 
were prepared according to published literature procedures. 
General Procedure 4.1: A 10 ml round bottom flask was equipped with a rubber septum 
and magnetic stir bar and was charged with N-phenyl-1,2,3,4-tetrahydroisoquinoline 
(0.244 mmol, 1.0 equiv), Ru(bpy)3Cl2 (0.002 mmol, 0.01 equiv), and DMF (1.0 mL). The 
flask was degassed (3x freeze/pump/thaw) before BrCCl3 (0.731 mmol, 3.0 equiv) was 
added. The mixture was then irradiated by a 1 W blue LED 30 cm strip under an 
atmosphere of argon for 3h. After the starting material was consumed as indicated by 
TLC, the blue LED was removed and the nucleophile (1.218 mmol, 5.0 equiv) was 
added. The reaction was covered with aluminum foil and stirred at room temperature. 
After approximately 12h, the reaction was poured into a separatory funnel containing 75 
mL of a saturated solution of NaHCO3 and 25 mL of EtOAc. The layers were separated 
and the aqueous layer was extracted with EtOAc (2 x 25 mL). The combined organic 
layers were washed with brine (25 mL), dried over Na2SO4, filtered and concentrated. 
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The residue was purified by silica gel column chromatography in the indicated solvent 
mixture to afford the desired product. 
Cyanation 
 
2-Phenyl-1,2,3,4-tetrahydroisoquinoline-1-carbonitrile (4.10). According to the 
general procedure, 4.07 (51.0 mg, 0.244 mmol, 1.0 equiv), Ru(bpy)3Cl2 (2.0 mg, 0.002 
mmol, 0.01 equiv), and BrCCl3 (72.0 μL, 0.731 mmol, 3.0 equiv) in DMF (1.0 mL) were 
irradiated with 1W blue LED lights until starting material was consumed as indicated by 
TLC. The reaction vessel was covered with aluminum foil before NaCN (60.0 mg, 1.218 
mmol, 5.0 equiv) was added. After workup, the crude oil was purified via silica gel 
chromatography (1:39 EtOAc/hexanes) to afford 4.10 in 85% yield. Rf (1:39 
EtOAc/hexanes): 0.15; 
1
H NMR (CDCl3, 400 MHz): δ 7.27 (dd, J = 7.6, 8.8 Hz, 2 H), 
7.23–7.14 (m, 4 H), 6.99 (d, J = 7.6 Hz, 2 H), 6.93 (t, J = 7.2 Hz, 1 H), 5.43 (s, 1 H), 3.68 
(dddd, J = 1.2, 3.4, 6.0, 12.4 Hz, 1 H), 3.39 (ddd,  J = 4.0, 10.8, 12.4 Hz, 1 H), 3.07 (ddd, 
J = 6.0, 10.8, 16.4 Hz, 1 H), 2.87 (dt, J = 3.2, 16 Hz, 1 H). 
aza-Henry  
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1-(Nitromethyl)-2-phenyl-1,2,3,4-tetrahydroisoquinoline (4.11): According to the 
general procedure, 4.07 (51.0 mg, 0.244 mmol, 1.0 equiv), Ru(bpy)3Cl2 (2.0 mg, 0.002 
mmol, 0.01 equiv), and BrCCl3 (72.0 μL, 0.731 mmol, 3.0 equiv) in DMF (1.0 mL) were 
irradiated with 1W blue LED lights until starting material was consumed as indicated by 
TLC. The reaction vessel was covered with aluminum foil before Et3N (0.17 mL, 1.218 
mmol, 5.0 equiv) and MeNO2 (66.0 μL, 1.218 mmol, 5.0 equiv) were added. The crude 
mixture was dissolved in a minimal amount of dichloromethane (approx. 0.5 mL) 
followed by excess diethyl ether (approx. 3.0 mL). A precipitate was observed and the 
heterogeneous mixture was filtered quickly over a plug of plug of silica that was washed 
heavily with diethyl ether. Concentration of the filtrate provided aza-Henry product 4.11 
in 95% yield.
1
H NMR (CDCl3, 500 MHz) δ 7.16–7.03 (m, 5 H), 6.98 (d, J = 6.8 Hz, 1 
H), 6.83 (d, J = 8.0 Hz, 2 H), 6.70 (t, J = 7.4 Hz, 1 H), 5.40 (dd, J = 7.6, 6.9 Hz, 1 H), 
4.72 (dd, J = 11.8, 7.6 Hz, 1 H), 4.41 (dd, J = 11.8, 6.9 Hz, 1 H), 3.54–3.44 (m, 2 H), 
2.94 (ddd, J = 16.1, 8.5, 5.6 Hz, 1 H), 2.65 (ddd, J = 16.1, 5.1, 4.9 Hz, 1 H). 
 
2-(4-Bromophenyl)-1-(nitromethyl)-1,2,3,4-tetrahydroisoquinoline (4.13): According 
to the general procedure, 4.12 (50.0 mg, 0.174 mmol, 1.0 equiv), Ru(bpy)3Cl2 (1.5 mg, 
0.002 mmol, 0.01 equiv), and BrCCl3 (51.0 μL, 0.521 mmol, 3.0 equiv) in DMF (1.0 mL) 
were irradiated with 1W blue LED lights until starting material was consumed as 
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indicated by TLC. The reaction vessel was covered with aluminum foil before Et3N 
(120.0 μL, 0.868 mmol, 5.0 equiv) and MeNO2 (46.0 μL, 0.868 mmol, 5.0 equiv) were 
added. The crude mixture was dissolved in a minimal amount of dichloromethane 
(approx. 0.5 mL) followed by excess diethyl ether (approx. 3.0 mL). A precipitate was 
observed and the heterogeneous mixture was filtered quickly over a plug of plug of silica 
that was washed heavily with diethyl ether. Concentration of the filtrate provided aza-
Henry product 4.13 in 93% yield.
1
H NMR (CDCl3, 500 MHz) δ 7.23 (d, J = 8.8 Hz, 2 H), 
7.17–7.07 (m, 3 H), 7.02 (d, J = 7.5 Hz, 1 H), 6.74 (d, J = 8.8 Hz, 2 H), 5.38 (dd, J = 7.5, 
7.0 Hz, 1 H), 4.74 (dd, J = 11.9, 7.5 Hz, 1 H), 4.47 (dd, J = 11.9, 7.0 Hz, 1 H), 3.59–3.47 
(m, 2 H), 2.97 (ddd, J = 16.2, 8.5, 6.0 Hz, 1 H), 2.70 (ddd, J = 16.2, 4.8, 4.8 Hz, 1 H). 
 
2-(4-Methoxyphenyl)-1-(1-nitroethyl)-1,2,3,4-tetrahydroisoquinoline (4.15): 
According to the general procedure, 4.14 (100.0 mg, 0.418 mmol, 1.0 equiv), 
Ru(bpy)3Cl2 (3.0 mg, 0.004 mmol, 0.01 equiv), and BrCCl3 (120.0 μL, 1.254 mmol, 3.0 
equiv) in DMF (1.7 mL) were irradiated with 1W blue LED lights until starting material 
was consumed as indicated by TLC. The reaction vessel was covered with aluminum foil 
before Et3N (290.0 μL, 2.089 mmol, 5.0 equiv) and EtNO2 (150.0 μL, 2.089 mmol, 5.0 
equiv) were added. The crude mixture was dissolved in a minimal amount of 
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dichloromethane (approx. 0.5 mL) followed by excess diethyl ether (approx. 3.0 mL). A 
precipitate was observed and the heterogeneous mixture was filtered quickly over a plug 
of plug of silica that was washed heavily with diethyl ether. Concent1ration of the filtrate 
provided aza-Henry product 4.15 in 95% yield as a ~ 2:1 inseparable mixture of 
diastereomers.
1
H NMR (CDCl3, 500 MHz) δ 7.30–7.10 (m, 6 H), 7.02–6.99 (m, 2 H), 
6.84–6.81 (m, 2 H), 5.26 (d, J = 7.7 Hz, 1 H), 5.24 (d, J = 7.7 Hz, 1 H), 5.05 (dq, J = 7.7, 
7.0 Hz, 1 H), 4.89 (dq, J = 7.7, 6.5 Hz, 1 H), 3.84 (ddd, J = 13.3, 7.5, 5.5 Hz, 2 H),  3.62–
3.55 (m, 2 H), 3.09–3.03 (m, 1 H), 2.95–2.85 (m, 1 H), 1.70 (d, J = 6.5 Hz, 3 H), 1.55 (d, 
J = 7.0 Hz, 3 H). 
Allylation 
 
1-(2-Methylallyl)-2-phenyl-1,2,3,4-tetrahydroisoquinoline (4.16): According to the 
general procedure, 4.07 (53.0 mg, 0.253 mmol, 1.0 equiv), Ru(bpy)3Cl2 (2.0 mg, 0.002 
mmol, 0.01 equiv), and BrCCl3 (75.0 μL, 0.760 mmol, 3.0 equiv) in DMF (1.0 mL) were 
irradiated with 1W blue LED lights until starting material was consumed as indicated by 
TLC. The reaction vessel was covered with aluminum foil before 
methallyltrimethylsilane (220 μL, 1.266 mmol, 5.0 equiv) was added. After workup, the 
crude oil was purified via silica gel chromatography (1:39 EtOAc/hexanes) to afford 4.16 
in 85% yield. Rf (1:39 EtOAc/hexanes): 0.15;
1
H NMR (CDCl3, 400 MHz): δ 7.42–7.38 
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(t, J = 8.8 Hz, 2 H), 7.31–7.24 (m, 4 H), 7.08 (d, J = 8.4 Hz, 2 H), 6.92–6.88 (t, J = 7.2 
Hz, 1 H), 5.02 (t, J = 7.2 Hz, 1 H), 4.98 (s, 1 H), 4.84 (s, 1 H), 3.81–3.78 (dd, J = 5.2, 6.8, 
2 H), 3.19 (dt, J = 7.6, 16 Hz, 1 H), 3.00 (dt, J = 4.2, 16 Hz, 1 H), 2.86 (dd, J = 6.8, 13.6 
Hz, 1 H), 2.57 (dd, J = 7.2, 14 Hz, 1 H), 1.96 (s, 3H). 
 
2-(4-Methoxyphenyl)-1-(2-methylallyl)-1,2,3,4-tetrahydroisoquinoline (4.17): 
According to the general procedure, 4.14 (50.0 mg, 0.209 mmol, 1.0 equiv), Ru(bpy)3Cl2 
(2.0 mg, 0.002 mmol, 0.01 equiv), and BrCCl3 (62.0 μL, 0.627 mmol, 3.0 equiv) in DMF 
(0.85 mL) were irradiated with 1W blue LED lights until starting material was consumed 
as indicated by TLC. The reaction vessel was covered with aluminum foil before 
methallyltrimethylsilane (180 μL, 1.045 mmol, 5.0 equiv) was added. After workup, the 
crude oil was purified via silica gel chromatography (1:99 EtOAc/hexanes) to afford 4.17 
in 44% yield. Rf (1:99 EtOAc/hexane): 0.15; 
1
H NMR (CDCl3, 400 MHz): δ 7.17–7.10 
(m, 4 H), 6.55 (d, J = 9 Hz, 2 H), 6.82 (d, J = 9.2 Hz, 2 H), 4.82 (s, 1 H), 4.70 (t, J = 7.1 
Hz, 1 H), 4.68 (s, 1 H), 3.76 (s, 3 H), 3.61–3.57 (m, 2 H), 2.99 (ddd, J = 6.8, 9.0, 16.0 Hz, 
1 H), 2.74 (dt, J = 4.1, 16.2 Hz, 1 H), 2.65 (dd, J = 7.2, 13.9 Hz, 1 H), 2.41 (dd, J = 6.7, 
13.9 Hz, 1 H), 1.78 (s, 3 H). 
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6,7-Dimethoxy-1-(2-methylallyl)-2-phenyl-1,2,3,4-tetrahydroisoquinoline (4.19): 
According to the general procedure, 4.18 (54.0 mg, 0.200 mmol, 1.0 equiv), Ru(bpy)3Cl2 
(2.0 mg, 0.002 mmol, 0.01 equiv), and BrCCl3 (59.0 μL, 0.760 mmol, 3.0 equiv) in DMF 
(0.8 mL) were irradiated with 1W blue LED lights until starting material was consumed 
as indicated by TLC. The reaction vessel was covered with aluminum foil before 
methallyltrimethylsilane (176 μL, 1.00 mmol, 5.0 equiv) was added. After workup, the 
crude oil was purified via silica gel chromatography (1:19 EtOAc/hexanes) to afford 4.19 
in 43% yield as a colorless oil. Rf (1:19 EtOAc/hexanes): 0.15;IR (neat): νmax 3069, 2933, 
2849, 2834, 1598, 1598, 1516, 1502, 1464, 1452, 1388, 1353, 1247, 1230, 1211, 1110, 
1032 cm
-1
;
1
H NMR (CDCl3, 400 MHz): δ 7.22 (t, J = 7.6 Hz, 2 H), 6.91 (d, J = 8.4 Hz, 2 
H), 6.74 (t, J = 7.2 Hz, 1 H), 6.60 (s, 2 H), 4.82 (s, 1 H), 4.77 (t, J = 7.0 Hz, 1 H), 4.70 (s, 
1 H), 3.85 (s, 6 H), 3.69–3.63 (m, 1 H), 3.58 (ddd, J = 4.5, 9.6, 13.9 Hz, 1 H), 2.95 (ddd, 
J = 4.8, 8.6, 15.6 Hz, 1 H), 2.70 (dt, J = 4.3, 16.0 Hz, 1 H), 2.65 (dd, J = 6.7, 13.5 Hz, 1 
H), 2.40 (dd, J = 7.0, 13.7 Hz, 1 H), 1.80 (s, 3 H); 
13
C NMR (CDCl3, 100 MHz): δ 149.7, 
147.5, 146.8, 143.2, 141.7, 130.5, 129.2, 126.6, 117.6, 114.8, 113.4, 111.3, 110.6, 57.8, 
55.9, 55.8, 44.4, 41.5, 26.4, 23.0; HRMS (ESI) m/z calculated for C21H26NO2
+
 ([M+1]
+
) 
324.1964, found 324.1961.  
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Mannich 
 
1-(2-Phenyl-1,2,3,4-tetrahydroisoquinolin-1-yl)propan-2-one (4.20): According to the 
general procedure, 4.07 (52.0 mg, 0.249 mmol, 1.0 equiv), Ru(bpy)3Cl2 (2.0 mg, 0.002 
mmol, 0.01 equiv), and BrCCl3 (74.0 μL, 0.568 mmol, 3.0 equiv) in DMF (1.0 mL) were 
irradiated with 1W blue LED lights until starting material was consumed as indicated by 
TLC. The reaction vessel was covered with aluminum foil before acetone 
trimethylsilylenol ether (124.0 μL, 0.745 mmol, 3.0 equiv) was added. After workup, the 
crude oil was purified via silica gel chromatography (1:19 EtOAc/hexanes) to afford 4.20 
in 59% yield. Rf (1:19 EtOAc/hexanes): 0.15;
1
H NMR (CDCl3, 400 MHz): δ 7.27 (t, J = 
7.8 Hz, 2 H), 7.21–7.40 (m, 4 H), 6.96 (d, J = 8.2 Hz, 2 H), 6.80 (t, J = 7.3 Hz, 1 H), 5.43 
(t, J = 6.3 Hz, 1 H), 3.67 (ddd, J = 5.1, 5.1, 12.2 Hz, 1 H), 3.55 (ddd, J = 4.5, 9, 13.1 Hz, 
1 H), 3.11–3.05 (m, 1 H), 2.87–2.81 (m, 1 H), 2.09 (s, 3 H). 
 
1-(2-(4-Bromophenyl)-1,2,3,4-tetrahydroisoquinolin-1-yl)propan-2-one (4.21): 
According to the general procedure, 4.12 (52.0 mg, 0.180 mmol, 1.0 equiv), Ru(bpy)3Cl2 
(1.0 mg, 0.002 mmol, 0.01 equiv), and BrCCl3 (53.0 μL, 0.541 mmol, 3.0 equiv) in DMF 
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(0.75 mL) were irradiated with 1W blue LED lights until starting material was consumed 
as indicated by TLC. The reaction vessel was covered with aluminum foil before acetone 
trimethylsilylenol ether (90.0 μL, 0.541 mmol, 3.0 equiv) was added. After workup, the 
crude oil was purified via silica gel chromatography (1:19 EtOAc/hexanes) to afford 4.21 
in 65% yield. Rf (1:19 EtOAc/hexanes): 0.15; 
1
H NMR (CDCl3, 400 MHz): δ 7.23 (d, J = 
8.8 Hz, 2 H), 7.11–7.04 (m, 4 H), 6.72 (d, J = 8.8 Hz, 2 H), 5.26 (t, J = 6.4 Hz, 1 H), 3.51 
(ddd, J = 5.2, 12.4, 12.4 Hz, 1 H), 3.42 (ddd, J = 4.4, 8.4, 13.2 Hz, 1 H), 2.95 (m, 2 H), 
2.74 (m, 2 H), 2.00 (s, 3 H). 
 
Dimethyl 2-(2-phenyl-1,2,3,4-tetrahydroisoquinolin-1-yl)malonate (4.22): According 
to the general procedure, 4.07 (64.0 mg, 0.306 mmol, 1.0 equiv), Ru(bpy)3Cl2 (2.0 mg, 
0.003 mmol, 0.01 equiv), and BrCCl3 (91.0 μL, 0.917 mmol, 3.0 equiv) in DMF (1.0 mL) 
were irradiated with 1W blue LED lights until starting material was consumed as 
indicated by TLC. The reaction vessel was covered with aluminum foil before 
dimethylmalonate (171 μL, 1.529 mmol, 5.0 equiv) and K2CO3 (211.0 mg, 1.529 mmol, 
5 equiv) were added. After workup, the crude oil was rapidly purified via silica gel 
chromatography (1:39 EtOAc/hexanes) to afford 4.22 in 69% yield. Rf (1:39 
EtOAc/hexane): 0.2;
1
H NMR (CDCl3, 400 MHz): δ 7.26–7.10 (m, 6 H), 7.00 (d, J = 8.0 
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Hz, 2 H), 6.78 (t, J = 7.2 Hz, 1 H), 5.73 (d, J = 9.2 Hz, 1 H), 3.97 (d, J = 9.2 Hz, 1 H), 
3.74–3.61 (m, 2 H), 3.67 (s, 3 H), 3.56 (s, 3 H), 3.08 (ddd, J = 6.4, 8.8, 16.0 Hz, 1 H), 
2.89 (dt, J = 5.2, 16.4 Hz, 1 H). 
 
Methyl 3-oxo-2-(2-phenyl-1,2,3,4-tetrahydroisoquinolin-1-yl)butanoate (4.23): 
According to the general procedure, 4.07 (52.0 mg, 0.248 mmol, 1.0 equiv), Ru(bpy)3Cl2 
(2.0 mg, 0.002 mmol, 0.01 equiv), and BrCCl3 (73.0 μL, 0.745 mmol, 3.0 equiv) in DMF 
(1.0 mL) were irradiated with 1W blue LED lights until starting material was consumed 
as indicated by TLC. The reaction vessel was covered with aluminum foil before 
methylacetoacetate (130.0 μL, 1.242 mmol, 5.0 equiv) was added. Upon workup, the 
crude oil was rapidly purified via silica gel chromatography (1:39 EtOAc/hexanes) to 
afford 4.23 in 68% yield as a ~ 3:2 inseparable mixture of diastereomers. Rf (1:39 
EtOAc/hexane): 0.2; 
1
H NMR (CDCl3, 400 MHz): δ 7.24–7.08 (m, 12 H), 6.97 (dd, J = 
7.1, 7.8 Hz, 4 H), 6.84 (dd, J = 6.4, 7.1 Hz, 1 H), 6.76 (dd, J = 6.3, 7.4 Hz, 1 H), 5.75 (d, 
J = 9.6 Hz, 1 H), 5.61 (d, J = 9.7 Hz, 1 H), 4.17 (d, J = 9.3 Hz, 1 H), 4.01 (d, J = 9.0 Hz, 
1 H), 3.75–3.58 (m, 7 H), 3.53 (s, 3 H), 3.11–3.04 (m, 1 H), 2.97–2.86 (m, 2 H), 2.70–
2.67 (m, 1 H), 2.17 (s, 3 H), 2.11 (s, 3 H). 
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Allylation 
 
5-(2-Phenyl-1,2,3,4-tetrahydroisoquinolin-1-yl)furan-2(5H)-one (4.24): According to 
the general procedure, 4.07 (54.0 mg, 0.258 mmol, 1.0 equiv), Ru(bpy)3Cl2 (2.0 mg, 
0.002 mmol, 0.01 equiv), and BrCCl3 (77.0 μL, 0.774 mmol, 3.0 equiv) in DMF (1.0 mL) 
were irradiated with 1W blue LED lights until starting material was consumed as 
indicated by TLC. The reaction vessel was covered with aluminum foil before siloxy 
furan (81.0 mg, 0.516 mmol, 2.0 equiv) was added. After workup, the crude oil was 
purified via silica gel chromatography (1:4 EtOAc/hexanes) to afford 4.24 in 55% yield 
as a 1:1 mixture of inseparable diastereomers. Rf (1:3 EtOAc/hexanes): 0.25;
1
H NMR 
(CDCl3, 400 MHz): δ 7.53 (d, J = 5.6 Hz, 1 H), 7.39 (d, J = 5.6 Hz, 1 H), 7.33–7.16 (m, 
10 H), 7.00 (d, J = 8.4 Hz, 2 H), 6.90 (d, J = 8.4 Hz, 2 H), 6.84 (dd, J = 7.2, 14.4 Hz, 2 
H), 6.13 (dd, J = 1.6, 5.6 Hz, 1 H), 5.93 (dd, J = 1.6, 5.6 Hz, 1 H), 5.45 (dd, J = 2.0, 2.0 
Hz, 1 H), 5.35 (d, J = 6.4 Hz, 1 H), 5.18 (d, J = 4.4 Hz, 1 H), 4.92 (d, J = 6.0 Hz, 1 H), 
3.79 (ddd, J = 5.6, 5.6, 11.6 Hz, 1 H), 3.69–3.56 (m, 2 H), 3.45 (ddd, J = 5.2, 8.0, 12.8 
Hz, 1 H), 3.10–2.91 (m, 4 H). 
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Indolation 
 
1-(1H-Indol-3-yl)-2-phenyl-1,2,3,4-tetrahydroisoquinoline (4.25): According to the 
general procedure, 4.07 (52.0 mg, 0.249 mmol, 1.0 equiv), Ru(bpy)3Cl2 (2.0 mg, 0.002 
mmol, 0.01 equiv), and BrCCl3 (74.0 μL, 0.745 mmol, 3.0 equiv) in DMF (1.0 mL) were 
irradiated with 1W blue LED lights until starting material was consumed as indicated by 
TLC. The reaction vessel was covered with aluminum foil before indole (145.0 mg, 1.242 
mmol, 5.0 equiv) and KO
t
Bu (139.0 mg, 1.242 mmol, 5.0 equiv) were added 
successively. After workup, the crude solid was purified via silica gel chromatography 
(13:7 benzene/hexanes) to afford 4.25 in 83% yield. Rf (13:7 benzene/hexanes): 0.15;
 
1
H NMR (CDCl3, 400 MHz): δ 7.90 (bs, 1 H), 7.58 (d, J = 8.0 Hz, 1 H), 7.32–
7.23 (m, 6 H), 7.22–7.16 (m, 5 H), 7.07–7.03 (m, 4 H), 6.81 (t, J = 7.2 Hz, 1 H), 6.62 (d, 
J = 2.0 Hz, 1 H), 6.20 (s, 1 H), 3.65 (d, J = 7.6 Hz, 1 H), 3.64 (d, J = 8.0 Hz, 1 H), 3.09 
(ddd, J = 7.6, 7.6, 15.6 Hz, 1 H), 2.83 (dt, J = 4.4, 16.4 Hz, 1 H).  
Alkynylation 
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2-Phenyl-1-(phenylethynyl)-1,2,3,4-tetrahydroisoquinoline (4.26): According to the 
general procedure, 4.07 (53.0 mg, 0.253 mmol, 1.0 equiv), Ru(bpy)3Cl2 (2.0 mg, 0.002 
mmol, 0.01 equiv), and BrCCl3 (75.0 μL, 0.760 mmol, 3.0 equiv) in DMF (1.0 mL) were 
irradiated with 1W blue LED lights until starting material was consumed as indicated by 
TLC. The reaction vessel was covered with aluminum foil before Et3N (176.0 μL, 1.266 
mmol, 5.0 equiv), CuBr (5.5 mg, 0.038 mmol, 0.15 equiv), and phenylacetylene (140.0 
μL, 1.266 mmol, 5.0 equiv) were added successively. After workup, the crude oil was 
purified via silica gel chromatography (1:39bEtOAc/hexanes) to afford 4.26 in 82% 
yield. Rf (1:39bEtOAc/hexanes): 0.25; 
1
H NMR (CDCl3, 400 MHz): δ 7.29–7.19 (m, 5 
H), 7.16–7.09 (m, 6 H), 7.04 (d, J = 8.0 Hz, 2 H), 6.80 (t, J = 7.6 Hz, 1 H), 5.56 (s, 1 H), 
3.66 (ddd, J = 3.6, 6.0, 12.0 Hz, 1 H), 3.58 (ddd, J = 4.0, 10.0, 12.4 Hz, 1 H), 3.05 (ddd, J 
= 6.0, 10.0, 16.0 Hz, 1 H), 2.88 (dt, J = 4.0, 16.4 Hz, 1 H). 
 
2-Phenyl-1-(4-phenylbut-1-yn-1-yl)-1,2,3,4-tetrahydroisoquinoline (4.27): According 
to the general procedure, 4.07 (60.0 mg, 0.287 mmol, 1.0 equiv), Ru(bpy)3Cl2 (2.0 mg, 
0.003 mmol, 0.01 equiv), and BrCCl3 (85.0 μL, 0.860 mmol, 3.0 equiv) in DMF (1.1 mL) 
were irradiated with 1W blue LED lights until starting material was consumed as 
indicated by TLC. The reaction vessel was covered with aluminum foil before Et3N 
(200.0 μL, 1.433 mmol, 5.0 equiv), CuBr (6.0 mg, 0.043 mmol, 0.15 equiv), and 4-
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phenyl butyne (200.0 μL, 1.433 mmol, 5.0 equiv) were added successively. After 
workup, the crude oil was purified via silica gel chromatography (1:199 Et2O/pentanes) 
to afford 4.27 in 53% yield. Rf (1:99 Et2O/pentane): 0.2; IR (neat): νmax 3061, 3025, 2923, 
2835, 1597, 1502, 1453, 1428, 1377, 1342, 1288, 1224, 1202, 1153, 1032, 938 cm
-1
; 
1
H 
NMR (CDCl3, 400 MHz): δ 7.32 (t, J = 8.2 Hz, 2 H), 7.28–7.17 (m, 7 H), 7.07 (d, J = 6.1 
Hz, 2 H), 7.06 (t, J = 8.0 Hz, 2 H), 6.89 (t, J = 7.2 Hz, 1 H), 5.41 (s, 1 H), 3.71–3.66 (m, 
1 H), 3.53 (ddd, J = 4.3, 10.6, 12.4 Hz, 1 H), 3.09 (ddd, J = 5.9, 10.4, 16.3 Hz, 1 H), 2.90 
(dt, J = 3.7, 16.1 Hz, 1 H), 2.70 (t, J = 7.4 Hz, 2 H), 2.41 (dt, J = 1.8, 7.2 Hz, 2 H); 
13
C 
NMR (CDCl3, 125 MHz): δ 149.7, 140.8, 136.2, 134.4, 129.2, 129.0, 128.7, 128.4, 127.5, 
127.2, 126.3, 126.2, 119.4, 116.5, 84.6, 80.2, 51.7, 43.3, 35.2, 29.0, 21.2; HRMS (ESI) 
m/z calculated for C25H24N
+
 ([M+1]
+
) 338.1909, found 338.1915. 
 
6,7-Dimethoxy-2-phenyl-1-(phenylethynyl)-1,2,3,4-tetrahydroisoquinoline (4.28): 
According to the general procedure, 4.18 (66.0 mg, 0.245 mmol, 1.0 equiv), Ru(bpy)3Cl2 
(2.0 mg, 0.002 mmol, 0.01 equiv), and BrCCl3 (72.5 μL, 0.735 mmol, 3.0 equiv) in DMF 
(1.0 mL) were irradiated with 1W blue LED lights until starting material was consumed 
as indicated by TLC. The reaction vessel was covered with aluminum foil before Et3N 
(170.0 μL, 1.225 mmol, 5.0 equiv), CuBr (5.3 mg, 0.037 mmol, 0.15 equiv), and 
phenylacetylene (130.0 μL, 1.225 mmol, 5.0 equiv) were added successively. After 
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workup, the crude oil was purified via silica gel chromatography (1:19 → 1:9 
EtOAc/hexanes) to afford 4.28 in 89% yield as a brownish-yellow solid. Rf (1:19 
EtOAc/hexane): 0.15; IR (neat): νmax 3060, 3001, 2993, 2834, 2253, 1598, 1517, 1502, 
1490, 1463, 1443, 1408, 1376, 1266, 1248, 1214, 1157, 1116, 1070, 1027 cm
-1
; 
1
H NMR 
(CDCl3, 400 MHz): δ 7.37–7.33 (m, 4 H), 7.26–7.25 (m, 2 H), 7.15 (d, J = 8 Hz, 2 H), 
6.92 (t, J = 7.2 Hz, 1 H), 6.90 (s, 1 H), 6.69 (s, 1 H), 5.61 (s, 1 H), 3.93 (s, 3 H), 3.90 (s, 3 
H), 3.82–3.77 (m, 1 H), 3.68 (ddd, J = 3.9, 10.9, 10.9 Hz, 1 H), 3.10 (ddd, J = 5.8, 10.7, 
16.0 Hz, 1 H), 2.88 (dt, J = 3.1, 15.8 Hz, 1 H); 
13
C NMR (CDCl3, 100 MHz): δ 149.6, 
148.3, 147.6, 131.8, 129.2, 128.1, 128.0, 127.1, 126.4, 123.0, 119.7, 116.9, 111.4, 110.1, 
88.7, 84.7, 56.1, 55.9, 52.1, 43.4, 28.5; HRMS (ESI) m/z calculated for C25H24NO2
+
 
([M+1]
+
) 370.1807, found 370.1807. 
 
 
pKa Calculation 
Nicholas and Arnold’s equation:152 
     
 
        
  (            (  )           (  )      ( ) ) 
Known values: 
R = Gas constant, 8.3145 J mol
-1
 K
-1
 
T = 300 K 
F = Faraday’s constant, 9.6485 x 104 J V-1 mol-1 
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ΔG˚tr(H+)sol = Energy of the transfer of a proton from water to solvent, 46.0 KJ mol
-1 
(MeCN)
 
ΔG˚f(H)g = Energy of formation of hydrogen atom, 203.2 KJ mol
-1 
Upon conversion of energy units to kcal mol
-1
, the simplified equation becomes:
153
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Variables: 
Ered(Et3N) = +0.73 V 
BDE(CHA) = 90.7 kcal mol
-1 
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CHAPTER 5. TOTAL SYNTHESIS OF GLIOCLADIN C AND RELATED 
BISINDOLE ANALOGUES ENABLED BY VISIBLE LIGHT 
5.1 Bisindole Alkaloids 
 The hexahydropyrroloindoline class of natural products encompasses several 
structurally diverse scaffolds that possess a wide range of biological activities.
164
 In 
particular, bispyrrolo[2,3-b]indolines and related derivatives represent a subset of this 
class that are derived from dimeric tryptophan or tryptamine (Figure 5.1).
165
 
Pyrroloindolines can combine to form higher-order oligomers including hodgkinsine 
(5.14), psychotetramine (5.15), and psychotrimine (5.16). The pyrroloindoline subunit is 
found in nature bearing exclusively the cis cyclotryptophan or cyclotryptamine five-
membered ring fusion, most likely due to the higher strain energy associated with the 
trans fusion. These components are often linked at the benzylic C3 to another 
pyrroloindoline molecule or to an indole derivative at varying positions around the 
heteroarene. Examples of such connectivities include C3–C3', C3–N1', C3–C6', and C3–
C7' bisindole alkaloids. Many of these molecules also contain diketopiperazine (DKP) or 
epidithiodiketopiperazine (ETP) moieties such as leptosins D-F (5.3-5.5), bionectins A-B 
(5.7-5.8), chaetocin (5.9), verticillin (5.10) and naseseazines A-B (5.17-5.18). The 
biological activities of these alkaloids include antibacterial (5.9 and 5.10), antitumor (5.1 
and 5.2-5.5), and analgesic (5.16) properties. Given the molecular complexities and 
potent biological properties of bisindole alkaloids, much effort has been geared towards 
their preparation. 
129 
 
 
 
Figure 5.1 Representative bisindole alkaloids 
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5.2 Gliocladin C: Isolation, Biological Activity & Possible Biogenesis 
 Gliocladin C (5.1) was first isolated in 1994 from the fungal strain Gliocladium 
roseum OUPS-N132 found on the sea hare Aplysia kurodai off the coast of Kata, Japan.
7
 
In 2010, its isolation from terrestrial fungus Gliocladium catenulatum was also 
reported.
166
 A series of 1D and 2D NMR experiments helped to elucidate the structure 
and relative configuration of gliocladin C as a C3–C3' heterodimeric pyrroloindoline 
alkaloid containing a unique triketopiperazine unit, previously unseen in Gliocladium sp. 
metabolites. The absolute configuration was confirmed through total synthesis, as 
reported by Overman and Shin in 2007.
167
 Upon analysis of cytotoxicity, gliocladin C 
exhibited potent activity against P388 lymphocytic leukemia cell lines with an ED50 of 
2.4 μg mL-1.  
 The biogenesis of gliocladin C is not as well understood as the corresponding 
DKP- and ETP-containing natural products given its unusual triketopiperazine (TKP) 
moiety. However, the biosynthesis of dimeric pyrroloindoline alkaloids has been 
thoroughly investigated.
165 
These dimers are postulated to arise through initial one-
electron oxidation of tryptophan or tryptamine monomers (a, Figure 5.2), followed by 
cyclization of the 3-aminoethyl side chain onto the imine. This results in the formation of 
a new cis-fused five membered ring and a benzylic radical. Radical combination forms 
the bispyrroloindoline skeleton. Alternatively, it is possible that other resonance forms of 
intermediate A could result in dimerization at C6, C7, or N1. For heterodimeric 
pyrroloindolines, possible biosynthetic pathways have been revealed through degradation 
studies on verticillin A (5.10).
168
 Upon reduction of the disulfide and treatment with base, 
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a Grob-type fragmentation of the hydroxydiketopiperazine monomer results in the 
formation of the indole unit (b, Figure 5.2). This leads to the core structure of gliocladine 
C (5.6). Based on these studies, a similar mechanism for the biosynthesis of 5.1 can be 
extrapolated. 
 
Figure 5.2 Possible biosynthetic route for heterodimeric pyrroloindolines 
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5.3 Previous Approaches to Pyrrolindoline Alkaloids 
Gliocladin C and Related C3–C3' Bisindole Alkaloids 
 A pioneering study on the synthesis of 3-indolylpyrroloindolines was conducted 
by Somei and co-workers using a strategy employing nucleophilic trapping reactions on 
1-hydroxytryptamines.
169
 The authors discovered that when 1-hydroxy-Nb-
trifluoroacetyltryptamine (5.19) was treated with mesyl chloride in chloroform in the 
presence of 10 equiv of indole and triethylamine at 0 ˚C, a number of nucleophilic 
substitution products result (Figure 5.3). Formation of the desired C3–C3' bisindole 
product 5.20 was observed in 30% along with tetrahydropyrrolindole 5.21, 6-
mesyloxytryptamine 5.22, and 3-(indol-2-yl)pyrroloindoline 5.23 in 4, 1, and 7% yields, 
respectively. Interestingly, when the reaction was run in THF, 4-chlorobutoxy 
pyrroloindoline 5.24 was also isolated. 
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Figure 5.3 Somei’s nucleophilic substitution of 1-hydroxytryptamine 
 The first total synthesis of gliocladin C (5.1) with concomitant assignment of 
absolute configuration was achieved in 2007 by Overman and Shin in a total of 21 steps 
beginning from isatin.
167
 In order to establish the C3 quaternary stereocenter of the 
molecule, isatin was first condensed with indole to produce bisindole 5.25. Next, a key 
asymmetric Mukayama Aldol condensation reaction between 5.25 and serine-derived 
aldehyde 5.26 in the presence of a Lewis acid and 2,6-di-tert-butyl-4-methylpyridine 
(DTBMP) produced oxindole 5.27 with high diastereoselectivity (Scheme 5.1). Upon 
hydrolysis of the oxazoline and protection of the 1,3-diol, reductive cyclization with 
LiAlH4 occurred to form 3-indolylpyrrolindoline 5.28. The formation of the 
triketopiperazine (TKP) was accomplished via treatment of intermediate 5.29 with 
ClCOCO2Et and Et3N, followed by HMDS at 140 ˚C. 
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Scheme 5.1 Overman’s first generation synthesis of gliocladin C 
 Overman and co-workers were subsequently able, in 2011, to improve their 
synthesis with a more concise approach to the pyrroloindoline skeleton.
170
 From 
intermediate 5.30, a catalytic asymmetric rearrangement of an in situ generated 
trichlorodimethylethyl carbonate using Fu’s chiral iron catalyst 5.31 affected the 
conversion to oxindole 5.32 (Scheme 5.2). Aldol condensation of advanced intermediate 
5.33 with preformed lithium enolate of TKP derivative 5.34 led to cyclization precursor 
5.35. Upon treatment with Sc(OTf)3, tandem cyclization/Boc deprotection occurred, 
producing gliocladin C in 14 total steps. Notably, bis-Boc-protected gliocladin C (5.36) 
was converted in six steps to gliocladine C (5.6). Selective methyl Grignard addition and 
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TBS protection, followed by Sharpless asymmetric dihydroxylation leads to intermediate 
5.37. After acetate protection, treatment with hydrogen sulfide and oxygen followed by 
de-acetylation gives 5.6. 
 
Scheme 5.2 Overman’s 2nd generation synthesis of gliocladin C and synthesis of 
gliocladine C 
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 Other approaches to gliocladin C were reported by the Trost and Movassaghi 
groups. For their approach, Trost and co-workers developed a general palladium-
catalyzed asymmetric allylation of oxindoles to oxyallenes using a chiral acid catalyst 
(Scheme 5.3).
171
 For the construction of C3–C3' bisindoles, oxindole 5.30 was reacted 
with benzyloxyallene in the presence of Pd2(dba)3•CHCl3 in combination with benzoic 
acid and chiral ligand 5.38 to give allylated oxindole 5.39 in good yield, d.r. and % ee. 
This methodology was also extended to a variety of 3-aryl substituted oxindoles. 
Furthermore, the authors were able to elaborate intermediate 5.39 in six steps to the core 
pyrroloindoline structure of gliocladin C (5.40).  
 
Scheme 5.3 Trost’s formal synthesis of gliocladin C 
 The strategy adopted by Boyer and Movassaghi employed a direct silver-
catalyzed Friedel-Crafts reaction between an indole and a bromopyrroloindoline via a 
tertiary benzylic cation intermediate (Scheme 5.4).
172
 Treatment of bromopyrroloindoline 
5.41 with TIPS-protected 5-bromoindole 5.42 in the presence of AgBF4 and DTBMP as 
an acid scavenger in nitroethane formed 3-(3'-indolyl)pyrroloindoline 5.43 in 83% yield. 
Use of the bulky N-TIPS group was necessary to block substitutions on the C2' and C6' 
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positions on the indole, while the 5-bromo substituent blocked the C5' position from 
addition. A total synthesis of gliocladin C was then completed upon removal of the TIPS 
and bromo groups of 5.43, followed by oxidation by Bu4NMnO4 to produce diol 5.44. 
Selective protection of secondary alcohol, N-deprotection, and acid-catalyzed elimination 
formed 5.45. De-silylation, oxidation, and another N-deprotection gave gliocladin C in 13 
steps overall. 
 
Scheme 5.4 Movassaghi’s synthesis of gliocladin C 
Other C3–C3', C3–C7', C3–C6', & C3–N1' Bisindole Alkaloids 
 Since the isolation of C3–C3'dimeric bispyrroloindoline alkaloids in the early 
1960’s, there have been numerous synthetic approaches to their core structures. One of 
the earliest synthesis was reported by Hendrickson and co-workers in 1964 in which 
dimerization of 3-aminoethyloxidole occurred upon oxidation with iodine in THF.
173
 This 
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subsequently led to the preparation of racemic and meso-chimonanthine ((±)-5.11 and 
5.12). Very soon after, Scott et al. described a concise approach to these compounds 
beginning from N-methyltryptamine.
174
 Treatment of Grignard salt 5.46 with ferric 
chloride in ether resulted in the formation of (±)-5.11 and 5.12 in 19 and 7% yields, 
respectively, as well as other dimeric compounds (Figure 5.4). Much later, a similar N-
activation strategy was applied by Takayama and co-workers on tryptamine derivative 
5.47 using PIDA in TFE.
175
 A subsequent reduction with Red-Al led to the formation of 
(±)-5.11 and 5.12, as well as C3–C6' bisindole 5.48 and N-methyltryptamine. For the 
preparation of enantiopure (+)-chimonanthine ((+)-5.11), Overman and co-workers 
adopted a strategy inspired by Hendrikson’s alkylation approach. Accordingly, treatment 
of bisoxindole 5.49 with bis-electrophile 5.50 in the presence of base led to almost 
exclusively the C2-symmetric bisoxindole 5.51 (Figure 5.4).
176
 This intermediate was 
derived in eight subsequent steps to (+)-5.11. This strategy was also employed for the 
synthesis of (-)-5.11, ent-WIN 64821, ditryptophenaline,
177
 as well as for higher-order 
oligomer intermediates.
178
 It is worth noting that Overman and co-workers have also 
developed a double Heck cyclization to achieve similar intermediates for the synthesis of 
hodgkinsine.
179
 Movassaghi and co-workers developed a unique method to access C3–
C3' bispyrroloindoline alkaloids utilizing a radical dimerization protocol. By taking 
advantage of the reactivity of chiral bromopyrroloindolines, a pyrroloindoline radical 
could be generated using stoichiometric CoCl(PPh3)3. This intermediate undergoes 
homodimerization to directly access the core structure of (+)-chimonanthine ((+)-5.10) 
(Figure 5.4).
180
 The simplicity of this process enabled the dimerization of a variety of 
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bromopyrroloindolines en route to the total synthesis of a number of natural products 
including, (-)-calycanthine, (+)-folicanthine,
180 
(+)-WIN 64821, (-)-ditryptophenaline,
181
 
(+)-11,11'-dideoxyverticillin A,
182
 and (+)-chaetocin.
183
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Figure 5.4 Approaches to C3–C3' Dimers 
 The preparation of C3-C7' bisindole alkaloids have been accomplished via 
palladium-mediated cross-coupling and stepwise synthesis of the pyrroloindoline. 
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Overman and co-workers were able to effect the Stille coupling of C7 iodo compound 
5.54 with vinyl tin 5.55, followed by an symmetric Heck cyclization to produce oxindole 
5.56 en route to idiospermuline (5.13) (Scheme 5.5).
184
 
 
Scheme 5.5 Overman’s synthesis of idiospermuline 
  As a prelude to the gliocladin C synthesis in which bromopyrroloindolines were 
alkylated with indole C3-nucleophiles, Kim and Movassaghi had also developed the 
addition of indole C6-nucleophiles to bromopyrroloindolines via silver catalysis (Scheme 
5.6).
185
 Using potassium trifluoroboronate 5.57, bromopyrroloindoline 5.58 was alkylated 
in the presence of AgSbF6 and 18-crown-6 in NO2Et, providing C3–C6' alkaloid (+)-
naseseazine A (5.17) upon Cbz deprotection.  
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Scheme 5.6 Movassaghi’s synthesis of (+)-naseseazine A 
 The first total synthesis of (±)-psychotrimine (5.16) was reported by Takayama 
and co-workers in which they established the C3–N1' linkage via Strecker reaction and α-
alkylation.
186
 Later, Newhouse and Baran developed a one-pot coupling of tryptophan 
derivative 5.59 with NIS and o-iodoaniline, followed by cyclization to directly access 
5.60 en route to 5.16 (Scheme 5.7).
187
 
 
Scheme 5.7 Baran’s synthesis of (±)-psychotrimine 
Chemistry of Pyrroloindoline Derivatives 
 As demonstrated by Movassaghi’s dimerization protocol, bromopyrroloindolines 
are reactive substrates that can be readily exploited to introduce functionality at the 
tertiary benzylic C3-position. Consequently, bromopyrroloindolines have been widely 
utilized in the synthesis of complex pyrroloindoline alkaloids. This has been largely 
facilitated by the ease of their preparation, with either diastereoisomer easily accessible 
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with the right choice of reagents (NBS or Br2).
188
  An early example of their utility was 
shown by Crich and co-workers who treated bromopyrroloindoline 5.62, prepared via 
benzylic bromination of 5.61 with NBS, with allyltributyltin in the presence of AIBN at 
reflux to give allylated pyrroloindoline 5.63 in 80% yield (Figure 5.5).
189
 Interestingly, 
pyrroloindoline 5.64 could also be directly oxidized with CAN to access 
hydroxypyrroloindoline derivatives. In addition to radical reactions, 
bromopyrroloindolines can participate in nucleophilic substitutions. Espejo and Rainier
190
 
demonstrated nucleophilic displacement of 5.65 with indole to directly access C3–N1' 
bisindole alkaloids and successfully applied this strategy to the syntheses of kapakahines 
E and F.
191
 This is proposed to occur via enolate displacement of bromide, forming a 
transient cyclopropyl intermediate that can be opened by nucleophilic attack of indole on 
either face of the molecule. 
 Selenopyrroloindolines have similar reactivities and have been utilized for the 
synthesis of pyrroloindoline alkaloids. Danishefsky and co-workers showed that 
selenopyrroloindoline 5.66 could be treated with di-t-butyl peroxide and prenyl tributyltin 
to access reverse prenylated pyrroloindolines (Figure 5.5).
192
 This transformation was 
utilized as the key step in the total synthesis of amauromine.  The authors also discovered 
that 5.66 can undergo radical dimerization in trace amounts upon reaction with 
bis(tributyltin) under UV irradiation.
193
 The group of de Lera later improved the yield of 
this reaction to 20-30% in toluene.
194
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Figure 5.5 Chemistry of pyrroloindoline derivatives 
5.4 Coupling of Indoles with Bromopyrroloindolines
195
 
 Inspired by Crich’s work on radical-mediated couplings of bromopyrroloindolines 
(vide supra), our group investigated the photoreduction of similarly activated bromides 
using visible light photoredox catalysis. This study led to a general reductive 
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dehalogenation procedure via the reductive quenching cycle of photocatalyst Ru(bpy)3Cl2 
using diisopropylethylamine and formic acid as hydrogen-atom donors.  Tertiary benzylic 
radical 5.67 was the key intermediate generated in this reaction (Figure 5.6). The goal 
was to intercept this reactive intermediate with an appropriate indole partner and disfavor 
the alternative termination pathway involving hydrogen-atom abstraction. This route 
would essentially enable direct access to a number of pyrroloindoline alkaloids shown in 
Figure 5.1.  
 
Figure 5.6 Photoredox approach to C3–C3' bisindole alkaloids 
Initial experiments were geared towards the coupling of readily accessible 
bromopyrroloindoline 5.68 with C2,C3-unsubstituted indoles (Figure 5.7). The expected 
outcome from a radical-mediated process would result in C3–C2' regioselectivity, 
whereas a nucleophilic substitution process would result in C3–C3' regioselectivity, as 
observed in Somei’s study. Accordingly, upon subjecting 5.68 and N-methylindole (5.69, 
2 equiv) to visible light irradiation in the presence of Ru(bpy)3Cl2 (2.5 mol %) and Et3N 
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(2.0 equiv), C3–C2' bisindole 5.70 was obtained in only 10% yield after 24 h. The major 
byproduct in the reaction was the corresponding reduced hexahydropyrroloindoline 
(Br→H). Nevertheless, these results supported the radical addition mechanism. To 
optimize the reaction, triethylamine was replaced with 4-methoxytriphenylamine (3.49), 
which was used for the indole malonation reactions to prevent α-hydrogen-atom 
abstraction. Use of 3.49 unfortunately failed to promote the reaction. This is likely 
attributed to a kinetically competent back electron transfer process from Ru(bpy)3
+
 to the 
radical cation of 3.49 (Section 3.3).  
 
Figure 5.7 Preparation of C3–C2' bisindoles 
As a consequence of the futile quencher optimization, an excess amount of the 
indole was used in combination with triethylamine in order to suppress formation of the 
reduction product and improve the yield of desired product 5.70. Experimentation 
revealed that at least 5 equiv of the indole is required for an efficient reaction, providing 
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5.70 in 52% yield (Figure 5.7). The reaction of simple bromopyrroloindoline 5.68 with 
N-unprotected 3-methylindole had little effect, with 55% yield obtained of coupling 
product 5.71. More highly functionalized bromopyrroloindolines derived from (L)-
tryptophan were then prepared according to procedures developed by Movassaghi and de 
Lera.
180, 188
 Bromopyrroloindolines containing a diketopiperazine (DKP) were of 
particular interest due to the presence of these moieties in the core structures of several 
natural products (Figure 5.1). Using 3-methylindole and indole itself as coupling partners, 
C3–C2' bisindoles 5.72 and 5.73 were produced in 60 and 45% yields, respectively. It is 
worth noting that while several pyrroloindoline linkages are known in natural products, 
including C3–C3', C3–N1', C3–C6', and C3–C7' bisindoles, there are as of yet no 
reported natural products bearing the C3–C2' linkage. Thus, this approach represents a 
means of accessing a novel class of unusual bisindole analogues. 
To reverse the regioselectivity from C2' to C3', N-trimethylsilyl indole and N-
triisopropylsilyl indole were explored as coupling partners for 5.68 in an effort to 
sterically direct the coupling. This is an approach that was later successful for 
Movassaghi’s nucleophilic addition reactions.172 Unfortunately, silylated indoles were 
readily de-silylated under the photoredox conditions and resulted in a complex mixture of 
products. Indole substrate 5.74, in which the C2' position was blocked by a carboxylate, 
was then screened and ultimately provided the desired C3C3' bisindole 5.75 in 55% 
yield (Figure 5.8). With the success of preliminary reactions, a diverse substrate scope 
was assessed under these conditions. A number of highly functionalized C3–C3' 
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bisindoles were produced in moderate to good yields (40–58%) using a variety of 
bromopyrroloindolines and indole-3-carboxylates.  
 
Figure 5.8 Preparation of C3–C3' bisindoles 
By engineering the indole radical acceptor, access to both the natural C3C3' 
connectivity as well as unnatural C3C2' connectivity can be accomplished using visible 
light photoredox catalysis. Based on the concept of diverted total synthesis, most notably 
promoted by Danishefsky,
196
 rapid access to a diverse set of bisindoles can lead to the 
discovery of either new biological targets or better substrates for known biological 
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targets. Moreover, few alternative methods exist that can accomplish more than one type 
of indole substitution in a controlled fashion in practical yield. 
Upon analysis of the substrate screen results, there appeared to be a 15–20% 
decrease in yield for the coupling of indoles with DKP-containing bromopyrroloindolines 
compared to simple bromopyrroloindolines.  These substrates also contained sulfonamide 
protecting groups instead of carbamates. Control reactions were run to determine whether 
the DKP moiety or different protecting groups were responsible for the change in yield. 
Towards this end, PhSO2- and Cbz- protected bromopyrroloindolines 5.85 and 5.86 were 
synthesized and subjected to the photoredox coupling reaction with indole-2-carboxylic 
acid benzyl ester 5.87. The reaction of 5.85 and 5.86 provided the coupling products 5.88 
and 5.89 in 40% and 62% yields, respectively, indicating that the lower yields can be 
attributed to the electron-withdrawing sulfonamide group and not the DKP moiety (eq. 
1). This further suggests that even a minor change in the electronics of the radical species 
affects the outcome of the coupling reaction. 
 
The indole coupling partner was also optimized for this reaction. Reagent 
screening identified indole-2-carboxaldehyde (5.91) as the best indole acceptor and led to 
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enhanced yields of bisindole products. Coupling of bromopyrroloindoline 5.90 with 5.91 
provided the desired product 5.92 in 84% yield, significantly higher than previous results. 
A general increase in yield was observed for other reactions with 5.91, as substrate 5.93 
provided product 5.94 in 72% yield (Figure 5.9). In considering potential synthetic 
applications of the photoredox-based methodology, this transformation was also 
performed on large scale conducive to multistep synthesis (1.0 g) and resulted in the 
same efficiency observed on discovery scale (50 mg).  
 
Figure 5.9 Coupling of bromopyrroloindolines with indole-3-carboxaldehyde 
 The mechanism for this transformation is similar to that of the photoredox-
mediated indole malonations discussed in section 3.3. Excited state Ru(bpy)3
2+
* oxidizes 
Et3N to form Ru(bpy)3
+
 and (Et3N)
•+
.  The pyrroloindoline radical is generated from the 
reduction of the C–Br bond by the strong single electron reductant, Ru(bpy)3
+
. Radical 
addition then occurs on the indole unit, preferably at the C2-position followed by C3. 
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One possible explanation for the better results using indole-2-carboxaldehyde as the 
coupling partner is the stability of the subsequent radical adduct generated upon the 
initial C–C forming event (Scheme 5.8). For C2-radical additions, where the LUMO has 
the largest co-efficient, the adduct radical is usually stabilized by the π cloud of the 
aromatic ring. In the case of 5.91, there is a captodative stabilizing effect upon addition at 
the C3-position to form a C2 adduct radical, which is vicinal to both an electron-donating 
group as well as an electron withdrawing group. 
 
Scheme 5.8 Proposed mechanism for bromopyrroloindoline-indole coupling 
The photoredox-based indole coupling procedure compares favorably with other 
known methods but offers distinct advantages. The efficiency of the protocol as well as 
the excellent functional group tolerance facilitates entry into C3C3' bisindole alkaloid 
core structures in as little as three steps and, unlike other approaches, unusual C3C2' 
bisindoles can also be accessed using this protocol. Moreover, the generality of the 
reaction enabled the rapid preparation of diverse analogues. With these advantages, the 
scope of our research expanded into the application of radical coupling to the total 
synthesis of bisindole alkaloids.  
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5.5 Total Synthesis of Gliocladin C
197
 
 Gliocladin C, bearing an unusual triketopiperazine (TKP) unit, appeared to be a 
suitable entry molecule for the total synthesis of C3C3' bisindole alkaloid natural 
products. Without the complications of bearing a disulfide bridge found in other members 
of its class, the synthesis of this molecule would provide a general standard to gauge the 
utility of the photoredox-based coupling strategy.  The initial investigation was based 
upon a retrosynthetic route depicted in Scheme 5.9. Intermediate A was identified as the 
key target that would result from the coupling of a pyrroloindoline radical with a C2-
substitued indole (B).  Coupling precursor C would result from the amidation/annulation 
reaction of D with methylamine and a bis-electrophile. Bromopyrrolindoline D would be 
synthesized from the bromocyclization of a D-tryptophan derivative. Upon accessing 
intermediate A, removal of the directing group and dehydrogenation would lead to 5.1.  
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Scheme 5.9 Initial retrosynthetic strategy for gliocladin C 
 The feasibility of directing group removal was assessed prior to instigating the 
forward synthetic route. The initial focus was placed upon the removal of carboxylic acid 
derivatives. Methods for the decarboxylation of indole acids are known, but only a few 
variations exist in the literature, most employing copper species and elevated 
temperatures. Accordingly, several of these methods were employed for our system, 
including copper chromite in quinoline at 215 ˚C,198 copper(I)oxide in DMA at 200 ˚C,199 
and substoichiometric amount of indole acid copper salts at 200 ˚C.200 Most of these 
conditions resulted in decomposition and no reaction was observed for lower temperature 
reactions. Microwave conditions were also utilized without success.  
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 With the poor results for decarboxylations, decarbonylation of coupled C2' 
aldehydes were tested. Wilkinson’s catalyst, RhCl(PPh3)3, has commonly been used in 
stoichiometric amounts to affect the decarbonylation of various aldehydes under mild 
conditions.
201
 As a model system, indole aldehyde 5.92 was subjected to known 
decarbonylation conditions using 1 equiv RhCl(PPh3)3 in 3:1 xylenes/TFE (eq. 2). This 
substrate required more forcing conditions to react and was heated at 140 ˚C for 4 h. 
Successful decarbonylation was observed and compound 5.96 was obtained in 72% yield. 
 
First Generation Synthesis  
The total synthesis of gliocladin C commenced upon the successful 
decarbonylation of the model system.  Preparation of the coupling partner began with 
commercially available Boc-D-tryptophan methyl ester 5.97 (Scheme 5.10). Orthogonal 
protection of the indole nitrogen with a Cbz group occurred in quantitative yield. 
According to the procedure by de Lera and co-workers,
188
 tryptophan derivative 5.98 was 
treated with NBS and PPTS as an acid promoter to give bromopyrroloindoline 5.99 in 
91% yield as a single diastereomer. To convert the methyl ester to the methyl amide, 
conventional peptide coupling reagents were initially utilized, however, low yields were 
obtained (45%) and purification was difficult due to the presence of excess reagents. 
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Nevertheless, direct amidation to compound 5.100 occurred smoothly upon stirring in 
excess aqueous methylamine in THF over three days at room temperature (rt). To append 
the TKP moiety, the N-Boc group was selectively removed in 86% yield using TMSI in 
acetonitrile.  
 
Scheme 5.10 First generation synthesis of gliocladin C 
A suitable bis-electrophile for 5.101 was then screened. Treatment of the amino 
amide with reagents such as 1,1-oxalyldiimidazole did not lead to any conversion, thus 
conditions from Overman’s first generation gliocladin C synthesis were adopted.167 
Accordingly, compound 5.101 was reacted with ethyl chlorooxalate in the presence of 
Et3N in CH2Cl2 at 0 ˚C to rt. This resulted in a mixture of products, including non-
cyclized compound 5.102 as well as desired TKP product 5.103. Upon flash 
chromatography on silica gel, compound 5.102 converted to 5.103 after additional 
iterations, giving a combined yield of 82%. Interestingly, neither stirring crude 5.102 in 
EtOAc in the presence of silica gel nor treatment with dilute acid (AcOH, HCl) effected 
the conversion as efficiently as flash chromatography. 
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Scheme 5.11 Formation of TKP 
 The photoredox coupling reaction was assessed with triketopiperazine 5.103 and 
indole-3-carboxaldehyde (5.91). In the presence of Ru(bpy)3Cl2 (2.5 mol%) and Et3N (2 
equiv) in DMF under blue light irradiation, the reaction of 5.103 with 5.91 provided 
coupled compound 5.104 in 50–70% yield (Scheme 5.12, a). With the success of the 
photoredox coupling step, the bisindole core structure of gliocladin C was established and 
completion of the synthesis required only a few more manipulations. To remove the 
formyl group, bisindole 5.104 was subjected to the optimized decarbonylation conditions 
using RhCl(PPh3)3 in xylenes with heating at 140 ˚C in a sealed tube. Surprisingly, no 
reaction was observed. It was reasoned that the presence of too many Lewis bases on the 
TKP ring was responsible for deactivating the catalyst towards the desired reactivity at 
the indolyl aldehyde. To avoid this issue, the linear synthesis was then re-routed such that 
indole coupling (D → E) and decarbonylation steps preceded installation of the TKP of 
intermediate A (Scheme 5.12, b). 
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Scheme 5.12 Photoredox coupling and failed decarbonylation (a); new synthetic route (b)  
 Intermediate 5.100 was then subjected to the photoredox conditions and, 
encouragingly, coupling product 5.106 was isolated in good yield (Scheme 5.13). 
However, upon scale-up this reaction gave inconsistent results with regards to conversion 
of bromopyrroloindoline. Upon careful inspection with control reactions, it was 
discovered that the headspace of the reaction flask was directly correlated to the change 
in conversion. Specifically, with a large volume of headspace, the reaction stalled. Given 
the high vapor pressure of Et3N (51.8 mm Hg, 20˚C), it was conjectured that the electron 
donor was rapidly equilibrating above the reaction solution, particularly in flasks that 
were large relative to the reaction solution. This ultimately led to the replacement of Et3N 
with tri-n-butylamine, which has a higher boiling point and lower vapor pressure (0.3 mm 
Hg, 20˚C). With the new conditions, inconsistencies were avoided and compound 5.106 
was obtained in 92% yield with a lower catalyst loading of just 1 mol%. This reaction 
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could be performed on large scale (10 g) as well, providing 82% yield of coupling 
product 5.106. Subsequent decarbonylation with RhCl(PPh3)3 in xylenes at 140 ˚C was 
successful, providing the desired bisindole 5.107 in 86% yield.  
 
Scheme 5.13 Successful photoredox coupling and decarbonylation 
Development of a Catalytic Decarbonylation Reaction 
Despite the success of the photoredox coupling reaction and directing group 
removal, the use of stoichiometric rhodium complex for the decarbonylation reaction 
hampered the efficiency and scalability of the route to the bisindole core. Thus, the 
development of a catalytic transformation to remove the indole C2' aldehyde was 
investigated.  Very few precedents in the literature exist for catalytic decarbonylation 
methods; particularly on indolyl substrates. Some known methods involve a 
decarbonylation step en route towards a metal-catalyzed C–C bond forming 
transformation. Both amide 5.107 and ester 5.92 were used as substrates to screen 
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decarbonylation conditions. Tsuji and co-workers had reported the use of 
[Ir(cod)2Cl]PPh3 for the catalytic decarbonylation of aryl, vinyl, and benzylic aldehydes, 
but indole substrates were omitted in their study.
202
 Not surprisingly, use of those 
conditions for substrate 5.92 did not result in any conversion of starting material (Table 
5.1, entry 1). Another report by Li and co-workers utilized (CO)2Rh(acac) for C–H 
arylations of phenylpyridines via decarbonylation of aryl aldehydes.
203
 The use of t-
butylperoxide (TBP) enabled catalytic turnover of the [Rh]–CO intermediate. However, 
these conditions were also ineffective on our substrates (entry 2). More activated cationic 
complexes were then screened. In a report by Dong and co-workers,
204
 cationic rhodium 
complexes were used to affect intramolecular carbonyl hydroacylation and under certain 
conditions, a decarbonylation event occurred rather than their desired transformation. 
Using those conditions with substrate 5.107 led only to Boc deprotection, likely due to 
the Lewis acidity of the complex (entry 3).  
The focus was then aimed at developing a set of conditions to turn over 
Wilkinson’s catalyst, which had been successful for decarbonylation in stoichiometric 
amounts. The main challenge was extrusion of CO from RhCl(CO)(PPh3)2 that was being 
formed as a stoichiometric byproduct. Efforts to regenerate RhCl(PPh3)3 from this species 
proved to be quite challenging. Initial attempts towards this goal involved slow addition 
of substrate 5.107 over 14 h to a solution of 50 mol% RhCl(PPh3)3 in xylenes at 140 ˚C. 
This was to prevent any potential deactivation of the catalyst by starting material. This 
strategy only led to trace amounts of product (Table 5.1, entry 4). Using ester 5.92 under 
similar conditions with LiBF4 only led to Boc deprotection (entry 5). 
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Table 5.1 Catalytic decarbonylation optimization 
 
Entry R Catalyst Ligand/Additives Conditions Result 
1 OMe 
[Ir(cod)2Cl]PPh3 
(5 mol%) --- dioxane, 100 ˚C NR 
2 OMe 
(CO)2Rh(acac) 
(20 mol%) TBP (2.5 equiv) PhCl, 140 ˚C NR 
3 NHMe 
[Rh(nbd)2]BF4 
(20 mol%) 
(R)-Ph-
MeOBIPHEP 
DCE, 120 ˚C 5.110 
4 NHMe 
RhCl(PPh3)3 
(50 mol%) --- 
Xylenes, 140 ˚C 
Slow addition 
Trace 
 5.108 
5 OMe 
RhCl(PPh3)3 
 (50 mol%) LiBF4 (2 equiv) 
Xylenes, 140 ˚C 
 
5.111 
6 NHMe 
Rh(CO)Cl(PPh3)2 
(50 mol%) dppp (1 equiv) 
Xylenes/TFE 
140 C, slow 
addition 
65%
a
  
5.108 
7 NHMe 
RhCl(PPh3)3 
(20 mol%) DPPA (1 equiv) 
Xylenes, 140 ˚C 
Slow addition 
30%
b 
5.108 
8 NHMe 
RhCl(PPh3)3 
(20 mol%) DPPA (2 equiv) 
Xylenes, 140 ˚C 
Slow addition 
60%
a 
5.108 
9 NHMe 
RhCl(PPh3)3 
(20 mol%) DPPA (3 equiv) 
Xylenes, 140 ˚C 
Slow addition 
20%
 a 
5.108 
10 NHMe 
Rh(CO)Cl(PPh3)2 
(20 mol%) 
dppp (44 mol%) 
DPPA (2 equiv) 
Xylenes, 140 ˚C 
Slow addition 
85%
 a 
5.108 
11 NHMe 
Rh(CO)Cl(PPh3)2 
(10 mol%) 
dppp (44 mol%) 
DPPA (2 equiv) 
Xylenes, 140 ˚C 
Slow addition 
30%
 b 
5.108 
12 NHMe 
Rh(dppp)2Cl 
(20 mol%) DPPA (2 equiv) 
Xylenes, 140 ˚C 
Slow addition 
40%
b 
5.108 
161 
 
 
13 NHMe 
Rh(CO)Cl(PPh3)2 
(10 mol%) 
dppp (44 mol%) 
DPPA (2 equiv) 
Xylenes, 140 ˚C 
Slow addition 
Open to air 
NR 
a
Isolated yield upon purification on SiO2. 
b
Conversion. NR = no reaction. 
 A report by Meyer and Kruse described catalytic decarbonylations of simple 
indolyl aldehydes in xylenes at 140 ˚C using as little as 0.5 mol% of the cationic complex 
Rh(dppp)2Cl, generated in situ from Rh(CO)Cl(PPh3)3 and diphenylphosphinopropane 
(dppp).
205
 Unfortunately, use of these conditions did not lead to any observed conversion 
of either 5.107 or 5.92. Modifications of this procedure were then tested and included 
higher catalyst loading (5–50 mol%), more polar solvent systems (xylenes/TFE), and 
slow addition of substrate. After screening various combinations, conversion to the 
desired product 5.108 was finally attained in 65% yield using 50 mol% pre-catalyst 
Rh(CO)Cl(PPh3)3 and 1 equiv dppp in xylenes at 140 ˚C, with slow addition of substrate 
5.107. The use of 50 mol% of rhodium remained unsatisfactory, however, lower catalyst 
loadings led to significant drops in yield.  
 O’Connor and Ma had developed a method of turning over the [Rh]–CO species 
using stoichiometric amounts of diphenylphosphoryl azide (DPPA) with RhCl(PPh3)3.
206
 
This strategy was based upon a previous report that described the reaction of 
Rh(CO)Cl(PPh3)3 with butanoyl azide (Figure 5.10).
207
 This combination forms 
intermediate complex 5.112 at low temperature, which then undergoes reductive 
elimination to form an isocyanate as well as dinitrogen complex 5.113. Since N2 is a 
poorly bound ligand, this species is highly unstable and readily decomposes at room 
temperature. The authors found that use of DPPA resulted in the best turnover given its 
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greater stability and lower volatility compared to most other azides. Primary aldehydes 
were readily decarbonylated using 5 mol% RhCl(PPh3)3 at room temperature in THF with 
slow addition of DPPA (1 equiv) A proposed mechanism for this transformation is shown 
in Figure 5.10. Adaptation of this procedure for the decarbonylation of 5.107 required 
tuning of stoichiometry, catalyst loading, solvent, and temperature. Best results were 
obtained with 20 mol% catalyst in xylenes at 140 ˚C, with slow addition of DPPA (2 
equiv), which provided 60% yield of 5.108 (Table 5.1, entry 8). Either increasing or 
decreasing the equivalents of DPPA resulted in loss of yield (entries 7 and 9).  
 
Figure 5.10 Proposed mechanism of catalytic decarbonylation 
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It was soon discovered that the combination of both Kruse’s and O’Connor’s 
methods would ultimately provide the best results. The addition of 5.107 to a solution of 
Rh(CO)Cl(PPh3)3 and dppp in xylenes at 140 ˚C, followed by slow addition of DPPA (2 
equiv) led to an 85% isolated yield of 5.108. This is comparable to the results using 1 
equiv of RhCl(PPh3)3. Attempts to optimize this reaction further met with failure. 
Lowering the catalyst loading from 20 to 10 mol% or using pre-formed Rh(dppp)2Cl (20 
mol%) each led to lower conversions (entries 11 and 12). Furthermore, the sensitivity of 
this transformation towards oxygen was tested by performing the optimized reaction open 
to air, which led to no conversion of starting material (entry 13). Nevertheless, the new 
set of conditions using only 20 mol% of rhodium for decarbonylation would facilitate the 
synthesis of gliocladin C intermediate 5.108.  
Completion of the Synthesis 
 Upon optimization of the photoredox and decarbonylation reactions, the 
challenges that remained were the introduction of the TKP moiety and oxidation of the 
pyrroloindoline backbone. The indole nitrogen of 5.108 was first protected as the benzoyl 
carbamate and the Boc-amine was selectively deprotected using TMSI to give product 
5.114 in high yield (Scheme 5.14). In order to form the TKP unit, the same conditions as 
shown in scheme 5.11 for the conversion of 5.101 to 5.103 were applied for the 
conversion of 5.114 to 5.116. Amine 5.114 was reacted with ClCOCO2Et and Et3N in 
CH2Cl2, forming a mixture of two products, the non-cyclized ethyl oxamoyl 5.115 and 
the desired TKP 5.116 (~2.8:1). In contrast to the reactivity of bromopyrroloindoline 
5.102, treatment of 5.115 with silica gel did not affect the intramolecular amidation to the 
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desired compound 5.116. Therefore, Overman’s ring closing conditions were adopted for 
this purpose. Accordingly, the crude acylation mixture was heated at 140 ˚C in HMDS in 
a sealed tube for 8 h, providing TKP 5.115 in yields ranging from 35-56% over two steps. 
 
Scheme 5.14 Strategy for TKP formation 
Several methods for the dehydrogenation of 5.116 were then screened. The initial 
plan was to deprotonate the C11a methine, trap the enolate with an electrophile to form 
intermediate 5.118, and induce elimination to give the desired product 5.117. Treatment 
of 5.116 with LiHMDS at low temperature followed by the sequential additions of NBS 
and DBU failed to give the desired product (Table 5.2, entry 1). Instead, a complex 
mixture resulted, including possible addition of HMDS to the TKP.
208
 Given the 
bulkiness of LiHMDS, a smaller lithium base such as LiNEt2 was employed to favor 
deprotonation over nucleophilic attack. This also led to a complex mixture (entry 2). The 
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use of strong bases was abandoned and oxidants typically used for hydrogen atom 
abstraction were screened instead. However, substrate 5.116 was unreactive towards 
dehydrogenation with DDQ or hydroxylation with Py2AgMnO4 to give 5.118 (X = OH) 
(entries 3 and 4). The only condition that was found to effect the desired transformation 
was treatment with Pd/C in refluxing toluene for an extended period of time (entry 5). 
However, the yield was relatively low and the efficiency could not be improved with the 
addition of more Pd/C. 
Table 5.2 Oxidation conditions 
 
Entry Condiitons Result 
1 LiHMDS, THF, -78 °C, NBS, then DBU complex mixture 
2 LiNEt2, THF, -78 °C, then NBS complex mixture 
3 DDQ, MeOH/CHCl3 NR 
4 Py2AgMnO4, CH2Cl2 NR 
5 Pd/C, toluene, reflux, 2 d 20% 5.117  
 The challenges associated with the dehydrogenation strategy are possibly due to 
the accessibility of the C11a methine to different reagents. When looking at a 3D 
representation of 5.116, it appears that the hydrogen is oriented inside the concave face of 
the molecule and is thus partly blocked by the arene (Figure 5.11). Previous studies by 
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Movassaghi and co-workers on similar pyrroloindolines revealed the difficulty of 
enolization techniques to effect oxidation of diketopiperazine-containing dimers or 
heterodimers compared to simpler model systems. Their substrates ultimately required 
use of Py2AgMnO4 or Bu4NMnO4 to effect a radical hydroxylation via hydrogen atom 
abstraction.
182
 Furthermore, in those studies the α-C–H bonds that were reactive towards 
oxidation were oriented on the convex face of the molecule and in some cases would 
simply epimerize (see epi-5.116, Figure 5.11 for comparison). Compounded by the poor 
results of the acylation/annulation reaction (Figure 5.9), the dehydrogenation route to 
triketopiperazine 5.117 was unsatisfactory and needed to be reconsidered. 
 
Figure 5.11 3D representation of bisindole 5.116 
 To overcome the poor reactivity of the C11a methine in compound 5.116, 
oxidation of intermediate 5.114 was then explored. Specifically, conversion of the amine 
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into either the imine or enamine prior to annulation to form the TKP was considered. A 
relevant transformation reported by Lee and Woodward in 1979 described an elegant 
route to bicyclic imide 5.120 via oxime acylation/annulation of 5.119 with oxalyl 
chloride (eq. 3). Application of this method to our system would form the requisite TKP 
as well as the α,β-unsaturated imide.  
 
 Intermediate 5.114 was first converted to the imine via treatment with NBS in 
CH2Cl2, followed by DBU (Scheme 5.15). The reaction went smoothly at room 
temperature, providing quantitative yield of 5.121. Treatment of imine 5.121 with oxalyl 
chloride at room temperature did not lead to any reaction, nor did the addition of amine 
bases (Et3N, iPr2NEt, DBU). In an attempt to enhance the nucleophilicity of the amide, 
5.121 was treated with LiHMDS, followed by (COCl)2. However, this resulted in 
decomposition. Use of ethyl chlorooxalate was also investigated given the prior success 
with this reagent. Unfortunately, even annulations at elevated temperatures failed to give 
any desired product.  
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Scheme 5.15 Annulation attempts 
 After the unsuccessful attempts at thermal acylation, it was postulated that the 
imine nitrogen may be engaging in intramolecular hydrogen bonding with the amide N–
H, thereby lowering its nucleophilicity. Therefore, alternative methods to improve 
reactivity were explored. Microwave promoted reactions have been widely recognized 
for dramatic rate enhancements of difficult reactions due to the ability to rapidly attain 
high temperatures. If the lack of reactivity of 5.121 towards acylation under thermal 
conditions was due to an inherent stability of the molecule, microwave irradiation could 
potentially overcome this barrier. Indeed, treatment of 5.121 with ClCOCO2Et and Et3N 
in toluene under microwave irradiation at 150 ˚C for 30 min gave the desired 
triketopiperazine and olefin in one pot in 76% yield (two cycles of SM, Scheme 5.16). 
The formation of N-acyliminium ion 5.122 likely occurs first, followed by base-promoted 
generation of the enamine (5.123), and lastly, intramolecular amidation to form 
compound 5.124. With the backbone of gliocladin C finally established, the only step that 
remained to complete the synthesis was protecting group removal. Towards this end, 
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global Cbz deprotection using BCl3 in CH2Cl2 at -78 ˚C to rt furnished the natural 
product in 80% yield. Spectroscopic and optical rotation data obtained for 5.1 were in 
agreement with previous reports. In all, this route consisted of just 10 synthetic steps 
from commercially available starting material (5.97) and the final compound was 
obtained in excellent overall yield (33%). 
 
Scheme 5.16 Microwave-assisted TKP formation and final steps to gliocladin C 
 The successful implementation of a photoredox-based strategy for the formation 
of C3–C3' bisindole core structures ultimately enabled the shortest-to-date synthesis of 
gliocladin C. Furthermore, this study led to the development of a catalytic 
decarbonylation reaction on a complex indole intermediate as well as showcased the 
power of microwave-assisted transformations that allowed for a one-pot formation of an 
unsaturated triketopiperazine moiety. Future goals include the exploitation of 
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intermediate 5.121 for alternative annulation reactions to build differentially substituted 
diketopiperazine rings. 
5.6 Synthesis of C3–C2' Gliocladin C Derivative 
 The photoredox-mediated coupling of bromopyrroloindolines with indoles is a 
powerful method for generating a number of diverse bisindole derivatives, as 
demonstrated in section 5.4. Use of C2-substituted indoles directed the addition of 
pyrroloindoline radicals to the C3-position, thus enabling access to C3–C3' bisindole 
alkaloids such as gliocladin C. However, by taking advantage of the inherent C2 
reactivity of indoles towards radical additions, unusual C3–C2' bisindole analogues could 
be generated using the same optimized methodology. This should eventually allow for 
direct comparisons of biological activity with natural analogues which could provide 
insight on structure-activity relationships. Based on this aim, a C2 analogue of gliocladin 
C (5.125) was synthesized according to the retrosynthesis depicted in Scheme 5.17.  
 
Scheme 5.17 Retrosynthesis of C3–C2' gliocladin C 
 The synthesis of 5.125 began with the photoredox-mediated coupling of 
triketopiperazine-bromopyrroloindoline 5.103, used as an intermediate in the first 
generation synthesis of gliocladin C. Indole was reacted with 5.103 in the presence of 
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Bu3N (2 equiv), Ru(bpy)3Cl2 (1 mol%) in DMF under irradiation with blue LEDs over 12 
h (Scheme 18). However, this led to only trace amounts of the C3–C2' bisindole unit, 
with the highest yield of 17% reached only when 50 equiv of indole was used. Despite 
the fact that excess amounts of indole could be recovered upon purification, the poor 
performance of this transformation severely limited the potential amounts of final 
compound that could be generated from the sequence. With the assumption that the TKP 
ring was influencing the outcome, simple bromopyrroloindoline 5.100 was subjected to 
the photoredox conditions. Coupling product 5.127 was obtained in 38% yield using 20 
equiv of indole, with quantitative recovery of excess reagent. On a larger scale (1 g) 
using 5 equiv of indole, compound 5.127 was isolated in 24% yield. The remainder of the 
mass balance could not be identified. In some cases, the reduction product was detected 
(Br→H), however only in 10-20% yields and did not account for all the material. Later 
experiments indicated the instability of the product under photoredox conditions towards 
decomposition (see section 5.7).  
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Scheme 5.18 Indole coupling reactions  
 A one-pot imine acylation/annulation reaction was then planned for the formation 
of the triketopiperazine and olefin. The indole nitrogen of 5.127 was first protected as the 
benzoyl carbamate and the Boc group was removed with TMSI (Scheme 19).  However, 
treatment of amine 5.128 with NBS and DBU resulted in a significant amount of over-
brominated product (5.131) in addition to 5.130, likely due to the unblocked nucleophilic 
C3'-position on the indole. The use of a Cbz protecting group on the indole nitrogen had 
been expected to circumvent this reactivity; nevertheless, an alternative method for TKP 
formation was necessary.  
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Scheme 5.19 Imine formation attempts 
 To progress forward, an assessment of the previous strategy was carried out 
involving amine acylation/intramolecular amidation followed by dehydrogenation.  
Coupling product 5.127 was subjected to Boc deprotection and the corresponding 
secondary amine was reacted with ClCOCO2Et in the presence of Et3N in CH2Cl2 
(Scheme 20). Fortunately, as with compound 5.101, flash chromatography on silica gel 
facilitated the cyclization to the triketopiperazine compound 5.126. The last important 
challenge was the dehydrogenation of the pyrrolidine backbone. As an initial attempt, 
treatment of 5.126 with Pd/C in refluxing toluene for 12 h provided 56% yield of the 
desired compound (5.132, not shown). Interestingly, this transformation was more facile 
than dehydrogenation of the corresponding C3–C3' bisindole 5.116. The target C3–C2' 
gliocladin C analogue (5.125) was finally furnished in 73% yield upon deprotection of 
the aniline Cbz with BCl3 in CH2Cl2 at –78 ˚C. 
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Scheme 5.20 Completion of C3–C2' gliocladin C synthesis 
5.7 Catalyst & Quencher Optimization for Improved Indole Coupling
209
  
 The previous studies on photoredox-mediated indole functionalizations 
demonstrated a wide breadth of synthetic applications, including malonations as well as 
C3–C3' and C3–C2' bisindole preparations. However, those studies also revealed certain 
challenges that prevented the methodology from being truly general (Figure 5.12). In 
particular, during the reductive quenching cycle of photocatalysts (PC
n
) such as 
Ru(bpy)3Cl2, an electron donor is used either sacrificially (chapters 3 and 5–5.6) or as a 
substrate for oxidative coupling (chapter 4) and the reduced photocatalyst species (PC
n-1
), 
which has a strongly negative reduction potential, is used to reduce a C–X bond to 
generate an alkyl radical. With many of these reagents, there are often reactive species 
being produced that can potentially stall a desired transformation or promote an undesired 
one. This includes hydrogen-atom abstraction and enamine coupling with trialkyl amine 
reductive quenchers. Triaryl amines on the other hand, while shutting down those 
undesired pathways, also have tendencies to undergo competitive back electron transfer. 
The study presented in this section is aimed towards the development of alternative 
conditions for photoredox-mediated couplings of indoles and bromopyrroloindolines. 
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Figure 5.12 Reductive quenching and potential issues 
Biscatecholborate as a Reductive Quencher 
 In the ongoing exploration for improved substitutes for amine quenchers, 
biscatacholborate lithium salt 5.133 (LiB(cat)2) was discovered as a potential option. In 
2006, Yarasik investigated biscatacholborate tetramethylammonium salt as a reductive 
quencher for ruthenium-based photocatalysts, including Ru(bpy)3
2+
 salts.
210
 Upon single 
electron transfer from B(cat)2
¯
 to Ru(bpy)3
2+
*, the semiquinone (SQ) complex B(cat)(SQ) 
(5.134) and Ru(bpy)3
+ 
are produced (Figure 5.13). Several potential advantages were 
recognized. The spiroborate complex is anionic and it has been hypothesized that ion 
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pairing can occur with cationic Ru(bpy)3
2+
 to give enhanced quantum yields. 
Furthermore, upon oxidation of B(cat)2
¯
, the neutral species 5.134 can dissociate from the 
cationic metal photocatalyst. This in turn should suppress back electron transfer between 
the two components, an issue believed to hinder the alkylation of indoles using p-
CH3OC6H4NPh (section 3.2). Moreover, Yarasik measured the reduction potential of 
B(cat)2
¯
  as + 0.75 V vs SCE, which is comparable to many tertiary amines such as Et3N 
(+0.73 V vs SCE). 
 
Figure 5.13 Biscatecholborate as a reductive quencher 
 Biscatecholborate lithium salt 5.133 was tested as an electron donor in the 
photoredox-mediated coupling of bromopyrroloindoline 5.100 with indole. Using 
Ru(bpy)3Cl2 and Bu3N in DMF led to a slow reaction (12-14 h) and provided only 24-
38% yields of the desired product. Replacement of Bu3N with 5.133, however, also led to 
slow conversion in both DMF and DMSO (Scheme 5.21). The slow conversion may be 
attributed to poor ion pairing between the Ru(bpy)3
2+ 
 and B(cat)2¯. Yarasik had 
demonstrated that certain counterions present in solution dramatically affected the 
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quenching rate. Given our use of tightly bound Cl¯ and Li
+
 counterions, compared with 
more loosely bound PF6
–
 counterions used in Yarasik’s study, it was possible that this 
particular catalyst/quencher system was not compatible for this transformation. Thus, use 
of Ir(ppy)2(dtbbpy)PF6 as the photocatalyst was investigated in combination with 
LiB(cat)2. Fortunately, this combination with 10 equiv indole led to 60% isolated yield of 
5.127 and the reaction was complete in just 3h. This yield is significantly higher than 
previously obtained and the reaction finished in a fraction of the time.  It is possible that 
certain coupling products are unstable under photoredox conditions for an extended 
period of time and therefore the acceleration of reaction rate could be responsible for the 
success of the transformation. For the indole coupling reaction, the improved results 
could be to be due to a faster quenching rate between the catalyst and electron donor that 
ultimately prevents decomposition of the product. To support this hypothesis, product 
5.127 was re-subjected to the optimized photoredox conditions for an extended period of 
time (12 h) and recovered from the reaction mixture. Interestingly, only 50% of the 
original material was collected, indicating that decomposition had most likely occurred. 
However, attempts at isolating additional products that could help to elucidate the 
decomposition pathway were unsuccessful.  
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Scheme 5.21 Indole coupling with optimized conditions 
A variety of indoles were coupled with bromopyrroloindolines to demonstrate the 
utility of the alternative photoredox conditions (Figure 5.14). Gliocladin C intermediate 
5.107 was produced in 91% yield on large scale (1 g), which was higher than the yield 
obtained using the Ru(bpy)3Cl2/Bu3N system on the same scale. Furthermore, only 2 
equiv of the indole was necessary and the reaction was completed in a shorter timeframe 
(6 h vs. 12 h). The reaction of 5.100 with ethyl indole-2-carboxylate was also successful, 
providing 78% yield of the desired product 5.135. Other bromopyrroloindolines were 
tested, including derivatives of tryptamine and tryptophan to provide coupling products 
5.136 and 5.137 in 55 and 57% yield, respectively, on gram scale. Notably, the hetero-
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dimerization product of (D)-tryptophan and (L)-tryptophan derivatives (5.137) could 
potentially be useful for the synthesis of mesomeric dimeric bisindoles (vide infra). 
 
Figure 5.14 Substrate scope for LiB(cat)2/Ir
3+
* indole coupling 
 One of the advantages of utilizing radical chemistry for C–C bond formation is 
the ability to generate quaternary centers that could otherwise be difficult.  With the 
generation of tertiary alkyl radicals from bromopyrroloindolines, a variety of highly 
complex derivatives could be synthesized using photoredox catalysis. 
Bromopyrroloindoline 5.100 was coupled to other π-acceptors to demonstrate this 
concept (Figure 5.15). Substituted pyrrole and furan coupled successfully, providing 
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products 5.138 and 5.139 in 60 and 42% yields, respectively. Interestingly, butyl vinyl 
ether was found to be an excellent reactant for this transformation, giving 71% yield of 
aldehyde 5.140. This is expected to be a useful functional handle for further derivations. 
 
Figure 5.15 Substrate scope for LiB(cat)2/Ir
3+
* bromopyrroloindoline coupling 
 A potential application of this methodology is the use of coupling products 5.136 
and 5.137 for the preparation of dimeric bisindole alkaloids. For example, compound 
5.136 could be subjected to an oxidative rearrangement reaction to provide a mixture of 
spirooxindoles (5.141, Figure 5.16).  Reductive cyclization would then result in a mixture 
of racemic and mesomeric dimers 5.142 and 5.132. Use of enantiopure starting material 
and/or a chiral oxidant such as Davis’ oxaziridine, would lead to the stereocontrolled 
formation of dimers. The success of this transformation could also open up the possibility 
of synthesizing heterodimeric analogues, such as 5.144. 
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Figure 5.16 Future applications of pyrroloindoline couplings 
Mechanism 
 The proposed mechanism for the couplings is outlined in Figure 5.17. Visible 
light excitation of Ir
3+
 forms Ir
3+
*. Single electron transfer from B(cat)2¯ to Ir
3+
* (Ered = 
+0.66 V vs. SCE) forms B(cat)(SQ) 5.134 and Ir
2+
,  a powerful single electron reductant 
(Ered = -1.51 V). Reduction of the bromopyrroloindoline generates the alkyl radical 
(5.145). For coupling to heterocycles, addition at the α- or β-position will result in an 
adduct radical that can be oxidized and re-aromatized to from products. The semiquinone 
complex 5.145 is also a relatively strong reductant itself, with Ered = –1.10 V vs. SCE. 
Hence, it is also possible for this species to reduce the bromopyrroloindoline.  
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Figure 5.17 Proposed mechanism for LiB(cat)2/Ir
3+
* bromopyrroloindoline couplings 
 In the case of butyl vinyl ether, there are other mechanistic possibilities for the 
formation of product (Figure 5.18). One possible pathway involves β-scission of adduct 
radical 5.146, forming a butyl radical that can propagate the sequence. Alternatively, 
oxidation can occur to give oxonium 5.147, which can be either hydrolyzed or displaced 
by bromide. Further investigations on the mechanism on these transformations are 
currently underway. Other future studies include a thorough, side-by-side comparison of 
various quenchers and catalysts in order to better understand the factors influencing the 
outcome. 
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Figure 5.18 Mechanistic hypotheses for butyl vinyl ether coupling  
Miscellaneous Indole Coupling Studies  
 To probe the utility of the Ir(ppy)2(dtbbpy)PF6/LiB(cat)2 system further, 
experiments were conducted that explored potential back electron transfer processes. As 
discussed in section 3.3, back electron transfer was the proposed reason why α-
bromophenylacetate (5.150) failed to undergo reduction using p-CH3OC6H4NPh as the 
electron donor. Prior to testing less reactive bromides with the new catalyst system, a 
malonation reaction was first run to compare the general performance between the two 
conditions. N-Boc-tryptamine was reacted with diethyl bromomalonate (5.148) and 
LiB(cat)2 (2 equiv) in the presence of Ir(ppy)2(dtbbpy)PF6 (1 mol%) in DMSO under blue 
light irradiation (Figure 5.19). Compound 5.149 was obtained in 82% yield, comparable 
to the results using Ru(bpy)3Cl2/p-CH3OC6H4NPh/DMF only with a faster reaction rate. 
On the other hand, the reaction between N-methylindole and α-bromophenylacetate 
(5.150) led to 20% conversion to 5.151 under the new conditions whereas previously no 
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reaction was observed. While 20% conversion is still low, the experiment demonstrates 
the ability to improve the results of these transformations by fine-tuning the quencher and 
catalyst. Efforts to optimize these reactions further are currently under investigation.  
 
Figure 5.19 Improvements on indole coupling reactions 
5.8 Conclusion 
 Bisindole alkaloids comprise several structurally diverse scaffolds with unique 
biological properties. There have been a number of approaches to the synthesis of C3–C3' 
heterodimeric natural products, many of which involve condensations of isatin or 
nucleophilic trapping by indoles. However, with the use of visible light photoredox 
catalysis, a more general approach to pyrroloindoline-indole coupling has been 
accomplished. By taking advantage of a stabilized tertiary benzylic radical, a direct 
coupling methodology has been developed in which a variety of bromopyrroloindolines 
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and indoles could be joined in a divergent manner to produce several structural analogues 
of natural products. The reaction is mild and exhibits excellent functional group 
tolerance, but the yield is also influenced by the electronics of the substrates, particularly 
by the aniline protecting group.  
 The methodology was successfully applied to the total synthesis of gliocladin C, 
which as of yet represents the most concise overall route to this natural product. 
Furthermore, a rather high overall yield of 33% was accomplished, largely facilitated by 
an efficient and scalable key radical coupling step that establishes a chiral quaternary 
center.  Other interesting challenges that were overcome in that study were the 
development of a sub-stoichiometric catalytic rhodium decarbonylation reaction on a 
complex indole intermediate as well as the use of microwave conditions to promote an 
imine acylation/cyclization reaction to form the TKP ring. 
 With the inherent reactivity of radical additions onto indoles, C3–C2' analogues 
can also be accessed with this methodology. Improving the reaction rate of the coupling 
reaction by changing the catalytic system from Ru(bpy)3Cl2/Bu3N/DMF to 
Ir(ppy)2(dtbbpy)PF6/LiB(cat)2/DMSO improved the yield of the reaction of indole and a 
bromopyrroloindoline by two-fold. This facilitated an efficient synthesis (8 steps, 17% 
overall) of a C3–C2' gliocladin C analogue, which is currently undergoing evaluation of 
biological activity. Further modifications of the catalytic cycle are expected to improve 
the results of general indole functionalizations with a variety of different alkyl halides. 
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5.9 Experimental 
General Information: Chemicals were either used as received or purified according to 
Purification of Common Laboratory Chemicals. Glassware was dried in an oven at 170 
°C or flame dried and cooled under a dry atmosphere prior to use. All reactions were 
performed using common dry, inert atmosphere techniques. Reactions were monitored by 
TLC and visualized by a dual short wave/long wave UV lamp and stained with an 
ethanolic solution of potassium permanganate or p-anisaldehyde. Column flash 
chromatography was performed using 230-400 mesh silica gel. NMR spectra were 
recorded on Varian Mercury 300, Varian Unity Plus 400, and Varian Mercury 500 
spectrometers. Chemical shifts for 
1H NMR were reported as δ, parts per million, relative 
to the signal of CHCl3 at 7.26 ppm. Chemical shifts for 
13
C NMR were reported as δ, 
parts per million, relative to the center line signal of the CDCl3 triplet at 77 ppm. Proton 
and carbon assignments were established using spectral data of similar compounds. The 
abbreviations s, br. s, d, dd, br. d, ddd, t, q, br. q, m, and br. m stand for the resonance 
multiplicity singlet, broad singlet, doublet, doublet of doublets, broad doublet, doublet of 
doublet of doublets, triplet, quartet, broad quartet, multiplet and broad multiplet, 
respectively. IR spectra were recorded on a Nicolet FT-IR spectrometer. Optical rotations 
were obtained on a Rudolph Research Autopol II polarimeter (Na D line) using a micro 
cell with a 1-decimeter path length. Mass spectra were recorded at the Mass Spectrometry 
Facility at the Department of Chemistry of the Boston University in Boston, MA on a 
Waters Q-Tof API-US with ESI high resolution mass spectrometer. Concentration refers 
to removal of solvent under reduced pressure (house vacuum at ca. 20 mm Hg).  
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Bromopyrroloindoline were synthesized according to known procedures in the literature. 
General Procedure for the Coupling of indoles with bromopyrroloindolines: 
General Procedure 5.1: A flame dried 10 mL round bottom flask equipped with a rubber 
septum and magnetic stir bar was charged with tris(2,2´-bipyridyl)ruthenium(II) chloride 
hexahydrate (2.5 mol, 0.025 equiv), the corresponding bromopyrroloindoline (0.10 
mmol, 1.0 equiv), triethylamine (0.2 mmol, 2.0 equiv) and corresponding indole (0.5 
mmol, 5.0 equiv). The flask was purged with a stream of nitrogen and 1.0 mL of dry 
DMF was added. The resultant mixture was degassed via freeze pump-thaw (3 cycles) 
and placed at a distance of ~2 cm from a blue LED strip. After the reaction was complete 
(as judged by TLC analysis), the mixture was poured into a separatory funnel containing 
25 mL of EtOAc and 25 mL of H2O. The layers were separated and the aqueous layer 
was extracted with EtOAc (2 X 25 mL). The combined organic layers were dried (over 
Na2SO4) and concentrated. The residue was purified by chromatography on silica gel, 
using the solvent system indicated, to afford the desired indole coupled product. 
 
±(3aS*,8aR*)-di-tert-butyl 3a-(1-methyl-1H-indol-2-yl)-3,3a-dihydropyrrolo[2,3-
b]indole-1,8(2H,8aH)-dicarboxylate (5.70): According to general procedure 5.1, 
bromopyrroloindoline 5.68 (43.8 mg, 0.10 mmol), Et3N (28 L, 0.2 mmol), 1-
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methylindole (65.5 mg) and tris(2,2´-bipyridyl)ruthenium(II) chloride hexahydrate (1.9 
mg, 2.5 μmol) in dry DMF (1.0 mL) afforded 5.70 (25.4 mg, 52%) as a colorless oil after 
purification by chromatography on SiO2 (95:5 hexanes/acetone) (12 h reaction time). Rf 
(9:1 hexanes/EtOAc): 0.15; IR (neat): 3010, 2978, 1708, 1599, 1480, 1392, 1367, 1347, 
1320, 1270, 1253, 1213, 1143, 1091, 1015, 897, 851, 746 cm
−1
; 
1
H NMR (CDCl3, 300 
MHz):  7.77 (br. s, 1 H), 7.56 (d, J = 7.8 Hz, 1 H), 7.29-6.97 (m, 6 H), 6.61 (s, 1 H), 
6.49 (s, 1 H), 4.04 (dd, J = 11.4, 6.9 Hz, 1 H), 3.38 (s, 3 H), 2.94 (dt, J = 12.0, 4.5 Hz, 1 
H), 2.77 (dt, J = 12.0, 7.2 Hz, 1 H), 2.35 (dd, J = 11.7, 4.2 Hz, 1 H), 1.59 (s, 9 H), 1.48 (s, 
9 H); 
13
C NMR (CDCl3, 75 MHz):  153.6, 152.3, 142.8, 141.2, 138.8, 133.0, 128.9, 
126.7, 124.5, 123.4, 121.8, 120.3, 119.6, 115.4, 108.9, 101.3, 81.9, 80.2, 56.0, 44.6, 40.2, 
30.1, 28.4, 28.3; HRMS (ESI) m/z calculated for C32H35N3NaO6
+
 ([M+Na]
+
) 512.2525, 
found 512.2520. 
 
(3aS*,8aR*)-di-tert-butyl 3a-(3-methyl-1H-indol-2-yl)-3,3a-dihydropyrrolo[2,3-
b]indole-1,8(2H,8aH)-dicarboxylate (5.71): According to general procedure 5.1, 
bromopyrroloindoline 5.68 (43.8 mg, 0.10 mmol), Et3N (28 L, 0.2 mmol), 3-
methylindole (65.5 mg) and tris(2,2´-bipyridyl)ruthenium(II) chloride hexahydrate (1.9 
mg, 2.5 μmol) in dry DMF (1.0 mL) afforded 5.71 (27 mg, 55%) as a light yellow foam 
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after purification by chromatography on SiO2 (9:1, hexanes/EtOAc) (12 h reaction time). 
Rf (4:1 hexanes/EtOAc): 0.39; IR (neat): 3370, 2977, 1712, 1599, 1480, 1458, 1392, 
1366, 1323, 1253, 1164, 1017, 894, 750 cm
−1
; 
1
H NMR (CDCl3, 500 MHz):  7.66 (br. s, 
2 H), 7.51 (d, J = 7.5 Hz, 1 H), 7.33 (t, J = 7.5 Hz, 1 H), 7.32 (d, J = 8.0 Hz, 1 H), 7.19 
(d, J = 7.5 Hz, 1 H), 7.14-7.08 (m, 3 H), 6.56 (s, 1 H), 4.03 (dd, J = 11.5, 8.0 Hz, 1 H), 
2.97 (dt, J = 11.5, 5.0 Hz, 1 H), 2.75 (dt, J = 12.0, 7.5 Hz, 1 H), 2.50 (br. s, 1 H), 2.33 (s, 
3 H), 1.55 (s, 9 H), 1.52 (s, 9 H); 
13
C NMR (CDCl3, 75 MHz):  153.8, 152.6, 143.1, 
134.2, 133.7, 130.2, 129.4, 127.2, 124.2, 124.0, 122.0, 119.6, 118.4, 117.1, 110.7, 107.4, 
82.2, 82.1, 80.6, 56.5, 46.4, 38.5, 28.6, 28.5, 9.6; HRMS (ESI) m/z calculated for 
C29H35N3NaO4
+
 ([M+Na]
+
) 512.2525, found 512.2515. 
 
(2S,3aS,8aR)-1,8-di-tert-butyl 2-methyl 3a-(3-methyl-1H-indol-2-yl)-3,3a-
dihydropyrrolo[2,3-b]indole-1,2,8(2H,8aH)-tricarboxylate (5.72): According to 
general procedure 5.1, the bromopyrroloindoline (49.6 mg, 0.10 mmol), Et3N (28 L, 0.2 
mmol), 3-methylindole (65.5 mg) and tris(2,2´-bipyridyl)ruthenium(II) chloride 
hexahydrate (1.9 mg, 2.5 μmol) in dry DMF (1.0 mL) afforded 5.72 (32.8 mg, 60%) as a 
colorless oil after purification by chromatography on SiO2 (8:2 hexanes/EtOAc) (12 h 
reaction time). Rf  (7:3 hexanes/EtOAc): 0.33; []25D   = –11.2 (c 1.2, CHCl3); IR (neat): 
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3250, 2978, 2931, 1750, 1707, 1602, 1479, 1458, 1393, 1366, 1330, 1275, 1254, 1150, 
1126, 1081, 1052, 1025, 1007, 925, 897, 854, 795, 743 cm
−1
; 
1
H NMR (DMSO-d6, 60º 
500 MHz):  10.5 (br.s, 1 H), 7.57 (d, J = 8.0 Hz, 2 H), 7.50 (d, J = 7.5 Hz, 1 H), 7.37 (t, 
J = 8.0 Hz, 1 H), 7.35 (d, J = 8.0 Hz, 1 H), 7.33 (d, J = 8.0 Hz, 1 H), 7.18 (t, J = 7.5 Hz, 1 
H), 7.05 (t, J = 7.5 Hz, 1 H), 6.94 (t, J = 7.5 Hz, 1 H), 6.23 (s, 1 H), 3.80 (dd, J = 10.0, 
6.0 Hz, 1 H), 3.71 (s, 3 H), 3.07 (dd, J = 12.5, 6.0 Hz, 1 H), 2.87 (t, J = 11.5 Hz, 1 H), 
1.73 (s, 3 H), 1.46 (s, 9 H), 1.35 (s, 9 H); 
13
C NMR (DMSO-d6, 100 MHz):  172.1, 
151.9, 142.2, 135.6, 134.0, 131.6, 129.7, 129.6, 125.1, 124.7, 121.8, 118.9, 118.3, 111.5, 
107.5, 81.5, 80.8, 80.0, 59.5, 55.5, 52.5, 37.8, 28.2, 8.4; HRMS (ESI) m/z calculated for 
C31H37N3NaO6
+
 ([M+Na]
+
) 570.2580, found 570.2574. 
 
(3S,5aS,10bR,11aS)-10b-(1H-indol-2-yl)-3-methyl-6-(phenylsulfonyl)-
2,3,5a,6,11,11a-hexahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-1,4(10bH)-
dione (5.73): According to general procedure 5.1, the bromopyrroloindoline (47.5 mg, 
0.10 mmol), Et3N (28 L, 0.2 mmol), indole (58.5 mg) and tris(2,2´-
bipyridyl)ruthenium(II) chloride hexahydrate (1.9 mg, 2.5 μmol) in dry DMF (1.0 mL) 
afforded 5.73 (23 mg, 45%) as a light yellow solid after purification by chromatography 
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on SiO2 (95:5 CHCl3/MeOH) (12 h reaction time). Rf (9:1 CHCl3/MeOH): 0.48; []25D   = –
25.8 (c = 0.65, MeOH); IR (neat): 3146, 3109, 2847, 1683, 1618, 1474, 1457, 1447, 
1386, 1316, 1292, 1262, 1203, 1168, 1089, 1048, 1019, 1004, 976, 928, 893, 871, 823, 
780, 747 cm
−1
; 
1
H NMR (CD3OD, 500 MHz):  7.57 (d, J = 8.5 Hz, 1 H), 7.38 (dd, J = 
7.5, 0.5 Hz, 1 H), 7.37-7.33 (m, 2 H), 7.24 (2 d, J = 9.0, Hz, 2 H), 7.19 (dt, J = 7.5, 0.5 
Hz, 1 H), 7.17 (dt, J = 8.0, 1.0 Hz, 1 H), 7.12 (ddd, J = 8.5, 7.0, 1.5 Hz, 1 H), 7.05 (tt, J = 
7.5, 1.5 Hz 1 H), 6.99 (ddd, J = 7.5, 7.0, 0.5 Hz, 1 H), 6.64 (d, J = 7.5 Hz, 1 H), 6.62 (d, J 
= 7.5 Hz, 1 H), 6.42 (s, 1 H), 5.18 (d, J = 0.5 Hz, 1 H), 4.65 (dd, J = 9.5, 4.0 Hz, 1 H), 
4.16 (q, J = 7.0 Hz, 1 H), 3.21 (dd, J = 14.0, 4.0 Hz, 1 H), 2.92 (dd, J = 14.0, 10.0, 1 H), 
1.37 (d, J = 7.5 Hz, 3 H), (t, J = 12.0 Hz, 1 H), 2.96 (dd, J = 14.0, 11.0 Hz, 1 H), 2.85 
(dd, J = 12.5, 6.5 Hz, 1 H); 
13
C NMR (CD3OD, 75 MHz):  172.1, 170.0, 141.1, 139.1, 
138.9, 138.2, 136.1, 134.1, 130.6, 129.3, 127.9, 127.2, 126.5, 123.0, 121.6, 119.4, 118.3, 
112.1, 104.2, 86.5, 59.9, 57.8, 53.1, 35.6, 14.7; HRMS (ESI) m/z calculated for 
C28H24N4NaO4S
+
 ([M+Na]
+
) 535.1416, found 535.1415.  
  
(3aS*,8aR*)-di-tert-butyl 3a-(2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl)-3,3a-
dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate (5.75): According to general 
procedure 5.1, bromopyrroloindoline 5.68 (43.8 mg, 0.10 mmol), Et3N (28 L, 0.2 
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mmol), 1-methylindole-2-carboxylicacid methyl ester 5.74 (94.5 mg) and tris(2,2´-
bipyridyl)ruthenium(II) chloride hexahydrate (1.9 mg, 2.5 μmol) in dry DMF (1.0 mL) 
afforded 5.75 (31 mg, 56%) as a colorless solid after purification by chromatography on 
SiO2 (8.5:1.5 hexanes/EtOAc) (12 h reaction time). Rf (4:1 hexanes/EtOAc): 0.31; IR 
(neat): 2976, 1709, 1482, 1393, 1367, 1311, 1239, 1165, 1016, 752 cm
−1
; 
1
H NMR 
(DMSO-d6, 40º, 400 MHz):  7.67 (br. d, J = 7.2 Hz, 1 H), 7.53 (d, J = 8.4 Hz, 1 H), 
7.28-7.22 (m, 3 H), 7.09 (br. d, J = 7.6 Hz, 1 H), 6.99 (t, J = 8.0 Hz, 2 H), 6.51 (s, 1 H), 
3.95-3.89 (m, 1 H), 3.77 (s, 3 H), 3.72 (s, 3 H) 2.77-2.69 (m, 1 H), 2.54-2.46 (m, 2 H), 
1.49 (s, 9 H), 1.38 (s, 9 H); 
13
C NMR (DMSO-d6, 40º, 100 MHz):  164.0, 153.6, 152.1, 
142.4, 137.3, 135.1, 128.8, 128.3, 125.1, 125.0, 124.2, 123.7, 120.7, 119.3, 115.5, 111.5, 
83.1, 81.5, 79.9, 58.9, 53.1, 45.8, 40.1 31.5, 28.4, 28.3; HRMS (ESI) m/z calculated for 
C31H37N3NaO6
+
 ([M+Na]
+
) 570.2580, found 570.2579. 
 
Methyl 1-methyl-3-((3S,5aS,10bR,11aS)-3-methyl-1,4-dioxo-6-(phenylsulfonyl)-
2,3,4,5a,6,10b,11,11a-octahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indol-10b-yl)-
1H-indole-2-carboxylate (5.76): According to general procedure 5.1, the 
bromopyrroloindoline (47.5 mg, 0.10 mmol), Et3N (28 L, 0.2 mmol), 1-methylindole-2-
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carboxylicacid methyl ester 16 (94.5 mg) and tris(2,2´-bipyridyl)ruthenium(II) chloride 
hexahydrate (1.9 mg, 2.5 μmol) in dry DMF (1.0 mL) afforded 5.76 (27 mg, 46%) as a 
colorless solid after purification by chromatography on SiO2 (96:4 CHCl3/MeOH) (12 h 
reaction time). Rf (4:96 MeOH/CHCl3): 0.12; []25D   = +64.5 (c 0.6, CHCl3); IR (neat): 
3012, 1694, 1461, 1389, 1365, 1236, 1168, 1091, 983, 747 cm
−1
; 
1
H NMR (CDCl3, 500 
MHz):  7.68 (d, J = 8.0 Hz, 1 H), 7.39 (2 d, J = 8.5 Hz, 2 H), 7.35 (dt, J = 8.0, 1.0 Hz, 1 
H), 7.27 (d, J = 8.0 Hz, 1 H), 7.23 (d, J = 8.5 Hz, 1 H), 7.16-7.10 (m, 2 H), 6.91 (t, J = 
7.5 Hz, 1 H), 6.71 (t, J = 7.5 Hz, 2 H), 6.55 (s, 1 H), 6.54 (t, J = 7.5 Hz,1 H), 5.83 (br. s, 1 
H), 5.65 (s, 1 H), 4.65 (dd, J = 10.0, 5.5 Hz, 1 H), 4.10 (q, J = 7.0 Hz, 1 H), 3.86 (s, 3 H), 
3.77 (s, 3 H), 3.27 (dd, J = 14.0, 6.0 Hz, 1 H), 2.93 (dd, J = 13.5, 10.0 Hz, 1 H), 1.47 (d, J 
= 7.0 Hz, 3 H); 
13
C NMR (CDCl3, 100 MHz):  170.0, 167.9, 163.1, 140.2, 138.1, 137.8, 
135.8, 132.0, 129.7, 127.7, 127.1, 126.9, 126.1, 125.1, 124.7, 124.4, 121.9, 120.6, 117.2, 
110.1, 86.9, 59.8, 55.8, 52.4, 52.1, 38.1, 32.6, 15.2; HRMS (ESI) m/z calculated for 
C31H28N4NaO6S
+
 ([M+Na]
+
) 607.1627, found 607.1617. 
 
Methyl 3-((3S,5aS,10bR,11aS)-3-benzyl-1,4-dioxo-6-(phenylsulfonyl)-
2,3,4,5a,6,10b,11,11a-octahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indol-10b-yl)-1-
methyl-1H-indole-2-carboxylate (5.77): According to General Procedure 5.1, the 
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bromopyrroloindoline (55 mg, 0.10 mmol), Et3N (28 L, 0.2 mmol), 1-methylindole-2-
carboxylicacid methyl ester 5.74 (94.5 mg) and tris(2,2´-bipyridyl)ruthenium(II) chloride 
hexahydrate (1.9 mg, 2.5 μmol) in dry DMF (1.0 mL) afforded 5.77 (32 mg, 48%) as a 
colorless solid after purification by chromatography on SiO2 (1:4 hexanes/EtOAc) (12 h 
reaction time). Rf (1:4 hexanes/EtOAc): 0.16; []25D   = +29.3 (c 0.7, CHCl3); IR (neat): 
3027, 2950, 1695, 1461, 1365, 1236, 1168, 1091, 748 cm
−1
;
1
H NMR (CDCl3, 500 MHz): 
 7.72 (d, J = 8.0 Hz, 1 H), 7.39 (t, J = 7.5 Hz, 2 H), 7.37 (dd, J = 8.0, 1.5 Hz, 1 H), 7.33-
7.30 (m, 2 H), 7.28-7.24 (m, 2 H), 7.23 (d, J = 8.0 Hz, 1 H), 7.20 (dd, J = 8.0, 1.5 Hz, 2 
H), 7.16-7.12 (m, 2 H), 6.91 (t, J = 7.5 Hz, 1 H), 6.71 (t, J = 7.5 Hz, 2 H), 6.60 (s, 1 H), 
6.52 (t, J = 8.0 Hz, 1 H), 5.74 (br. s, 1 H), 5.41 (s, 1 H), 4.65 (dd, J = 10.0, 5.5 Hz, 1 H), 
4.26 (dd, J = 11.0, 4.0 Hz, 1 H), 3.88 (s, 3 H), 3.80 (s, 3 H), 3.69 (dd, J = 15.0, 3.5 Hz, 1 
H), 3.24 (dd, J = 13.0, 6.0 Hz, 1 H), 2.91 (dd, J = 14.0, 10.0 Hz, 1 H), 2.81 (dd, J = 15.0, 
11.0 Hz, 1 H); 
13
C NMR (CDCl3, 75 MHz):  169.7, 166.9, 163.1, 140.2, 138.1, 137.8, 
136.2, 135.9, 132.0, 129.7, 129.2, 128.9, 127.7, 127.4, 127.1, 126.9, 126.1, 125.1, 124.7, 
124.4, 121.9, 120.8, 120.6, 117.2, 110.1, 86.9, 59.6, 56.9, 55.7, 52.4, 38.4, 35.6, 32.6; 
HRMS (ESI) m/z calculated for C37H32N4NaO6S
+
 ([M+Na]
+
) 683.1940, found 683.1954. 
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Methyl 1-methyl-3-((3S,5aR,10bS,11aS)-3-methyl-1,4-dioxo-6-(phenylsulfonyl)-
2,3,4,5a,6,10b,11,11a-octahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indol-10b-yl)-
1H-indole-2-carboxylate (5.78): According to General Procedure 5.1, the 
bromopyrroloindoline (47.5 mg, 0.10 mmol), Et3N (28 L, 0.2 mmol), 1-methylindole-2-
carboxylicacid methyl ester 5.74 (94.5 mg) and tris(2,2´-bipyridyl)ruthenium(II) chloride 
hexahydrate (1.9 mg, 2.5 μmol) in dry DMF (1.0 mL) afforded 5.78 (28 mg, 48%) as a 
colorless solid after purification by chromatography on SiO2 (98:2 CHCl3/MeOH) (12 h 
reaction time). Rf (96:4 CHCl3/MeOH): 0.12; []25D   = –92.2 (c 0.5, CHCl3); IR (neat): 
3222, 3012, 1683, 1461, 1389, 1366, 1234, 1169, 745 cm
−1
; 
1
H NMR (CDCl3, 500 MHz): 
 7.80 (d, J = 8.5 Hz, 1 H), 7.48 (2 d, J = 8.5 Hz, 2 H), 7.34 (dt, J = 7.5, 1.5 Hz, 1 H), 
7.31 (dd, J = 7.5, 1.0 Hz, 1 H), 7.23 -7.19 (m, 2 H), 7.15 (t, J = 7.5 Hz, 1 H), 6.93 (tt, J = 
7.5, 1.0 Hz, 1 H), 6.78 (s, 1 H), 6.75 (d, J = 7.5 Hz, 1 H), 6.74 (d, J = 8.0 Hz, 1 H) 6.59 
(td, J = 8.0, 1.0 Hz, 1 H), 6.11 (br. s, 1 H), 5.93 (d, J = 8.5 Hz, 1 H), 4.21 (q, J = 7.0 Hz, 
1 H), 4.10 (t, J = 9.5 Hz, 1 H), 3.81 (s, 3 H), 3.78 (s, 3 H), 2.90-2.88 (m, 2 H), 1.57 (d, J 
= 7.0 Hz, 3 H); 
13
C NMR (CDCl3, 100 MHz):  169.0, 164.9, 163.2, 142.5, 138.1, 137.8, 
134.6, 132.4, 130.3, 128.1, 127.3, 126.9, 126.7, 125.4, 125.1, 124.3, 122.1, 120.6, 118.8, 
118.3, 110.2, 85.7, 59.2, 54.7, 52.6, 51.5, 44.4, 32.6, 17.2; HRMS (ESI) m/z calculated 
for C31H28N4NaO6S
+
 ([M+Na]
+
) 607.1627, found 607.1625. 
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Methyl 3-((3S,5aR,10bS,11aS)-3-benzyl-1,4-dioxo-6-(phenylsulfonyl)-
2,3,4,5a,6,10b,11,11a-octahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indol-10b-yl)-1-
methyl-1H-indole-2-carboxylate (5.79): According to General Procedure 5.1, the 
bromopyrroloindoline (55 mg, 0.10 mmol), Et3N (28 L, 0.2 mmol), 1-methylindole-2-
carboxylicacid methyl ester 5.74 (94.5 mg) and tris(2,2´-bipyridyl)ruthenium(II) chloride 
hexahydrate (1.9 mg, 2.5 μmol) in dry DMF (1.0 mL) afforded 5.79 (30 mg, 45%) as a 
colorless solid after purification by chromatography on SiO2 (1:1 hexanes/EtOAc) (12 h 
reaction time). Rf (1:1 EtOAc/hexanes): 0.12; []25D   = −113.8 (c 0.5, CHCl3); IR (neat): 
3028, 2950, 1684, 1476, 1446, 1396, 1366, 1235, 1169, 1091, 746 cm
−1
; 
1
H NMR 
(CDCl3, 500 MHz):  7.81 (d, J = 8.5 Hz, 1 H), 7.51 (2 d, J = 7.5 Hz, 2 H), 7.42 (dt, J = 
8.0, 0.5 Hz, 1 H), 7.34-7.14 (m, 9 H), 6.96 (t, J = 7.5 Hz, 1 H), 6.82 (s, 1 H), 6.78 (t, J = 
7.5 Hz, 2 H), 6.60 (t, J = 7.5 Hz, 1 H), 5.98 (d, J = 8.5 Hz, 1 H), 5.67 (s, 1 H), 4.34 (dd, J 
= 11.0, 2.0 Hz, 1 H), 4.34 (ddd, J = 8.0, 7.0, 1.5 Hz, 1 H), 3.82 (s, 3 H), 3.81 (s, 3 H), 
3.79 (dd, J = 15.0, 3.5 Hz, 1 H), 2.91-2.79 (m, 3 H); 
13
C NMR (CDCl3, 75 MHz):  
167.9, 163.5, 163.0, 142.2, 137.9, 137.5, 135.8, 134.2, 132.2, 130.0, 129.3, 129.2, 127.9, 
127.6, 127.0, 126.6, 126.5, 125.1, 124.9, 124.1, 121.8, 120.4, 118.8, 117.8, 110.0, 85.3, 
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58.6, 56.2, 54.5, 52.4, 44.3, 37.4, 32.0; HRMS (ESI) m/z calculated for C37H32N4NaO6S
+
 
([M+Na]
+
) 683.1940, found 683.1954. 
 
(3aS*,8aR*)-di-tert-butyl 3a-(2-(methoxycarbonyl)-1H-indol-3-yl)-3,3a-
dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate (5.80): According to General 
Procedure 5.1, the bromopyrroloindoline (44 mg, 0.10 mmol), Et3N (28 L, 0.20 mmol), 
methyl indole-2-carboxylate (88 mg) and tris(2,2´-bipyridyl)ruthenium(II) chloride 
hexahydrate (1.9 mg, 2.5 μmol) in dry DMF (1.0 mL) afforded 5.80 (31 mg, 58%) as a 
colorless solid after purification by chromatography on SiO2 (8.5:1.5 hexanes/EtOAc) (12 
h reaction time). Rf (7:3 hexanes/EtOAc): 0.33; IR (neat): 3324, 2977, 1718, 1518, 1480, 
1438, 1395, 1366, 1336, 1248, 1203, 1154, 1018, 751 cm
−1
; 
1
H NMR (DMSO-d6, 60º, 
300 MHz):  11.82 (br. s, 1 H), 7.67 (d, J = 8.1 Hz, 1 H), 7.44 (d, J = 8.1 Hz, 1 H), 7.31 
(d, J = 7.5 Hz, 1 H), 7.26 (t, J = 7.8 Hz, 1 H), 7.18 (t, J = 7.8 Hz, 1 H), 7.00 (t, J = 7.5 
Hz, 1 H), 6.91-6.83 (m, 2 H), 6.59 (s, 1 H), 3.92-3.88 (m, 1 H), 3.85 (s, 3 H), 2.82-2.66 
(m, 3 H), 1.45 (s, 9 H), 1.37 (s, 9 H); 
13
C NMR (DMSO-d6, 60º, 75 MHz):  162.7, 
154.0, 152.5, 142.9, 136.6, 135.8, 129.0, 126.7, 125.5, 125.0, 124.0, 123.8, 123.5, 121.7, 
120.6, 115.9, 113.5, 84.1, 81.4, 79.9, 56.5, 52.6, 46.2, 39.6, 28.7; HRMS (ESI) m/z 
calculated for C30H35N3NaO6
+
 ([M+Na]
+
) 556.2424, found 556.2410. 
198 
 
 
 
(2S,3aS,8aR)-1,8-di-tert-butyl 2-methyl 3a-(2-(methoxycarbonyl)-1H-indol-3-yl)-
3,3a-dihydropyrrolo[2,3-b]indole-1,2,8(2H,8aH)-tricarboxylate (5.81): According to 
General Procedure 5.1,  the bromopyrroloindoline (49.6 mg, 0.10 mmol), Et3N (28 L, 
0.2 mmol), methyl indole-2-carboxylate (87.5 mg) and tris(2,2´-bipyridyl)ruthenium(II) 
chloride hexahydrate (1.9 mg, 2.5 μmol) in dry DMF (1.0 mL) afforded 29 (33 mg, 56%) 
as a colorless foam after purification by chromatography on SiO2 (8:2 Hexanes/EtOAc) 
(12 h reaction time). Rf (7:3 hexanes/EtOAc): 0.19; []25D   = +82.9 (c 0.65, CHCl3); IR 
(neat): 3324, 2977, 1718, 1518, 1480, 1438, 1395, 1366, 1336, 1248, 1203, 1154, 1018, 
751 cm
−1
; 
1
H NMR (C6D6, 60º, 300 MHz):  8.67 (s, 1 H), 7.99 (br. s, 1 H), 7.21 (d, J = 
8.4 Hz, 1 H), 7.07 (s, 1 H), 6.99-6.94 (m, 3 H), 6.82 (d, J = 8.1 Hz, 1 H), 6.74 (t, J = 7.8 
Hz, 1 H), 6.45 (d, J = 7.8 Hz, 1 H), 4.31 (dd, J = 11.2, 6.3 Hz, 1 H), 3.77 (s, 3 H), 3.45 (s, 
3 H), 3.28 (dd, J = 12.0, 10.5 Hz, 1 H), 2.84 (dd, J = 11.7, 6.9 Hz, 1 H), 1.43 (s, 9 H), 
1.40 (s, 9 H); 
13
C NMR (C6D6, 60º, 75 MHz):  172.2, 162.1, 152.4, 143.6, 135.7, 129.5, 
128.3, 125.7, 124.8, 123.5, 122.5, 120.5, 118.6, 112.0, 84.4, 80.9, 80.1, 60.4, 55.4, 52.1, 
51.3, 41.1, 28.2, 27.9; HRMS (ESI) m/z calculated for C32H37N3NaO8
+
 ([M+Na]
+
) 
614.2478, found 614.2482. 
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Methyl 3-((3S,5aS,10bR,11aS)-3-methyl-1,4-dioxo-6-(phenylsulfonyl)-
2,3,4,5a,6,10b,11,11a-octahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indol-10b-yl)-
1H-indole-2-carboxylate (5.82): According to General Procedure 5.1, the 
bromopyrroloindoline (47.5 mg, 0.10 mmol), Et3N (28 L, 0.2 mmol), methyl indole-2-
carboxylate (87.5 mg) and tris(2,2´-bipyridyl)ruthenium(II) chloride hexahydrate (1.9 
mg, 2.5 μmol) in dry DMF (1.0 mL) afforded 5.82 (22.8 mg, 40%) as a colorless solid 
after purification by chromatography on SiO2 (95:5 CHCl3/MeOH) (12 h reaction time). 
Rf (9:1 CHCl3/MeOH): 0.50; []25D   = +19.6 (c 0.95, CHCl3); IR (neat): 3272, 2918, 2855, 
1679, 1600, 1518, 1475, 1445, 1393, 1360, 1335, 1313, 1241, 1206, 1163, 1133, 1089, 
1040, 981, 951, 884, 843, 783, 737 cm
−1
; 
1
H NMR (DMSO-d6, 500 MHz):  12.1 (br.s, 1 
H), 7.97 (s, 1 H), 7.48 (d, J = 8.0 Hz, 1H), 7.44 (d, J = 8.0 Hz, 1H) 7.42 (dt, J = 8.0, 1.0 
Hz, 1H), 7.32 (dd, J = 8.0, 1.0 Hz, 1 H), 7.21 (dt, J = 7.5, 1.0 Hz, 1 H), 7.07 (d, J = 8.0 
Hz, 1 H), 6.98 (ddd, J = 8.5, 7.0, 1.0 Hz, 1 H), 6.77 (t, J = 7.5 Hz, 1 H), 6.60 (t, J = 8.0 
Hz, 2 H), 6.32 (s, 1 H), 6.27 (t, J = 7.0 Hz, 1 H), 5.33 (d, J = 7.5 Hz, 1 H), 4.67 (dd, J = 
10.5, 4.0 Hz, 1 H); 4.18 (q, J = 13.5, 6.5 Hz, 1 H) 3.98 (s, 3 H), 3.23 (dd, J = 13.0, 4.0 
Hz, 1 H), 2.83 (dd, J = 13.5, 11.0 Hz, 1 H), 1.19 (d, J = 7.0 Hz, 3 H); 
13
C NMR (DMSO-
d6, 125 MHz):  170.4, 168.6, 162.3, 140.2, 137.7, 136.6, 136.2, 132.5, 130.2, 128.7, 
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128.1, 126.3, 126.1, 125.0, 124.3, 122.5, 122.3, 121.5, 120.1, 117.3, 113.0, 87.4, 59.8, 
55.6, 52.7, 51.3, 37.7, 14.8; HRMS (ESI) m/z calculated for C30H26N4NaO6S
+
 ([M+Na]
+
) 
593.1471, found 593.1475. 
 
Methyl 3-((3S,5aS,10bR,11aS)-3-benzyl-1,4-dioxo-6-(phenylsulfonyl)-
2,3,4,5a,6,10b,11,11a-octahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indol-10b-yl)-
1H-indole-2-carboxylate (5.83): According to General Procedure 5.1, the 
bromopyrroloindoline (55.1 mg, 0.10 mmol), Et3N (28 L, 0.2 mmol), methyl indole-2-
carboxylate (87.5 mg) and tris(2,2´-bipyridyl)ruthenium(II) chloride hexahydrate (1.9 
mg, 2.5 μmol) in dry DMF (1.0 mL) afforded 5.83 (28 mg, 43%) as a colorless solid after 
purification by chromatography on SiO2 (98:2 CHCl3/MeOH) (12 h reaction time). Rf 
(96:4 CHCl3/MeOH): 0.20; []25D   = +6.26 (c 0.75, CHCl3); IR (neat): 3361, 2977, 1692, 
1480, 1336, 1248, 1167, 1091, 740 cm
−1
; 
1
H NMR (CDCl3, 500 MHz):  9.12 (br. s, 1 
H), 7.70 (dd, J = 8.0, 1.0 Hz, 1 H), 7.41 (t, J = 7.5 Hz, 2 H), 7.31 (t, J = 7.5 Hz, 2 H), 
7.26-7.18 (m, 7 H), 7.06 (t, J = 8.0 Hz, 1 H), 6.67 (t, J = 7.5 Hz, 1 H), 6.52 (t, J = 7.5 Hz, 
2 H), 6.47 (s, 1 H), 6.39 (t, J = 8.0 Hz, 1 H), 5.49 (d, J = 8.0 Hz, 1 H), 5.38 (br. s, 1 H), 
4.77 (dd, J = 10.5, 4.5 Hz, 1 H), 4.29 (dd, J = 11.0, 4.0 Hz, 1 H), 3.98 (s, 3 H), 3.69 (dd, J 
= 15.0, 3.5 Hz, 1 H), 3.35 (dd, J = 13.5, 4.5 Hz, 1 H), 2.93 (dd, J = 13.5, 11.0 Hz, 1 H), 
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2.80 (dd, J = 15.0, 11.0 Hz, 1 H); 
13
C NMR (CDCl3, 75 MHz):  169.9, 166.4, 161.1, 
140.3, 137.8, 136.2, 135.8, 135.1, 131.8, 129.9, 129.2, 128.9, 127.9, 127.4, 127.3, 126.5, 
126.4, 125.1, 124.9, 124.5, 122.3, 121.7, 120.7, 117.9, 111.6, 87.7, 59.7, 56.8, 55.2, 52.4, 
38.5, 35.4; HRMS (ESI) m/z calculated for C36H30N4NaO6
+
 ([M+Na]
+
) 669.1784, found 
669.1771. 
 
Methyl 3-((3S,5aR,10bS,11aS)-3-benzyl-1,4-dioxo-6-(phenylsulfonyl)-
2,3,4,5a,6,10b,11,11a-octahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indol-10b-yl)-
1H-indole-2-carboxylate (5.84): According to General Procedure 5.1, the 
bromopyrroloindoline (55.1 mg, 0.10 mmol), Et3N (28 L, 0.2 mmol), methyl indole-2-
carboxylate (87.5 mg) and tris(2,2´-bipyridyl)ruthenium(II) chloride hexahydrate (1.9 
mg, 2.5 μmol) in dry DMF (1.0 mL) afforded 5.84 (26.4 mg, 40%) as a colorless solid 
after purification by chromatography on SiO2 (97:3 CHCl3/MeOH) (12 h reaction time). 
Rf (94:6 CHCl3/MeOH): 0.33; []25D   = –101.4 (c 1.35, MeOH); IR (neat): 3316, 3062, 
3028, 2948, 1676, 1597, 1519, 1497, 1475, 1435, 1360, 1335, 1313, 1294, 1238, 1202, 
1165, 1133, 1089, 1030, 980, 843, 740 cm
−1
; 
1
H NMR (CDCl3, 500 MHz):  9.24 (br. s, 
1 H), 7.85 (dd, J = 8.0, 1.0 Hz, 1 H), 7.49 (dt, J = 8.0, 1.0 Hz, 1 H), 7.40 (br. d, J = 7.5 
Hz, 1 H), 7.36-7.25 (m, 9 H), 7.11 (dt, J = 7.5, 1.0 Hz, 1 H), 6.71 (s, 1 H), 6.69 (td, J = 
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7.5, 1.0 Hz, 1 H), 6.59 (br. t, J = 8.0 Hz, 2 H), 6.52 (dds, J = 8.5, 7.5, 1.0 Hz, 1 H), 5.88 
(d, J = 9.0 Hz, 1 H), 5.77 (br. s, 1 H), 4.36 (ddd, J = 11.0, 3.5, 1.5 Hz, 1 H), 4.04 (ddd, J 
= 11.5, 6.5, 1.5 Hz, 1 H), 3.95 (s, 3 H), 3.84 (dd, J = 14.5, 3.5 Hz, 1 H), 3.14 (t, J = 12.0 
Hz, 1 H), 2.96 (dd, J = 14.0, 11.0 Hz, 1 H), 2.85 (dd, J = 12.5, 6.5 Hz, 1 H); 
13
C NMR 
(CDCl3, 75 MHz):  168.4, 163.9, 161.1, 142.7, 137.6, 136.4, 135.4, 134.3, 132.2, 130.5, 
129.5, 129.4, 128.6, 128.0, 127.7, 127.5, 126.8, 126.4, 125.5, 125.2, 122.8, 122.6, 122.4, 
120.7, 119.2, 111.9, 86.9, 59.8, 56.5, 54.5, 52.6, 43.8, 37.7; HRMS (ESI) m/z calculated 
for C36H31N4O6S
+
 ([M+H]
+
) 647.1964, found 647.1935. 
 
(5aS,10bR,11aS)-benzyl 10b-(2-((benzyloxy)carbonyl)-1H-indol-3-yl)-2-methyl-1,4-
dioxo-3,4,5a,10b,11,11a-hexahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-
6(2H)-carboxylate (5.88): According to General Procedure 5.1, the 
bromopyrroloindoline (47.0 mg, 0.10 mmol), Et3N (28 L, 0.2 mmol), benzyl indole-2-
carboxylate 5.87 (87.5 mg) and tris(2,2´-bipyridyl)ruthenium(II) chloride hexahydrate 
(1.9 mg, 2.5 μmol) in dry DMF (1.0 mL) afforded 5.88 (40.0 mg, 62%) as a colorless 
solid after purification by chromatography on SiO2 (50:47:3 CH2Cl2/hexanes/iPrOH) (12 
h reaction time). Rf (50:45:5 CH2Cl2/hexane/iPrOH): 0.52; []25D   = 150.7 (c 0.80, 
CHCl3); IR (neat): 3288, 3033, 1706, 1676, 1517, 1482, 1429, 1402, 1385, 1313, 1287, 
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1242, 1204, 1174, 746 cm
−1
; 
1
H NMR (CDCl3, 500 MHz):  9.36 (br. s, 1 H), 7.79 (br. s, 
1 H), 7.50 (d, J = 7.5 Hz, 1 H); 7.41-7.40 (m, 6 H), 7.31-7.24 (m, 6 H), 7.20 (dt, J = 7.5, 
1.0 Hz, 1 H), 7.19-7.16 (m, 1 H), 6.73-6.70 (m, 1 H), 6.48 (s, 1 H), 5.80 (d, J = 8.5 Hz, 1 
H), 5.34 (d, J = 12.0  Hz, 1 H), 5.28 (d, J = 12.0  Hz, 1 H), 5.25 (d, J = 12.5 Hz, 1 H), 
5.20 (d, J = 12.5 Hz, 1 H), 4.49 (br. d, J = 6.0 Hz, 1 H), 3.92 (d, J = 16.5 Hz, 1 H), 3.59 
(d, J = 17.0 Hz, 1 H), 3.51 (dd, J = 13.5, 5.0 Hz, 1 H), 3.12 (dd, J = 13.5, 11.0 Hz, 1 H), 
2.80 (s, 3 H); 
13
C NMR (CDCl3, 100 MHz):  167.7, 163.9, 161.2, 153.1, 140.9, 136.1, 
135.5, 135.0, 134.9, 129.6, 128.9, 128.3, 127.9, 127.8, 127.4, 127.0, 125.5, 124.0, 123.9, 
122.5, 122.2, 120.7, 117.0, 111.8,  84.6, 67.8, 67.5, 58.9, 54.3, 54.1, 39.3, 33.6; HRMS 
(ESI) m/z calculated for C38H33N4O6
+
 ([M+H]
+
) 641.2400, found 641.2413. 
 
benzyl 3-((5aS,10bR,11aS)-2-methyl-1,4-dioxo-6-(phenylsulfonyl)-
2,3,4,5a,6,10b,11,11a-octahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indol-10b-yl)-
1H-indole-2-carboxylate (5.89): According to General Procedure 5.1, the 
bromopyrroloindoline (47.5 mg, 0.10 mmol), Et3N (28 L, 0.2 mmol), benzyl indole-2-
carboxylate 5.87 (87.5 mg) and tris(2,2´-bipyridyl)ruthenium(II) chloride hexahydrate 
(1.9 mg, 2.5 μmol) in dry DMF (1.0 mL) afforded 35 (26.0 mg, 40%) as a colorless solid 
after purification by chromatography on SiO2 (50:47:3, CH2Cl2:Hexane:
i
PrOH) (12 h 
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reaction time).  Rf (CH2Cl2:Hexane:
i
PrOH 50:45:5): 0.47; []25
D
  = +37.2 (c 0.85, CHCl3); 
IR (neat): 3316, 3062, 3028, 2948, 1676, 1597, 1519, 1497, 1475, 1435, 1360, 1335, 
1313, 1294, 1238, 1202, 1165, 1133, 1089, 1030, 980, 843, 740 cm
−1
; 
1
H NMR (CDCl3, 
500 MHz):  9.19 (br. s, 1 H), 7.64 (dd, J = 8.0, 1.0 Hz, 1 H), 7.54-7.45 (m, 5 H), 7.40-
7.37 (m, 2 H), 7.22-7.18 (m, 4 H), 7.06 (dt, J = 8.0, 1.0 Hz, 1 H), 6.70 (br. t, J = 7.5 Hz, 1 
H), 6.52 (t, J = 8.0, 1.0 Hz, 1 H), 6.46 (s, 1 H), 6.39 (dd, J = 7.5, 1.0 Hz, 1 H), 6.37 (dd, J 
= 7.5, 1.0 Hz, 1 H), 5.47 (d, J = 12.0 Hz, 1 H), 5.41 (d, J = 12.0 Hz, 1 H), 4.52 (dd, J = 
10.5, 5.0 Hz, 1 H), 4.03 (d, J = 17.0 Hz, 1 H), 3.73 (d, J = 17.0 Hz, 1 H), 3.39 (dd, J = 
13.5, 4.5 Hz, 1 H), 2.96 (dd, J = 13.5, 11.0 Hz, 1 H), 2.82 (s, 3 H); 
13
C NMR (CDCl3, 100 
MHz):  167.8, 163.2, 160.8, 140.2, 137.8, 135.9, 135.2, 135.0, 131.8, 129.7, 129.0, 
128.0, 127.4, 126.5, 125.1, 124.9, 124.3, 122.2, 121.7, 120.6, 117.7, 111.7, 87.5, 67.6, 
59.1, 55.2, 54.2, 39.1, 33.5; HRMS (ESI) m/z calculated for C36H31N4O6S
+
 ([M+H]
+
) 
647.1964, found 647.1957. 
 
(2S,3aS,8aR)-8-benzyl 1-tert-butyl 2-methyl 3a-(2-formyl-1H-indol-3-yl)-3,3a-
dihydropyrrolo[2,3-b]indole-1,2,8(2H,8aH)-tricarboxylate (5.90): According to 
General Procedure 5.1, the bromopyrroloindoline (53.0 mg, 0.10 mmol), Et3N (28 L, 
0.2 mmol), indole-2-carboxaldehyde 5.91 (72.5 mg, 0.5 mmol) and tris(2,2´-
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bipyridyl)ruthenium(II) chloride hexahydrate (0.8 mg, 1.0 μmol) in dry DMF (1.0 mL) 
afforded 5.90 (38.0 mg, 72%) as a colorless solid after purification by chromatography on 
SiO2 (7:3 hexanes/EtOAc) (12 h reaction time). Rf (7:3 hexanes/EtOAc): 0.14; []25D   = 
+113.3 (c 1.2, CHCl3); IR (neat): 3334, 2978, 1720, 1649, 1522, 1482, 1455, 1406, 1333, 
1284, 1207, 1156, 1067, 1027, 907, 853, 749 cm
−1
; 
1
H NMR (CDCl3, 400 MHz):  9.12 
(br. s, 1 H), 8.22 (s, 1 H), 7.96 (d, J = 8.4 Hz, 1 H); 7.72 (br. s, 1 H), 7.47-7.36 (m, 5 H), 
7.25-7.20 (m, 6 H), 6.67 (s, 1 H), 5.28 (d, J = 12.0 Hz, 1 H), 5.04 (br. s, 1 H), 4.19 (t, J = 
8.4 Hz, 1 H), 3.82 (s, 3 H), 3.32 (dd, J = 12.8, 10.8 Hz, 1 H), 3.76 (dd, J = 13.2, 7.2 Hz, 1 
H), 1.40 (s, 9 H); 
13
C NMR (CDCl3, 100 MHz):  182.9, 1723.0, 153.2, 141.7, 136.9, 
135.8, 134.3, 133.4, 130.5, 128.4, 127.9, 127.2, 126.0, 124.7, 124.5, 123.3, 122.4, 121.6, 
119.1, 112.8, 83.1, 81.6, 67.5, 60.0, 52.4, 39.0, 28.2; HRMS (ESI) m/z calculated for 
C34H33N3O7Na
+
 ([M+Na]
+
) 618.2216, found 618.2196. 
 
(5aS,10bR,11aS)-benzyl 10b-(2-formyl-1H-indol-3-yl)-2-methyl-1,4-dioxo-
3,4,5a,10b,11,11a-hexahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-6(2H)-
carboxylate (5.93): According to General Procedure 5.1, the bromopyrroloindoline  
(47.0 mg, 0.10 mmol), Et3N (28 L, 0.2 mmol), indole-2-carboxaldehyde 5.91 (72.5 mg, 
0.5 mmol) and tris(2,2´-bipyridyl)ruthenium(II) chloride hexahydrate (1.9 mg, 2.5 μmol) 
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in dry DMF (1.0 mL) afforded 5.93 (38.0 mg, 72%) as a colorless solid after purification 
by chromatography on SiO2 (50:47:3 CH2Cl2/Hexane/iPrOH) (12 h reaction time). Rf 
(50:45:5 CH2Cl2/Hexane/iPrOH): 0.52; []25D   = 19.4 (c 1.60, CHCl3); IR (neat): 3293, 
3030, 1719, 1675, 1517, 1481, 1426, 1401, 1366, 1327, 1287, 1268, 1155, 1065, 1021, 
747 cm
−1
; 
1
H NMR (CDCl3, 500 MHz):  9.38 (br. s, 1 H), 8.24 (s, 1 H), 7.79 (d, J = 8.5 
Hz, 1 H); 7.59 (br. d, 1 H), 7.48 (dd, J = 8.5, 1.0 Hz, 1 H), 7.41 (dt, J = 8.5, 1.0 Hz, 1 H), 
7.38-7.34 (m, 3 H), 7.28-7.25 (m, 5 H), 7.17 (td, J = 7.5, 1.0 Hz, 1 H), 7.14 (ddd, J = 7.0, 
1.0 Hz, 1 H),  6.43 (s, 1 H), 5.29 (d, J = 12.0 Hz, 1 H), 5.20 (d, J = 12.0  Hz, 1 H), 4.72 
(br. dd, J = 8.5, 7.0 Hz, 1 H), 4.14 (dd, J = 17.0, 1.0 Hz, 1 H), 3.72 (d, J = 17.0 Hz, 1 H), 
3.54-3.52 (m, 2 H), 2.86 (s, 3 H); 
13
C NMR (CDCl3, 100 MHz):  183.0, 166.6, 164.2, 
153.0, 140.3, 137.0, 135.7, 135.3, 133.4, 130.2, 128.4, 128.3, 128.1, 128.0, 127.0, 125.7, 
124.8, 124.3, 121.7, 121.3, 117.4, 113.2, 83.5, 68.1, 57.7, 54.7, 54.1, 37.2, 33.7;  HRMS 
(ESI) m/z calculated for C31H37N4O5
+
 ([M+H]
+
) 535.1981, found 535.1983. 
Gliocladin C Synthesis: 
 
(2S,3aR,8aR)-8-benzyl 1-tert-butyl 2-methyl 3a-(1H-indol-3-yl)-3,3a-
dihydropyrrolo[2,3-b]indole-1,2,8(2H,8aH)-tricarboxylate (5.96):  Aldehyde 5.92 (38 
mg, 64 μmol) and RhCl(PPh3)3 (59 mg, 64 μmol, 1.0 equiv) were placed in a sealed tube 
207 
 
 
and dissolved in xylenes/trifluoroethanol (3:1) (2.5 mL). The solution was degassed via 
freeze-pump-thaw (3 cycles) and then heated to 140 ˚C for 4 h. Upon cooling the solution 
to room temperature, the solvents were removed under reduced pressure and the crude oil 
was diluted with 20 mL EtOAc. This was washed sequentially with 20 mL each of 1 N 
HCl (aq), sat. NaHCO3 (aq), and brine. Dried over anhydrous Na2SO4, filtered and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography on SiO2 (7:3 hexanes/EtOAc) to yield 5.96 (27 mg, 72%) as a beige 
solid. 
1
H NMR (400 MHz, CDCl3) δ ppm 1.41 (s, 9 H) 2.84 - 3.07 (m, 2 H) 3.79 (s, 3 H) 
4.03 - 4.26 (m, 1 H) 5.22 - 5.43 (m, 2 H) 6.48 (br. s., 1H) 6.64 (br. s., 1 H) 6.90 - 7.23 (m, 
7 H) 7.28 - 7.49 (m, 4 H) 7.75 (d, J=7.83 Hz, 3 H) 7.91 (br. s., 1 H). 
 
(R)-benzyl 3-(2-((tert-butoxycarbonyl)amino)-3-methoxy-3-oxopropyl)-1H-indole-1-
carboxylate (5.98): Sodium hydroxide (3.1 g. 78 mmol, 2.5 equiv), Bu4HSO4 (1.1 g, 3.1 
mmol, 0.1 equiv.) and 9.0 mL of CbzCl (63 mmol, 2.0 equiv.) were added sequentially to 
a solution of 5.97 (10 g, 31 mmol) in CH2Cl2 (150 mL) at 23 C. The reaction mixture 
was stirred for 4 h and then poured into 1 N aq. HCl and extracted with CH2Cl2 (3 X 200 
mL). Combined organic layers were washed with sat. NaHCO3 (aq) followed by brine, 
dried over anhydrous Na2SO4, filtered and were concentrated under reduced pressure. 
The residue was purified by flash column chromatography on SiO2 (8:2 hexanes/EtOAc) 
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to yield 5.98 (14 g, >99%) as a white foam. Rf (8:2 hexanes/EtOAc): 0.35; []25D   = −40.2 
(c 1.2, CHCl3); IR (neat): 3369, 2975, 1736, 1501, 1455, 1398, 1362, 1248, 1165, 1085, 
1018, 747 cm
−1
; 
1
H NMR (CDCl3, 500 MHz): 8.16 (br. s, 1 H), 7.50-7.42 (m, 3 H), 7.41-
7.36 (m, 4 H), 7.32 (t, J = 7.5 Hz, 1 H), 7.25 (t, J = 8.0 Hz, 1 H), 5.44 (s, 2 H), 5.10 (d, J 
= 7.5 Hz, 1 H), 4.64 (q, J =  5.5 Hz, 1 H), 3.66 (s, 3 H), 3.26 (dd, J = 15.0, 5.5 Hz, 1 H), 
3.17 (dd, J = 15.0, 6.0 Hz, 1 H), 1.41 (s, 9 H); 
13
C NMR (CDCl3, 125 MHz): 172.2, 
155.0, 150.6, 135.4, 135.0, 130.5, 128.8, 128.7, 128.5, 124.8, 123.6, 122.9, 119.0, 116.1, 
115.2, 79.9, 68.7, 53.6, 52.3, 28.2, 27.8; HRMS (ESI) m/z calculated for C25H28N2NaO6
+
 
([M+Na]
+
) 475.1845, found 475.1844. 
 
(2R,3aS,8aS)-8-benzyl 1-tert-butyl 2-methyl 3a-bromo-3,3a-dihydropyrrolo[2,3-
b]indole-1,2,8(2H,8aH)-tricarboxylate (5.99): To a solution of 5.98 (3.0 g, 6.6 mmol) 
in CH2Cl2 (66 mL) were added sequentially 1.2 g of NBS (6.6 mmol, 1.0 eq) and 1.7 g of 
PPTS (6.6 mmol, 1.0 eq) at 23 C. The reaction mixture was stirred 12 h at 23 C and 
then poured into sat. NaHCO3 (aq), and extracted with CH2Cl2 (3 X 100 mL). Combined 
organic layers were washed with brine, dried over anhydrous Na2SO4, filtered and were 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography on SiO2 (8:2 hexanes/EtOAc) to yield 5.99 (3.2 g, 91%) as a white foam. 
Rf (8:2 hexanes/EtOAc): 0.35; []25D   = +136.9 (c 0.85, CHCl3); IR (neat): 2975, 1720, 
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1604, 1479, 1405, 1346, 1320, 1286, 1205, 1165, 1089, 1027, 902, 847, 752 cm
−1
; 
1
H 
NMR (CDCl3, 500 MHz): 7.64 (br. s, 1 H), 7.45-7.29 (m, 8 H), 7.15 (dt, J = 7.5, 0.5 Hz, 
1 H), 6.46 (s, 1 H), 5.45 (d, J = 12.0 Hz, 1 H), 5.24 (br. s, 1 H), 3.93 (dd, J = 10.5, 6.5 
Hz, 1 H), 3.75 (s, 3 H), 3.24 (dd, J = 13.0, 6.0 Hz, 1 H), 2.82 (dd, J = 13.0, 10.0 Hz, 1 H), 
1.37 (s, 9 H); 
13
C NMR (CDCl3, 125 MHz): 171.4, 153.2, 140.8, 135.8, 132.7, 130.8, 
128.7, 128.6, 128.2, 128.0, 124.8, 123.3, 118.3, 83.7, 81.8, 68.1, 59.6, 59.5, 52.4, 41.6, 
28.1; HRMS (ESI) m/z calculated for C25H27BrN2NaO6
+
 ([M+Na]
+
) 553.0950, found 
553.0964. 
 
(2R,3aS,8aS)-8-benzyl 1-tert-butyl 3a-bromo-2-(methylcarbamoyl)-3,3a-
dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate (5.100): Ester 5.99 (3.0 g, 5.6 
mmol) was dissolved in THF (90 mL) at 23 C. To this solution was added 30 mL of aq. 
MeNH2 (40 wt. % in H2O). The reaction mixture was stirred for 4 days and the THF was 
evaporated under reduced pressure. The aqueous solution was extracted with EtOAc (3 X 
100 mL). Combined organic layers were washed with brine, dried over anhydrous 
Na2SO4, filtered and were concentrated under reduced pressure. The residue was purified 
by flash column chromatography on SiO2 (3:2 hexanes/EtOAc) to yield 5.100 (2.6 g, 
87%) as a white foam. Rf (3:2 hexanes/EtOAc): 0.13; []25D   = +133 (c 1.0, CHCl3); IR 
(neat): 3357, 3307, 2978, 1716, 1666, 1604, 1561, 1479, 1407, 1367, 1350, 1320, 1286, 
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1215, 1162, 1138, 1091, 1051, 1027, 912, 847, 752 cm
−1
; 
1
H NMR (CDCl3, 500 MHz): 
7.62 (br. s, 1 H), 7.44 (br. d, J = 8.5 Hz, 2 H), 7.38-7.28 (m, 5 H), 7.14 (dt, J = 7.5, 0.5 
Hz, 1 H), 6.44 (s, 1 H), 5.76 (d, J = 4.5 Hz, 1 H), 5.45 (d, J = 12.5 Hz, 1 H), 5.30 (d, J = 
12.0 Hz, 1 H), 3.74 (dd, J = 10.0, 6.0 Hz, 1 H), 3.20 (dd, J = 13.0, 6.5 Hz, 1 H), 2.91 (dd, 
J = 13.0, 10.0 Hz, 1 H), 2.82 (d, J = 5.0 Hz, 3 H), 1.36 (s, 9 H); 
13
C NMR (CDCl3, 100 
MHz): 170.9, 153.3, 152.5, 140.8, 135.7, 133.0, 130.8, 128.6, 128.2, 127.9, 124.9, 123.4, 
118.1, 84.0, 81.8, 68.1, 61.5, 59.8, 42.0, 28.1, 26.4; HRMS (ESI) m/z calculated for 
C25H28BrN3NaO5
+
 ([M+Na]
+
) 552.1110, found 552.1097.  
 
(5aS,10bS,11aR)-benzyl 10b-bromo-2-methyl-1,3,4-trioxo-3,4,5a,10b,11,11a-
hexahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-6(2H)-carboxylate (5.103): 
Trimethylsilyliodide (280 μL, 2.0 mmol, 2.0 equiv) was added to a cooled solution of 530 
mg Boc-amine 5.100 (1.0 mmol, 1.0 equiv) in MeCN (10 mL) at 0 ˚C and stirred for 0.5 
h. The reaction was quenched upon the addition of 20 mL sat. NaHCO3 (aq) and the 
mixture was stirred 30 min at rt then extracted 3 X with 25 mL CH2Cl2. Combined 
organic layers were washed with brine, dried over anhydrous Na2SO4, filtered and were 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography on SiO2 (4:6, hexanes/EtOAc) to yield amine 5.101 (380 mg, 88%) as a 
beige solid. The 2˚ amine was dissolved in CH2Cl2 and cooled to 0 ˚C. To this was added 
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190 μL Et3N (1.4 mmol, 3.0 equiv) and 100 μL ClCOCO2Et (0.93 mmol, 2.0 equiv). The 
mixture was stirred 1 h before quenching with 10 mL 1 N HCl. The mixture was 
extracted 4 X with CH2Cl2 and the combined organic phases were washed with 40 mL 
sat. NaHCO3 (aq), dried over anhydrous Na2SO4, filtered, and were concentrated. Two 
major products are observed on TLC (4:6 hexanes/EtOAc), a non-polar compound 
(5.103, Rf = 0.69) and a polar compound (5.102, Rf = 0.21). Upon flash chromatography 
on SiO2 (7:3→4:6 hexanes/EtOAc) the polar compound converts to the more non-polar 
compound to yield 5.103 (180 mg, 82%) as a yellow solid upon one additional flash. 
[]25
D
  = +136.6 (c 0.3, CHCl3); IR (neat): 3021, 1715, 1689, 1602, 1480, 1467, 1449, 
1415, 1395, 1365, 1336, 1311, 1293, 1272, 1205, 1149, 1083, 1050, 1022, 877, 752 cm
-1
; 
1
H NMR (400 MHz, CDCl3)  ppm 7.79 (d, J=7.24 Hz, 1 H), 7.53 (d, J=7.04 Hz, 2 H). 
7.47 (d, J=7.63 Hz, 1 H), 7.31 - 7.43 (m, 3 H), 7.15 - 7.24 (m, 1 H), 6.87 (s, 1 H), 5.35 - 
5.45 (m, 1 H), 5.25 - 5.35 (m, 1 H), 4.22 (dd, J=12.13, 5.09 Hz, 1 H), 3.44 (dd, J=12.62, 
5.18 Hz, 1 H), 3.26 (s, 3 H), 2.97 (t, J=12.32 Hz, 1 H); 
13
C NMR (76 MHz, CDCl3)  
ppm 165.6, 157.0, 151.8, 150.4, 141.1, 135.2, 131.1, 130.2, 128.3, 124.7, 124.2, 115.9, 
83.2, 68.1, 58.3, 46.6, 27.1; HRMS (ESI) m/z calculated for C22H18BrN3NaO5
+
 
([M+Na]
+
) 506.0328, found 506.0342. 
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(2R,3aR,8aS)-8-benzyl 1-tert-butyl 3a-(2-formyl-1H-indol-3-yl)-2-
(methylcarbamoyl)-3,3a-dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate 
(5.106): A flame dried 100 mL round bottom flask equipped with a rubber septum and 
magnetic stir bar was charged with 0.028 g of tris(2,2´-bipyridyl)ruthenium(II) chloride 
hexahydrate (38 mol, 0.01 equiv), 2.0 g of bromopyrroloindoline 5.100 (3.8 mmol, 1.0 
equiv), 1.8 mL of tributylamine (7.6 mmol, 2.0 equiv) and 2.7 g indole-2-carboxaldehyde 
5.91 (19.0 mmol, 5.0 equiv). The flask was purged with a stream of argon and 30 mL of 
dry DMF was added. The resultant mixture was degassed by freeze pump-thaw method 
(3 cycles) and placed at a distance of ~2 cm from a blue LED strip. The reaction mixture 
was stirred under blue light irradiation for 12 h and then poured into water (250 mL) and 
extracted with EtOAc (3 X 150 mL). Combined organic layers were washed with brine, 
dried over anhydrous Na2SO4, filtered and were concentrated under reduced pressure. 
The residue was purified by flash column chromatography on SiO2 (3:2, 
hexanes/acetone) to yield 5.106 (1.8 g, 82%) as a beige solid. Excess indole-2-
carboxaldehyde was recovered upon purification and re-used. Rf (3:2, hexanes/acetone): 
0.30; []25
D
  = −201 (c 1.1, CHCl3); IR (neat): 3359, 3307, 3010, 2980, 1669, 1647, 1550, 
1481, 1407, 1353, 1331, 1284, 1268, 1214, 1155, 1083, 1026, 942, 853, 744 cm
−1
; 
1
H 
NMR (CDCl3, 400 MHz): 9.32 (s, 1 H), 8.22 (s, 1 H), 8.05 (d, J = 6.8 Hz, 1 H), 7.71 (br. 
s, 1 H), 7.42-7.34 (m, 4 H), 7.21-7.04 (m, 7 H), 6.64 (s, 1 H), 6.06 (s, 1 H), 5.25 (d, J = 
12.4 Hz, 1 H), 4.97 (d, J = 12.0 Hz, 1 H), 4.00 (dd, J = 9.6, 7.2 Hz, 1 H), 3.40 (dd, J = 
12.8, 10.0 Hz, 1 H), 2.95 (dd, J = 12.8, 6.8 Hz, 1 H), 2.86 (d, J = 4.8 Hz, 3 H), 1.37 (s, 9 
H); 
13
C NMR (CDCl3, 125 MHz): 183.1, 172.5, 153.2, 141.6, 137.1, 135.8, 134.9, 133.3, 
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130.3, 128.3, 127.9, 127.2, 126.0, 124.7, 124.6, 123.6, 122.9, 121.6, 119.0, 112.7, 83.5, 
81.5, 67.4, 61.9, 55.8, 39.3, 28.2, 26.5; HRMS (ESI) m/z calculated for C34H34N4NaO6
+
 
([M+Na]
+
) 617.2376, found 617.2373. 
 
(2R,3aS,8aS)-8-benzyl 1-tert-butyl 3a-(1H-indol-3-yl)-2-(methylcarbamoyl)-3,3a-
dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate (5.107): 
Stoichiometric decarbonylation: A flame dried 100 mL sealed tube equipped with a 
magnetic stir bar was charged with 0.5 g of 5.106 (0.84 mmol, 1.0 equiv), 0.78 g 
chlorotris(triphenylphosphine)rhodium(I) (0.84 mmol, 1.0 equiv) and 42 mL of xylenes. 
The reaction mixture was degassed via freeze pump-thaw (3 cycles) and then stirred at 
140 °C for 12 h. The resultant mixture was concentrated and the residue was dissolved in 
warm acetone (100 mL). A bright yellow solid precipitated out and was filtered. The 
filtrate was concentrated and the same precipitation was repeated. Silica gel was added to 
the acetone solution and concentrated. Flash column chromatography on silica gel (3:7 
hexanes/EtOAc) provided 5.107 (0.41 g, 86 %) as an orange solid.  
 
Catalytic decarbonylation: A flame dried 25 mL 2-necked flask equipped with a 
magnetic stir bar was charged with 100 mg of 5.105 (0.17 mmol, 1.0 equiv), 22 mg 
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Rh(CO)Cl(PPh3)2 (33 μmol, 0.2 equiv), and 6.0 mL xylenes. The reaction mixture was 
degassed by argon sparging (20 min) and then stirred at 140 °C. To the resultant red 
solution was added slowly and simultaneously a degassed solution of 
diphenylphosphinopropane (dppp, 31 mg, 75 mol, 0.44 equiv) in 2.0 mL xylenes and a 
solution of 73 µL diphenyl phosphoryl azide (DPPA, 0.34 mmol, 2.0 equiv) in 2.0 mL 
xylenes over 14 h via syringe pump. The resultant mixture was concentrated and the 
residue was purified by flash column chromatography on SiO2 (4:6 hexanes/EtOAc) to 
provide 5.107 (82 mg, 85 %) as an orange solid. Rf (4:6, hexanes/EtOAc): 0.27; []25D   = 
−102.6 (c 0.6, CHCl3);  IR (neat): 3360, 3339, 3323, 3313, 2977, 2933, 1712, 1693, 1544, 
1481, 1409, 1334, 1283, 1267, 1153, 1045, 1021, 744 cm
−1
; 
1
H NMR (CDCl3, 500 MHz): 
7.92 (s, 1 H), 7.75 (d, J = 8.0 Hz, 1 H), 7.67 (d, J = 7.5 Hz, 1 H), 7.37 (dd, J = 7.5, 1.0 
Hz, 1 H), 7.34 (br. d, J = 8.0 Hz, 1 H), 7.31 (dt, J = 7.5, 1.0 Hz, 1 H), 7.23-7.05 (m, 8 H), 
6.59 (s, 1 H), 6.47 (s, 1 H), 5.79 (q, J = 5.0 Hz, 1 H), 5.31 (d, J = 13.0 Hz, 1 H), 5.02 (d, J 
= 11.5 Hz, 1 H), 3.95 (dd, J = 10.0, 7.0 Hz, 1 H), 3.09 (dd, J = 13.0, 10.5 Hz, 1 H), 2.89 
(dd, J = 13.0, 6.5 Hz, 1 H), 2.86 (d, J = 4.5 Hz, 3 H), 1.40 (s, 9 H); 
13
C NMR (125 MHz): 
172.7, 153.6, 153.4, 141.2, 137.2, 136.0, 135.6, 128.9, 128.3, 127.9, 127.2, 124.8, 124.2, 
123.7, 123.3, 122.4, 120.9, 119.6, 118.2, 115.4, 111.6, 81.8, 81.2, 67.2, 61.8, 55.3, 37.9, 
28.2, 26.4; HRMS (ESI) m/z calculated for C33H34N4NaO5
+
 ([M+Na]
+
) 589.2427, found 
589.2454. 
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(2R,3aS,8aS)-8-benzyl 1-tert-butyl 3a-(1-((benzyloxy)carbonyl)-1H-indol-3-yl)-2-
(methylcarbamoyl)-3,3a-dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate 
(5.108a): Sodium hydroxide (0.16 g, 4.0 mmol, 4.0 equiv), Bu4NHSO4 (0.17 g, 0.5 
mmol, 0.5 equiv) and of  CbzCl (0.43 mL, 3.0 mmol, 3 equiv) were added sequentially to 
a solution of 5.108 (0.57 g, 1.0 mmol) in CH2Cl2 (125 mL) at 23 C. The reaction 
mixture was stirred for 5 h and then poured into 1 N aq. HCl and extracted with CH2Cl2 
(3 X 75 mL). Combined organic layers were washed with Sat. NaHCO3 followed by 
brine, dried over anhydrous Na2SO4, filtered and were concentrated under reduced 
pressure. The residue was purified by flash column chromatography on SiO2 (1:1 
hexanes/EtOAc) to yield 5.108a (0.69 g, 98%) as a white solid. Rf (1:1 hexanes/EtOAc): 
0.24; []25
D
  = −54.6 (c 0.8, CHCl3); IR (neat): 3380, 3347, 3279, 3035, 2976, 1718, 1557, 
1481, 1455, 1394, 1353, 1319, 1234, 1214, 1097, 1079, 1027, 911, 752 cm
−1
; 
1
H NMR 
(CDCl3, 500 MHz): 8.16 (br.d, J = 6.5 Hz, 1 H), 7.77 (d, J = 7.5 Hz, 1 H), 7.67 (d, J = 8.0 
Hz, 1 H), 7.42-7.27 (m, 10 H), 7.18 -7.05 (br. m, 5 H), 6.97 (br. s, 1 H), 6.61 (s, 1 H), 
5.81 (q, J = 6.0 Hz, 1 H), 5.40 (d, J = 12.5 Hz, 1 H), 5.35 (d, J = 12.0 Hz, 1 H), 5.28 (d, J 
= 12.5 Hz, 1 H), 5.01 (br. d, J = 11.5 Hz, 1 H), 3.94 (dd, J = 10.0, 7.0 Hz, 1 H), 3.06 (dd, 
J = 13.0, 10.0 Hz, 1 H), 2.85 (d, J = 4.5 Hz, 3 H), 2.79 (dd, J = 13.0, 6.5 Hz, 1 H), 1.40 
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(s, 9 H); 
13
C NMR (125 MHz): 172.5, 153.4, 153.3, 150.6, 141.3, 136.4, 135.9, 135.0, 
134.4, 129.3, 128.7, 128.4, 128.3, 127.8, 127.7, 127.3, 125.0, 124.4, 123.8, 123.6, 121.0, 
120.2, 118.3, 115.6, 81.3, 81.2, 68.7, 67.4, 61.5, 54.9, 37.6, 28.2, 26.4; HRMS (ESI) m/z 
calculated for C41H40N4NaO7
+
 ([M+Na]
+
) 723.2795, found 723.2787. 
 
(5aS,10bS,11aR)-benzyl 10b-(1-((benzyloxy)carbonyl)-1H-indol-3-yl)-2-methyl-
1,3,4-trioxo-3,4,5a,10b,11,11a-hexahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-
b]indole-6(2H)-carboxylate (5.116): Trimethysilyl iodide (0.28 mL, 1.9 mmol, 2.0 
equiv) was added dropwise to a solution of 5.108a (0.68 g, 0.97 mmol) in MeCN (10 mL) 
at 0 °C. The reaction mixture was stirred for 30 min at 0 °C  and then quenched with sat 
NaHCO3(aq) and stirred for an additional 0.5 h at 23 °C, followed by extraction with 
CH2Cl2 (3 X 75 mL). Combined organic layers were washed with brine, dried over 
anhydrous Na2SO4, filtered and were concentrated under reduced pressure. The residue 
was purified by flash column chromatography on silica gel (3:7 hexanes/EtOAc; Rf   = 
0.25) to yield the 2° amine (5.114, 0.52 g, 91%) as yellow solid. Amine 5.114 (0.28 g, 
0.47 mmol, 1 equiv) was dissolved in CH2Cl2 (5 mL) and cooled to 0 ˚C. To this was 
added 190 μL Et3N (1.4 mmol, 3.0 equiv) and 100 μL ClCOCO2Et (0.93 mmol, 2.0 
equiv). The mixture was stirred 0.5 h before quenching with 10 mL 1 N HCl. The 
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mixture was extracted with CH2Cl2 (3 X 20 mL) and the combined organic phases were 
washed with 50 mL sat. NaHCO3 (aq), dried over anhydrous Na2SO4, filtered, and were 
concentrated. The crude mixture was placed in a sealed tube containing 90 mL HMDS 
and heated at 140 ˚C for 48 h. The HMDS was removed under reduced pressure and the 
residue was purified by flash chromatography on SiO2 (1:2:17 EtOAc/petroleum 
ether/CH2Cl2) to yield 5.116 (110 mg, 35%, 2 steps) as a yellow solid. Rf (9:1, 
hexanes/EtOAc): 0.62; 
1
H NMR (400 MHz, CDCl3): 8.33 - 8.52 (m, 1 H) 8.16 (d, J=7.83 
Hz, 1 H) 7.53 - 7.88 (m, 10 H) 7.27 - 7.48 (m, 3 H) 7.07 - 7.23 (m, 2 H) 5.46 - 5.82 (m, 4 
H) 4.70 (dd, J=11.93, 5.09 Hz, 1 H) 3.55 (s, 3 H) 3.31 (dd, J=12.13, 5.28 Hz, 1 H) 3.17 
(t, J=12.03 Hz, 1 H). 
 
(5aS,10bS)-benzyl 10b-(1-((benzyloxy)carbonyl)-1H-indol-3-yl)-2-methyl-1,3,4-
trioxo-3,4,5a,10b-tetrahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-6(2H)-
carboxylate (5.117): Triketopiperazine 5.116 (10 mg, 0.015 mmol, 1 equiv) and 10% wt. 
Pd/C (2 mg) were refluxed in toluene for 2 d. The mixture was filtered over Celite and 
purified by flash chromatography on SiO2 (8:2→7:3 hexanes/EtOAc) to yield 5.117 (2 
mg, 20%) as a white solid. Rf (8:2, hexanes/EtOAc): 0.13. 
1
H NMR (400 MHz, CDCl3): 
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8.10 (d, J=7.04 Hz, 1 H) 7.86 (d, J=8.22 Hz, 1 H) 7.20 - 7.52 (m, 8 H) 6.97 - 7.14 (m, 2 
H) 6.90 (d, J=8.02 Hz, 1 H) 6.81 (d, J=16.24 Hz, 1 H) 5.16 - 5.44 (m, 2 H) 3.27 (s, 2 H). 
 
(3aS,8aS)-benzyl 3a-(1-((benzyloxy)carbonyl)-1H-indol-3-yl)-2-(methylcarbamoyl)-
3,3a-dihydropyrrolo[2,3-b]indole-8(8aH)-carboxylate (5.121): Amine 5.114 (0.1 g, 
0.17 mmol) was dissolved in 2 mL of CH2Cl2 and 0.036 g of NBS (0.2 mmol, 1.2 equiv.) 
was added at 23 °C and stirred for 0.5 h. To this was added DBU (0.34 mmol, 2.0 equiv.) 
and the mixture was stirred for an additional 0.5 h, followed by extraction with CH2Cl2 (2 
X 50 mL). Combined organic layers were washed with brine, dried over anhydrous 
Na2SO4, filtered and were concentrated under reduced pressure. The residue was purified 
by flash column chromatography on SiO2 (3:2 hexanes/EtOAc) to provide 5.121 (0.1 g, 
>99%) as light yellow foam.  Rf (3:2 hexanes/EtOAc): 0.25; []25D   = −37.6 (c 1.0, CHCl3); 
IR (neat): 3426, 3406, 3066, 3031, 2954, 1714, 1682, 1629, 1482, 1454, 1396, 1360, 
1307, 1281, 1233, 1153, 1095, 1048, 1021, 751 cm
−1
; 
1
H NMR (CDCl3, 500 MHz): 8.18 
(br.s, 1 H), 7.97 (br. s, 1 H), 7.53 -7.31 (br. m, 12.5 H), 7.22 -7.08 (br. m, 5 H), 6.72 (br. 
s, 1 H), 6.61 (br. s, 1 H), 5.43-5.30 (m, 4 H), 3.89 (dd, J = 17.5, 1.0 Hz, 1 H), 3.69 (br. d, 
J = 18.0 Hz, 1 H), 2.89 (d, J = 5.0 Hz, 3 H), 2.79 (dd, J = 13.0, 6.5 Hz, 1 H), 1.40 (s, 9 
H); 
13
C NMR (125 MHz): 171.8, 171.6, 161.9, 153.3, 152.4, 150.6, 140.2, 139.1, 136.4, 
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136.1, 135.5, 134.9, 134.7, 134.0, 129.5, 128.8, 128.5, 128.1, 127.9, 127.8, 125.4, 125.2, 
124.9, 124.2, 123.3, 122.6, 119.2, 116.1, 115.9, 96.4, 96.1, 68.8, 68.4, 67.4, 52.9, 52.1, 
48.0, 25.9; HRMS (ESI) m/z calculated for C36H31N4O5
+
 ([M+H]
+
) 591.2294, found 
591.2291. 
 
(5aS,10bS)-benzyl 10b-(1-((benzyloxy)carbonyl)-1H-indol-3-yl)-2-methyl-1,3,4-
trioxo-3,4,5a,10b-tetrahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-6(2H)-
carboxylate (5.124): A flame dried 30 mL microwave tube was charged with 5.121 (0.1 
g, 0.17 mmol, 1 equiv) and 15 mL toluene. To this solution was sequentially added 
ClCOCO2Et (0.12 mL, 1.2 mmol, 7.0 eq) and Et3N (0.17 mL, 1.2 mmol, 7.0 eq) then 
heated in a microwave for 0.5 h at 150 °C. The mixture was cooled and concentrated 
under reduced pressure. The residue was purified by flash column chromatography on 
SiO2 (7:3 hexanes/EtOAc) to provide 5.124 as a yellow solid (0.054 g, 49%; 76% brsm) 
and 0.035g of 5.121. The imine 5.121 was re-subjected to the above conditions to provide 
0.02g of 5.124 (76%, brsm over two cycles) and 0.01g of 5.121. Rf (8:2 hexanes/EtOAc): 
0.13; []25
D
  = −54.5 (c 0.5, CHCl3); IR (neat): 3029, 2952, 1718, 1685, 1643, 1479, 1453, 
1394, 1359, 1307, 1267, 1230, 1154, 1093, 1021, 750 cm
−1
; 
1
H NMR (Acetone-d6, 400 
MHz): 8.17 (br.d, J = 6.5 Hz,  1 H), 7.93 (d, J = 8.0 Hz, 1 H), 7.46 (2 d, J = 8.0 Hz, 2 H), 
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7.42 -7.27 (m, 10 H), 7.16 (dd, J = 8.0, 1.0 Hz, 1 H), 7.12 (dt, J = 7.5, 1.0 Hz, 1 H), 7.09 
(dt, J  = 7.5, 1.0 Hz, 1 H), 6.97 (d, J = 8.5 Hz, 1 H), 6.90 (s, 1 H), 6.86 (s, 1 H), 5.44 (s, 2 
H), 5.38 (d, J = 12.5 Hz, 1 H), 5.28 (d, J = 11.5 Hz, 1 H), 3.34 (s, 3 H); 
13
C NMR 
(Acetone-d6, 125 MHz): 156.8, 156.2, 152.7, 150.5, 149.1, 141.1, 136.2, 135.4, 134.7, 
132.2, 131.0, 130.0, 128.9, 128.8, 128.7, 128.7, 128.5, 128.3, 127.5, 125.7, 125.6, 125.0, 
124.3, 124.1, 123.6, 83.4, 69.2, 68.8, 58.2, 27.5; HRMS (ESI) m/z calculated for 
C38H29N4O7
+
 ([M+H]
+
) 653.2036, found 653.2065. 
 
(5aR,10bS)-10b-(1H-indol-3-yl)-2-methyl-5a,6-dihydro-1H-
pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-1,3,4(2H,10bH)-trione (gliocladin C, 5.1): A 
flame dried 25 mL round bottom flask was charged with 5.124 (50 mg, 76 μmol) and 10 
mL CH2Cl2. The solution was cooled to 78 C and to this was added 1M BCl3 in 
CH2Cl2 (0.53 mL, 0.53 mmol, 7.0 equiv). The reaction mixture was stirred for 12 h 
(during the reaction time the flask was allowed to warm to room temperature) and then 
quenched with aq. sat. NaHCO3. To this solution was added 150 mL of CHCl3 and the 
mixture was stirred for an additional 12 h. The organic layers were extracted (2 X 50 mL 
CHCl3) and washed with brine, dried over anhydrous Na2SO4, filtered and were 
concentrated under reduced pressure. The residue was purified by flash column 
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chromatography on SiO2 (9:1→ 8.5:1.5 benzene/acetone), providing 5.1 (23 mg, 80%) as 
yellow solid. Rf (1:1 hexanes/EtOAc): 0.1; []25D   = +128.0 (c 0.04, CHCl3); []
25
D
  = 
+125.0 (c 0.2, pyridine); IR (neat): 3344, 3272, 2941, 2922, 1730, 1679, 1635, 1605, 
1482, 1429, 1304, 1244, 1144, 1114, 746 cm
−1
; 
1
H NMR (Acetone-d6, 400 MHz): 10.3 
(br. s, 1 H), 7.43 (d, J = 8.2 Hz, 1 H), 7.33 (br. d, J = 8.2 Hz, 1 H), 7.23 (d, J = 2.5 Hz, 1 
H), 7.18 (br. d, J = 7.4 Hz, 1 H), 7.13 (ddd, J = 8.8, 7.4, 1.4 Hz, 1 H ), 7.11 (ddd, J = 8.2, 
7.1, 1.2 Hz, 1 H), 6.96 (s, 1 H), 6.90 (ddd, J = 8.0, 7.1, 1.0 Hz, 1 H), 6.86 ( br. d, J  = 8.0 
Hz, 1 H), 6.72 (ddd, J = 8.6, 7.5, 1.0 Hz, 1 H), 6.61 (br. d, J = 2.0 Hz, 1 H), 6.24 (d, J = 
2.7 Hz, 1 H), 3.34 (s, 3 H); 
13
C NMR (Acetone-d6, 125 MHz): 158.62, 158.01, 150.71, 
149.94, 138.50, 133.09, 131.13, 129.69, 126.95, 126.31, 125.47, 123.70, 122.76, 120.14, 
120.12, 119.67, 116.68, 112.64, 110.59, 84.73, 61.00, 27.10; HRMS (ESI) m/z calculated 
for C22H17N4O3
+
 ([M+H]
+
) 385.1301, found 385.1315. 
 
1
H NMR 
(Acetone-d6) 
Isolation 
(500 MHz) 
Synthetic 
(Overman; 600 MHz) 
Synthetic 
(Stephenson; 400 
MHz) 
5a 6.24 (d, 3.2) 6.24 (d, 2.6) 6.24 (d, 2.7) 
6a 6.61 (br. d, 3.2) 6.61 (br. d, 1.9) 6.61 (br. d, 2.0) 
7 6.86 (br. d, 8.2) 6.86 (br. d, 7.9) 6.86 (br. d, 8.0) 
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8 7.13 (br. dd, 8.2, 7.6) 7.13 (ddd, 8.2, 7.5, 
1.1) 
7.13 (ddd, 8.8, 7.4, 
1.4) 
9 6.72 (dddd, 7.6, 7.3, 
1.6, 1.1) 
6.72 (ddd, 7.4, 7.3, 
1.0) 
6.72 (ddd, 8.6, 7.5, 
1.0) 
10 7.18 (br. d, 7.3) 7.18 (br. d, 7.4) 7.18 (br. d, 7.4) 
11a 6.96 (s) 6.96 (s) 6.96 (s) 
13 3.25 (s) 3.25 (s) 3.25 (s) 
1' 10.3 (br. d, 1.6) 10.33 (br. s) 10.33 (br. s) 
2' 7.23 (d, 1.6) 7.23 (d, 2.6) 7.23 (d, 2.5) 
4' 7.33 (br. d, 8.2) 7.33 (dd, 8.2, 0.7) 7.33 (br. d, 8.2) 
5' 6.90 (ddd, 8.0, 7.1, 
0.9) 
6.90 (ddd, 8.0, 7.1, 
0.8) 
6.90 (ddd, 8.0, 7.1, 
1.0) 
6' 7.10 (ddd, 8.2, 7.1, 
1.0) 
7.11 (ddd, 8.1, 7.1, 
1.0) 
7.11 (ddd, 8.2, 7.1, 
1.2) 
7' 7.43 (br. d, 8.2) 7.43 (br. d, 8.2) 7.43 (br. d, 8.2) 
    
13
C NMR 
(Acetone-d6) 
Isolation 
(125 MHz) 
Synthetic 
(Overman; 125 MHz) 
Synthetic 
(Stephenson; 125 
MHz) 
1 158.62 158.62 158.62 
3 158.01 158.01 158.01 
4 150.71 150.70 150.71 
5a 84.72 84.69 84.73 
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6a 149.94 149.93 149.94 
7 110.59 110.58 110.59 
8 129.68 129.68 129.69 
9 119.66 119.65 119.67 
10 125.47 125.47 125.47 
10a 131.12 131.11 131.13 
10b 61.00 60.97 61.00 
11a 126.97 126.94 126.95 
12 133.08 133.08 133.09 
13 27.10 27.09 27.10 
1a' 138.49 138.47 138.50 
2' 123.71 123.70 123.70 
3' 122.75 116.66 116.68 
3a' 123.55 126.29 126.31 
4' 119.71 120.11 120.12 
5' 119.71 120.13 120.14 
6' 120.12 122.76 122.76 
7' 112.64 112.63 112.64 
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C3–C2' Gliocladin C Synthesis 
 
(5aS,10bR,11aR)-benzyl 10b-(1H-indol-2-yl)-2-methyl-1,3,4-trioxo-
3,4,5a,10b,11,11a-hexahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-6(2H)-
carboxylate (5.126): A flame dried 50 mL round bottom flask equipped with a rubber 
septum and magnetic stir bar was charged with tris(2,2´-bipyridyl)ruthenium(II) chloride 
hexahydrate (9.0 mg, 12 mol, 0.01 equiv), bromopyrroloindoline 5.103 (0.57 g, 1.2 
mmol, 1.0 equiv), tributylamine (0.57 mL, 2.4 mmol, 2.0 equiv) and indole (6.9 g, 59 
mmol, 50 equiv). The flask was purged with a stream of argon and 26 mL of dry DMF 
was added. The resultant mixture was degassed via freeze pump-thaw (3 cycles) and 
placed at a distance of ~2 cm from a blue LED strip. The reaction mixture was stirred 
under blue light irradiation for 12 h and then poured into water (50 mL) and extracted 
with EtOAc (3 X 50 mL). Combined organic layers were washed with brine, dried over 
anhydrous Na2SO4, filtered and were concentrated under reduced pressure. The residue 
was purified by flash column chromatography on SiO2 (7:3 hexanes/EtOAc) to yield 
5.126 (0.11 g, 17%) as a beige solid. Excess indole was recovered upon purification and 
re-used. Rf (7:3 hexanes/EtOAc): 0.25; []25D   = +120.0 (c 0.00027, CHCl3); IR (neat): 
3346, 3058, 2917, 2849, 1691, 1600, 1482, 1455, 1417, 1396, 1366, 1316, 1277, 1205, 
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1149, 1051, 1024, 752 cm
-1
; 
1
H NMR (400 MHz, CDCl3): 8.41 (br. s., 2 H) 7.88 (d, 
J=7.83 Hz, 2 H) 7.51 (d, J=7.63 Hz, 2 H) 7.00 - 7.43 (m, 22 H) 6.81 (s, 2 H) 6.35 (s, 2 H) 
5.23 (d, J=11.93 Hz, 2 H) 5.03 - 5.16 (m, 2 H) 4.41 (dd, J=10.76, 6.46 Hz, 2 H) 3.19 - 
3.38 (m, 5 H) 2.98 - 3.19 (m, 4 H). 
13
C NMR (76 MHz): 166.7, 157.6, 152.4, 151.0, 
142.2, 137.0, 136.8, 135.4, 130.7, 130.2, 128.6, 128.4, 128.2, 127.5, 124.8, 124.7, 122.4, 
120.4, 120.1, 116.2, 111.2, 101.7,  81.3, 68.2, 59.6, 54.3, 43.1, 27.3. HRMS (ESI) m/z 
calculated for C30H24N4NaO5
+
 ([M+Na]
+
) 543.1644, found 543.1652. 
 
(2R,3aR,8aS)-8-benzyl 1-tert-butyl 3a-(1H-indol-2-yl)-2-(methylcarbamoyl)-3,3a-
dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate (5.127): A flame dried 25 mL 
round bottom flask equipped with a rubber septum and magnetic stir bar was charged 
with tris(2,2´-bipyridyl)ruthenium(II) chloride hexahydrate (7.5 mg, 10 mol, 0.005 
equiv), bromopyrroloindoline 5.100 (1.1 g, 1.2 mmol, 1.0 equiv), tributylamine (0.95 mL, 
4.0 mmol, 2.0 equiv) and indole (1.2 g, 10.0 mmol, 5.0 equiv). The flask was purged with 
a stream of argon and 10 mL of dry DMF was added. The resultant mixture was degassed 
via freeze pump-thaw (3 cycles) and placed at a distance of ~2 cm from a blue LED strip. 
The reaction mixture was stirred under blue light irradiation for 12 h and then poured into 
water (100 mL) and extracted with EtOAc (3 X 75 mL). Combined organic layers were 
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washed with brine, dried over anhydrous Na2SO4, filtered and were concentrated under 
reduced pressure. The residue was purified by flash column chromatography on SiO2 (1:1 
hexanes/EtOAc) to yield 5.127 (0.273 g, 24%) as a white solid. Excess indole was 
recovered upon purification and re-used. Rf (1:1 hexanes/EtOAc): 0.32; []25D   = -45.3 (c 
0.0007, CHCl3);  IR (neat): 3359, 2975, 1715, 1667, 1555, 1482, 1456, 1407, 1366, 1323, 
1283, 1216, 1157, 1026, 914, 750 cm
-1
; 
1
H NMR (500 MHz, CDCl3): 7.69 (d, J=7.58 Hz, 
1 H) 7.30 - 7.50 (m, 4 H) 7.09 - 7.25 (m, 5 H) 7.01 - 7.09 (m, 1 H) 6.30 (br. s., 2 H) 5.94 
(br. s., 1 H) 5.32 (d, J=12.47 Hz, 1 H) 5.10 (d, J=12.47 Hz, 1 H) 4.17 - 4.39 (m, 1 H) 2.98 
(d, J=4.89 Hz, 1 H) 2.92 (d, J=4.89 Hz, 3 H) 2.77 - 2.87 (m, 1 H) 1.41 (s, 9 H); 
13
C NMR 
(76 MHz):  173.2, 153.6,  141.2, 138.1, 137.0, 135.8, 134.9, 129.2, 128.5, 128.0, 127.6, 
127.4, 124.5, 122.0, 120.3, 119.7, 117.9, 111.2, 101.8, 82.4, 81.7, 67.6, 60.9, 56.0, 38.2, 
28.2, 26.5, 20.7, 14.1. HRMS (ESI) m/z calculated for C33H34N4NaO5
+
 ([M+Na]
+
) 
589.2427, found 589.2424. 
 
(2R,3aR,8aS)-8-benzyl 1-tert-butyl 3a-(1-((benzyloxy)carbonyl)-1H-indol-2-yl)-2-
(methylcarbamoyl)-3,3a-dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate 
(5.127a): Indole 5.127 (110 mg, 0.19 mmol, 1.0 equiv) was dissolved in 2.5 mL of 
CH2Cl2 at 23 ˚C. To this solution, was added sequentially NaOH (30 mg, 0.78 mmol, 4.0 
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equiv), tetrabutylammonium hydrogen sulfate (32 mg, 0.095 mmol, 0.5 equiv), and 
benzyl chloroformate (83 μL, 0.58 mmol, 3.0 equiv). The reaction mixture was stirred 24 
h before pouring into 25 mL ice-cold 1 N HCl and extracting with CH2Cl2 (2 X 25 mL). 
The combined organic phases were washed with sat. NaHCO3 (aq) (50 mL) and brine (50 
mL), dried over anhydrous Na2SO4, filtered and were concentrated under reduced 
pressure. The residue was purified by flash column chromatography on SiO2 (6:4 
hexanes/EtOAc) to yield 5.127a (0.12 g, 90%) as a white foam. Rf (6:4 hexanes/EtOAc): 
0.31; 
1
H NMR (400 MHz, CDCl3): 7.94 (d, J=8.22 Hz, 1 H) 7.64 (br. s., 1 H) 7.28 - 7.56 
(m, 5 H) 7.21 (dd, J=15.63, 7.56 Hz, 3 H) 6.84 (s, 1 H) 6.56 (br. s., 1 H) 5.99 (s, 1 H) 
5.30 - 5.70 (m, 3 H) 5.11 (d, J=12.03 Hz, 1 H) 3.99 (t, J=8.36 Hz, 1 H) 2.97 (t, J=10.86 
Hz, 1 H) 2.68 - 2.88 (m, 3 H) 1.31 - 1.49 (m, 5 H). 
 
(2R,3aR,8aS)-benzyl 3a-(1-((benzyloxy)carbonyl)-1H-indol-2-yl)-2-
(methylcarbamoyl)-1,3,3a,8a-tetrahydropyrrolo[2,3-b]indole-8(2H)-carboxylate 
(5.128):  Trimethylsilyl iodide (49 μL, 0.34 mmol, 2.0 equiv.) was added dropwise to a 
solution of 5.127a (0.12 g, 0.17 mmol, 1.0 equiv) in MeCN (3 mL) at 0 °C. The reaction 
mixture was stirred for 1 h at 0 °C  and then quenched with sat NaHCO3(aq) and stirred 
for an additional 0.5 h at 23 °C, followed by extraction with CH2Cl2 (3 X 25 mL). 
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Combined organic layers were washed with brine, dried over anhydrous Na2SO4, filtered 
and were concentrated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (1:1, hexanes/EtOAc) to yield the 2° amine (5.128, 95 mg, 
93%) as yellow solid. Rf  (1:1 hexanes/EtOAc): 0.12; 
1
H NMR (400 MHz, CDCl3): 7.81 
(d, J=7.43 Hz, 2 H) 7.22 - 7.54 (m, 7 H) 7.04 - 7.17 (m, 2 H) 6.77 - 7.03 (m, 2 H) 6.54 (d, 
J=17.22 Hz, 1 H) 6.02 (br. s., 1 H) 4.87 - 5.42 (m, 4 H) 3.69 (br. s., 1 H) 2.69 - 2.87 (m, 3 
H) 2.55 (dd, J=11.74, 6.06 Hz, 1 H). 
 
(5aS,10bR,11aR)-benzyl 10b-(1H-indol-2-yl)-2-methyl-1,3,4-trioxo-
3,4,5a,10b,11,11a-hexahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-6(2H)-
carboxylate (5.126): Trimethylsilyl iodide (0.19 mL, 1.4 mmol, 2.0 equiv) was added 
dropwise to a solution of 5.127 (0.37 g, 0.68 mmol, 1.0 equiv) in MeCN (10 mL) at 0 °C. 
The reaction mixture was stirred for 45 min at 0 °C  and then quenched with sat 
NaHCO3(aq) and stirred for an additional 0.5 h at 23 °C, followed by extraction with 
CH2Cl2 (3 X 25 mL). Combined organic layers were washed with brine, dried over 
anhydrous Na2SO4, filtered and were concentrated under reduced pressure. The residue 
was purified by flash column chromatography on SiO2 (3:7 hexanes/EtOAc) to yield the 
2° amine (300 mg, 95%) as yellow solid. Rf  (1:1, hexanes/EtOAc): 0.17. The 2˚ amine 
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(0.33 g, 0.71 mmol, 1.0 equiv) was dissolved in CH2Cl2 and cooled to 0 ˚C. To this was 
added Et3N (0.3 mL, 2.1 mmol, 3.0 equiv) and ClCOCO2Et (0.16 mL, 1.4 mmol, 2.0 
equiv). The mixture was stirred 1 h before quenching with 10 mL 1 N HCl. The mixture 
was extracted 4 X with CH2Cl2 and the combined organic phases were washed with 40 
mL sat. NaHCO3 (aq), dried over anhydrous Na2SO4, filtered, and were concentrated. 
Two major products are observed on TLC (6:4 hexanes/EtOAc), a non-polar compound 
(Rf = 0.31) and a polar compound (Rf = 0.06). Upon flash chromatography on SiO2 (6:4 
hexanes/EtOAc) the polar compound converts to the more non-polar compound to yield 
5.126 (0.21 g, 57%) as a yellow solid upon one additional flash. []25
D
  = +120.0 (c 
0.00027, CHCl3); IR (neat): 3346, 3058, 2917, 2849, 1691, 1600, 1482, 1455, 1417, 
1396, 1366, 1316, 1277, 1205, 1149, 1051, 1024, 752 cm
-1
; 
1
H NMR (400 MHz, CDCl3): 
8.41 (br. s., 2 H) 7.88 (d, J=7.83 Hz, 2 H) 7.51 (d, J=7.63 Hz, 2 H) 7.00 - 7.43 (m, 22 H) 
6.81 (s, 2 H) 6.35 (s, 2 H) 5.23 (d, J=11.93 Hz, 2 H) 5.03 - 5.16 (m, 2 H) 4.41 (dd, 
J=10.76, 6.46 Hz, 2 H) 3.19 - 3.38 (m, 5 H) 2.98 - 3.19 (m, 4 H). 
13
C NMR (76 MHz): 
166.7, 157.6, 152.4, 151.0, 142.2, 137.0, 136.8, 135.4, 130.7, 130.2, 128.6, 128.4, 
128.2, 127.5, 124.8, 124.7, 122.4, 120.4, 120.1, 116.2, 111.2, 101.7,  81.3, 68.2, 59.6, 
54.3, 43.1, 27.3. HRMS (ESI) m/z calculated for C30H24N4NaO5
+
 ([M+Na]
+
) 543.1644, 
found 543.1652.          
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(5aS,10bR)-benzyl 10b-(1H-indol-2-yl)-2-methyl-1,3,4-trioxo-3,4,5a,10b-tetrahydro-
1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-6(2H)-carboxylate (5.132): 
Triketopiperazine 5.126 (0.11 g, 0.22 mmol, 1.0 equiv) and 10 wt.% Pd/C (0.11 g) were 
refluxed in toluene (3.0 mL) for 5 d. The mixture was filtered over Celite and purified by 
flash chromatography on SiO2 (6:4 hexanes/EtOAc) to yield 5.132 (63 mg, 56%) as a 
white solid. Rf (8:2, hexanes/EtOAc): 0.32; []25D   = -57.5 (c 0.0007, CHCl3); IR (neat): 
3338, 3063, 2925, 2852, 1719, 1685, 1599, 1480, 1455, 1409, 1335, 1309, 1230, 1155, 
1083, 1052, 1027, 752 cm
-1
; 
1
H NMR (400 MHz, CDCl3)  ppm 8.04 (br. s., 1 H) 7.85 (d, 
J=8.22 Hz, 1 H) 7.41 - 7.56 (m, 1 H) 7.28 - 7.37 (m, 3 H) 6.96 - 7.26 (m, 10 H) 6.71 - 
6.84 (m, 2 H) 6.27 (d, J=1.37 Hz, 1 H) 5.19 - 5.29 (m, 1 H) 5.11 - 5.19 (m, 1 H) 3.20 (s, 3 
H); 
13C NMR (76 MHz): δ 156.8, 156.1, 152.7, 149.3, 141.4, 136.7, 135.1, 134.8, 132.6, 
130.3, 128.9, 128.5, 128.4, 127.8, 125.1, 124.6, 124.3, 123.0, 120.8, 120.6, 117.6, 111.3, 
102.4, 84.4, 69.0, 59.0, 27.4; HRMS (ESI) m/z calculated for C30H22N4O5
+
 ([M+H]
+
) 
519.1668, found 519.1663. 
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(5aR,10bR)-10b-(1H-indol-2-yl)-2-methyl-5a,6-dihydro-1H-
pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-1,3,4(2H,10bH)-trione (C3–C2' gliocladin C, 
5.125): Cbz-amine 5.132 (50 mg,  96 μmol, 1.0 equiv) was placed in a flame dried round 
bottom flask, dissolved in CH2Cl2 (19 mL), and cooled to 78 C. To this solution was 
added a solution of 1M BCl3 in CH2Cl2 (0.29 mL 0.29 mmol, 3.0 equiv). The reaction 
mixture was stirred for 12 h (during the reaction time the flask was allowed to warm to 
room temperature) and then quenched with. sat. NaHCO3 (aq). To this solution was 
added 75 mL of CHCl3 and the mixture was stirred for an additional 12 h at rt. The 
suspension was extracted (2 X 25 mL CHCl3) and washed with brine, dried over 
anhydrous Na2SO4, filtered and was concentrated under reduced pressure. The residue 
was purified by flash column chromatography on SiO2 (7:3 hexanes/EtOAc), providing 
5.125 (37 mg, 97%) as yellow solid. Rf (1:1, hexanes/EtOAc): 0.35; []25D   = -17.0 (c 
0.005, CHCl3); IR (neat): 3340, 2958, 1735, 1682, 1638, 1602, 1483, 1455, 1429, 1345, 
1310, 1250, 1144, 1113, 1066, 1023, 748 cm
-1
; 
1
H NMR (500 MHz, acetone-d6): 10.18 
(br. s., 1 H) 7.51 (d, J=7.83 Hz, 1 H) 7.31 (dd, J=14.06, 7.95 Hz, 2 H) 7.14 (t, J=7.58 Hz, 
1 H) 7.08 (t, J=7.46 Hz, 1 H) 6.96 - 7.04 (m, 1 H) 6.90 (s, 1 H) 6.73 - 6.85 (m, 2 H) 6.58 
(br. s., 1 H) 6.34 (dd, J=10.88, 2.08 Hz, 2 H) 3.25 (s, 3 H); 
13
C NMR (101 MHz, acetone) 
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 158.5, 158.0, 150.8, 150.3, 139.5, 138.3, 133.7, 130.3, 129.2, 129.1, 125.8, 125.0, 
122.7, 121.2, 120.5, 120.0, 112.2, 111.0, 101.3, 84.8, 61.8, 27.2; HRMS (ESI) m/z 
calculated for C22H16N4O3
+
 ([M+H]
+
) 385.1301, found 385.1311. 
General Procedure for Indole Couplings with Biscatecholborate Quencher 
General Procedure 5.2: A flame dried 25 mL round bottom flask equipped with a rubber 
septum and magnetic stir bar was charged with Ir(ppy)2(dtbbpy)PF6 (10 mol, 0.01 
equiv), the corresponding bromopyrroloindoline (1.0 mmol, 1.0 equiv), biscatecholborate 
lithium salt (5.133, 2.0 mmol, 2.0 equiv) and corresponding indole or olefin (2.0–10.0 
equiv). The flask was purged with a stream of argon and 10 mL of dry DMSO was added. 
The resultant mixture was degassed by argon sparging for 20 min and placed at a distance 
of ~2 cm from a blue LED strip. After the reaction was complete (as judged by TLC 
analysis), the mixture was poured into a separatory funnel containing 75 mL of EtOAc 
and 75 mL of sat. Na2CO3 (aq). The layers were separated and the aqueous layer was 
extracted with EtOAc (2 X 50 mL). The combined organic layers were dried (over 
Na2SO4) and concentrated. The residue was purified by chromatography on SiO2, using 
the solvent system indicated, to afford the desired product. 
 
233 
 
 
(2R,3aR,8aS)-8-benzyl 1-tert-butyl 3a-(1H-indol-2-yl)-2-(methylcarbamoyl)-3,3a-
dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate (5.127): According to 
General Procedure 5.2, bromopyrroloindoline 5.100 (0.53 g, 1.0 mmol), LiB(cat)2 (0.47 
g, 2.0 mmol), indole (1.2 g, 10.0 mmol, 10.0 equiv) and Ir(ppy)2(dtbbpy)PF6 (9.1 mg, 
10.0 μmol) in dry DMSO (10.0 mL) afforded 5.127 (0.34 g, 60%) as a white solid after 
purification by chromatography on SiO2 (1:1 hexanes/EtOAc) (3 h reaction time). Excess 
indole was recovered upon purification and re-used. Rf (1:1 hexanes/EtOAc): 0.32;
 1
H 
NMR (500 MHz, CDCl3) 7.69 (d, J=7.58 Hz, 1 H) 7.30 - 7.50 (m, 4 H) 7.09 - 7.25 (m, 5 
H) 7.01 - 7.09 (m, 1 H) 6.30 (br. s., 2 H) 5.94 (br. s., 1 H) 5.32 (d, J=12.47 Hz, 1 H) 5.10 
(d, J=12.47 Hz, 1 H) 4.17 - 4.39 (m, 1 H) 2.98 (d, J=4.89 Hz, 1 H) 2.92 (d, J=4.89 Hz, 3 
H) 2.77 - 2.87 (m, 1 H) 1.41 (s, 9 H). 
 
(2R,3aR,8aS)-8-benzyl 1-tert-butyl 3a-(2-formyl-1H-indol-3-yl)-2-
(methylcarbamoyl)-3,3a-dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate 
(5.107): According to General Procedure 5.2, bromopyrroloindoline 5.100 (0.53 g, 1.0 
mmol), LiB(cat)2 (0.47 g, 2.0 mmol), indole-2-carboxaldehyde (0.29 g, 2.0 mmol, 2.0 
equiv) and Ir(ppy)2(dtbbpy)PF6 (9.1 mg, 10.0 μmol) in dry DMSO (10.0 mL) afforded 
5.107 (0.54 g, 91%) as a white solid after purification by chromatography on SiO2 (7:3 
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hexanes/acetone) (6 h reaction time). Rf (3:2 hexanes/acetone): 0.30; 
1
H NMR (CDCl3, 
400 MHz): 9.32 (s, 1 H), 8.22 (s, 1 H), 8.05 (d, J = 6.8 Hz, 1 H), 7.71 (br. s, 1 H), 7.42-
7.34 (m, 4 H), 7.21-7.04 (m, 7 H), 6.64 (s, 1 H), 6.06 (s, 1 H), 5.25 (d, J = 12.4 Hz, 1 H), 
4.97 (d, J = 12.0 Hz, 1 H), 4.00 (dd, J = 9.6, 7.2 Hz, 1 H), 3.40 (dd, J = 12.8, 10.0 Hz, 1 
H), 2.95 (dd, J = 12.8, 6.8 Hz, 1 H),2.86 (d, J = 4.8 Hz, 3 H), 1.37 (s, 9 H). 
 
(2R,3aR,8aS)-8-benzyl 1-tert-butyl 3a-(2-(ethoxycarbonyl)-1H-indol-3-yl)-2-
(methylcarbamoyl)-3,3a-dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate 
(5.135): According to the General Procedure, bromopyrroloindoline 5.100 (0.53 g, 1.0 
mmol), LiB(cat)2 (0.47 g, 2.0 mmol), ethyl indole-2-carboxylate (0.38 g, 2.0 mmol, 2.0 
equiv) and Ir(ppy)2(dtbbpy)PF6 (9.1 mg, 10.0 μmol) in dry DMSO (10.0 mL) afforded 
5.135 (0.50 g, 78%) as a white solid after purification by chromatography on SiO2 (1:1 
hexanes/EtOAc) (6 h reaction time). Rf (1:1 hexanes/EtOAc): 0.16; []25D   = −68.1 (c 
0.0059, CHCl3); IR (neat): 3294, 2979, 2932, 1695, 1603, 1548, 1517, 1482, 1464, 1403, 
1357, 1335, 1284, 1244, 1212, 1153, 1098, 1077, 1022, 915, 862, 746 cm
-1
;  
1
H NMR 
(500 MHz, CDCl3): 8.98 (s, 1 H) 7.48 - 7.72 (m, 1 H) 7.41 (d, J=7.58 Hz, 1 H) 7.36 (t, 
J=7.58 Hz, 1 H) 7.25 (d, J=8.31 Hz, 1 H) 7.00 - 7.18 (m, 6 H) 6.73 - 6.89 (m, 1 H) 6.66 
(t, J=7.83 Hz, 1 H) 6.54 (s, 1 H) 5.99 (d, J=8.80 Hz, 1 H) 5.21 (d, J=12.96 Hz, 1 H) 5.03 
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(br. s., 1 H) 4.31 - 4.48 (m, 2 H) 3.92 (dd, J=10.15, 7.21 Hz, 1 H) 2.84 - 3.04 (m, 2 H) 
2.82 (d, J=4.65 Hz, 3 H) 1.39 (t, J=7.09 Hz, 3 H) 1.31 (s, 7 H); 
13C NMR (76 MHz): δ 
173.7, 161.2, 153.4, 152.9, 142.0, 136.3, 135.6, 134.3, 129.8, 128.3, 127.0, 125.3, 124.0, 
122.7, 122.1, 120.5, 118.5, 112.2, 84.4, 81.1, 67.2, 63.4, 61.5, 54.9, 40.7, 28.2, 26.1, 
14.3; HRMS (ESI) m/z calculated for C36H38N4NaO7
+
 ([M+Na]
+
) 661.2638, found 
661.2647. 
 
(3aR,8aS)-di-tert-butyl 3a-(3-(2-((tert-butoxycarbonyl)amino)ethyl)-1H-indol-2-yl)-
3,3a-dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate (5.136): According to 
General Procedure 5.2, the bromopyrroloindoline (1.0 g, 2.3 mmol), LiB(cat)2 (1.1 g, 4.6 
mmol), N-Boc-tryptamine (3.0 g, 11.0 mmol, 5.0 equiv) and Ir(ppy)2(dtbbpy)PF6 (21 mg, 
10.0 μmol) in dry DMSO (25 mL) afforded 5.136 (0.77 g, 55%) as a white foam after 
purification by chromatography on SiO2 (0:100→1:99 MeOH/CH2Cl2) (12 h reaction 
time). Rf (8:2 hexanes/EtOAc): 0.33; IR (neat): 3354, 2978, 2933, 1698, 1600, 1481, 
1458, 1393, 1367, 1348, 1325, 1253, 1165, 1094, 1018, 852, 753 cm
-1
;
 1
H NMR (500 
MHz, CDCl3): 7.66 (d, J=6.85 Hz, 3 H) 7.18 - 7.41 (m, 3 H) 7.02 - 7.18 (m, 3 H) 6.58 
(br. s., 1 H) 4.04 (d, J=7.09 Hz, 1 H) 3.31 - 3.81 (m, 2 H) 3.00 - 3.30 (m, 2 H) 2.94 (td, 
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J=11.80, 4.77 Hz, 1 H) 2.64 (d, J=7.34 Hz, 2 H) 2.35 - 2.58 (m, 1 H) 1.55 (d, J=8.31 Hz, 
13 H) 1.42 - 1.63 (m, 30 H); 
13
C NMR (126 MHz):  156.0, 153.8,152.3, 142.9, 134.6, 
134.3, 129.4, 124.0, 123.7, 122.0, 121.9, 119.7, 119.0, 116.5, 110.6, 108.9, 82.1, 80.5, 
78.7, 56.0, 46.4, 41.0, 28.4, 28.3, 26.0. HRMS (ESI) m/z calculated for C35H46N4NaO6
+
 
([M+Na]
+
) 641.3315, found 641.3304. 
 
(2R,3aR,8aS)-8-benzyl 1-tert-butyl 2-methyl 3a-(3-((S)-2-((tert-
butoxycarbonyl)amino)-3-methoxy-3-oxopropyl)-1H-indol-2-yl)-3,3a-
dihydropyrrolo[2,3-b]indole-1,2,8(2H,8aH)-tricarboxylate (5.137): According to 
General Procedure 5.2, bromopyrroloindoline 5.99 (1.1 g, 2.0 mmol), LiB(cat)2 (0.93 g, 
4.0 mmol), Boc-tryptophan methyl ester (6.3 g, 20 mmol, 10 equiv) and 
Ir(ppy)2(dtbbpy)PF6 (18 mg, 20 μmol) in dry DMSO (20.0 mL) afforded 5.137 (0.88 g, 
57%) as a white solid after purification by chromatography on SiO2 (0:100→1:99 
MeOH/CH2Cl2) (12 h reaction time). Rf (8:2, hexanes/EtOAc): 0.16; []25D   = +1.3 (c 
0.0048, CHCl3);  IR (neat): 3385, 3360, 2980, 1719, 1482, 1456, 1437, 1409, 1367, 1332, 
1285, 1214, 1156, 1064, 1021, 752 cm
-1
; 
1
H NMR (500 MHz, CDCl3):  7.73 (br. s., 1 
H), 7.57 (d, J=7.6 Hz, 1 H), 7.50 (br. s., 1 H), 7.45 (d, J=7.3 Hz, 1 H), 7.41 (t, J=7.7 Hz, 
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1 H), 7.17 (m, 7 H), 6.50 (s, 1 H), 5.37 (d, J=12.5 Hz, 1 H), 5.07 (d, J=8.1 Hz, 2 H), 4.61 
(d, J=7.6 Hz, 1 H), 4.09 (m, 1 H), 3.81 (s, 2 H), 3.54 (s, 2 H), 3.24 (m, 2 H), 3.06 (dd, 
J=12.7, 6.6 Hz, 1 H), 2.93 (d, J=10.8 Hz, 1 H), 1.42 (s, 7 H), 1.30 (m, 6 H);
 13
C NMR 
(126 MHz):  172.8, 172.4, 154.8, 153.1, 141.4, 135.1, 133.1, 131.8, 129.9, 129.2, 128.2, 
127.9, 127.4, 124.8, 123.9, 122.3, 119.8, 118.9, 118.5, 110.8, 107.6, 82.4, 81.4, 79.6, 
67.6, 59.7, 55.5, 54.1, 52.3, 52.0, 37.6, 28.5, 27.9; HRMS (ESI) m/z calculated for 
C42H48N4NaO10
+
 ([M+Na]
+
) 791.3268, found 791.3254. 
 
(2R,3aR,8aS)-8-benzyl 1-tert-butyl 3a-(3-acetyl-1-methyl-1H-pyrrol-2-yl)-2-
(methylcarbamoyl)-3,3a-dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate 
(5.138): According to General Procedure 5.2, bromopyrroloindoline 5.100 (0.53 g, 1.0 
mmol), LiB(cat)2 (0.47 g, 2.0 mmol), 1-methyl-3-acetylpyrrole (0.59 μL, 5.0 mmol, 5.0 
equiv) and Ir(ppy)2(dtbbpy)PF6 (9.1 mg, 10.0 μmol) in dry DMSO (10.0 mL) afforded 
5.138 (0.34 g, 60%) as a white solid after purification by chromatography on SiO2 (1:1 
hexanes/EtOAc) (12 h reaction time). Rf (1:1 hexanes/EtOAc): 0.16; []25D   = −83.1 (c 
0.0081, CHCl3); IR (neat): 3393, 2978, 2930, 1710, 1645, 1547, 1483, 1406, 1378, 1359, 
1324, 1284, 1263, 1213, 1151, 1134, 1080, 1065, 1021, 926, 864, 750 cm
-1
; 
1
H NMR 
(500 MHz, CDCl3):  7.67 (m, 1 H), 7.38 (m, 3 H), 7.15 (m, 1 H), 6.63 (br. s., 1 H), 6.49 
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(s, 1 H), 6.29 (br. s., 1 H), 5.38 (d, J=12.2 Hz, 1 H), 5.10 (m, 1 H), 3.91 (t, J=7.8 Hz, 1 
H), 2.90 (m, 4 H), 2.79 (m, 1 H), 2.74 (s, 3 H), 2.48 (s, 3 H), 1.38 (s, 9 H); 
13
C NMR (126 
MHz):  194.7, 173.3, 152.7, 142.5, 136.4, 134.2, 132.4, 130.3, 128.4 , 127.7, 127.3, 
126.8, 125.2, 124.1, 122.4, 118.5, 112.5, 83.8, 80.9, 67.3,  63.5, 40.1, 39.0, 29.3, 28.1 , 
26.1; HRMS (ESI) m/z calculated for C32H36N4NaO6
+
 ([M+Na]
+
) 595.2533, found 
595.2537. 
 
 
(2R,3aS,8aS)-8-benzyl 1-tert-butyl 3a-(furan-2-yl)-2-(methylcarbamoyl)-3,3a-
dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate (5.139): According to 
General Procedure 5.2, bromopyrroloindoline 5.100 (0.53 g, 1.0 mmol), LiB(cat)2 (0.47 
g, 2.0 mmol), furan (0.36 μL, 5.0 mmol, 5.0 equiv) and Ir(ppy)2(dtbbpy)PF6 (9.1 mg, 
10.0 μmol) in dry DMSO (10.0 mL) afforded 5.139 (0.22 g, 42%) as a white solid after 
purification by chromatography on SiO2 (7:3, hexanes/acetone) (5 h reaction time). Rf 
(7:3, hexanes/acetone): 0.27; []25
D
  =  +9.6 (c 0.0065, CHCl3); IR (neat): 3309, 2980, 
1713, 1664, 1562, 1481, 1464, 1407, 1367, 1353, 1327, 1287, 1269, 1215, 1157, 1081, 
1052, 1028, 980, 910, 857, 750 cm
-1
; 
1
H NMR (500 MHz, CDCl3):  7.57 (d, J=6.6 Hz, 1 
H), 7.25 (m, 6 H), 7.06 (m, 1 H), 6.34 (s, 1 H), 6.13 (dd, J=3.3, 1.8 Hz, 1 H), 5.77 (d, 
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J=4.4 Hz, 1 H), 5.74 (d, J=3.2 Hz, 1 H), 5.36 (d, J=12.5 Hz, 1 H), 5.09 (d, J=12.5 Hz, 1 
H), 3.80 (dd, J=10.1, 6.7 Hz, 1 H), 2.77 (d, J=4.9 Hz, 3 H), 2.73 (m, 2 H), 1.32 (s, 7 H); 
13
C NMR (126 MHz, CDCl3):  172.1, 153.3, 152.8, 152.5, 142.6, 141.4, 135.9, 132.9, 
129.1, 128.3, 127.9, 127.5, 124.2, 123.6, 117.9, 110.0, 106.9, 80.9, 67.4, 61.2, 55.2, 36.9, 
28.0, 26.1; HRMS (ESI) m/z calculated for C29H31N3NaO6
+
 ([M+Na]
+
) 540.2111, found 
540.2109. 
 
(2R,3aS,8aS)-8-benzyl 1-tert-butyl 2-(methylcarbamoyl)-3a-(2-oxoethyl)-3,3a-
dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate (5.140): According to the 
General Procedure, bromopyrroloindoline 5.100 (0.53 g, 1.0 mmol), LiB(cat)2 (0.47 g, 
2.0 mmol), butyl vinyl ether (0.65 μL, 5.0 mmol, 5.0 equiv) and Ir(ppy)2(dtbbpy)PF6 (9.1 
mg, 10.0 μmol) in dry DMSO (10.0 mL) afforded 5.140 (0.35 g, 71%) as a white solid 
after purification by chromatography on SiO2 (7:3, hexanes/acetone) (12 h reaction time). 
Rf (7:3, hexanes/acetone): 0.17; []25D   = +33.9 (c 0.0073, CHCl3); IR (neat): 3347, 2980, 
2930, 1716, 1559, 1481, 1464, 1409, 1355, 1330, 1269, 1213, 1154, 1035, 912, 752 cm
-1
; 
1
H NMR (500 MHz, CDCl3):  9.60 (s, 1 H), 7.62 (m, 1 H), 7.45 (m, 2 H), 7.37 (m, 4 H), 
7.27 (m, 4 H), 7.09 (t, J=7.5 Hz, 1 H), 6.18 (s, 1 H), 5.77 (br. s., 2 H), 5.41 (d, J=12.2 Hz, 
1 H), 5.23 (d, J=12.0 Hz, 1 H), 3.81 (dd, J=9.7, 7.0 Hz, 1 H), 2.84 (m, 6 H), 2.32 (dd, 
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J=13.0, 10.0 Hz, 1 H), 1.38 (s, 9 H); 
13
C NMR (126 MHz, CDCl3): 198.7, 172.4, 153.2, 
152.6, 140.6, 135.6, 133.9, 128.8, 128.0, 127.9 127.7, 124.0, 123.6, 117.3, 80.9, 80.7, 
67.5, 60.9, 51.9, 49.4, 37.3, 27.8, 25.9; HRMS (ESI) m/z calculated for C27H31N3NaO6
+
 
([M+Na]
+
) 516.2111, found 516.2.108. 
 
5.10 Selected NMR Spectra 
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